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Introduction
Total hip arthroplasty (THA) has proven to be a highly successful procedure 
in terms of improving quality of life and cost-effectiveness in older patients1,2. With 
this success, an extension of indications for total hip arthroplasty was noted and the 
number of primary hip arthroplasties in Europe has risen to more than 600.000 
anually3.  Many different types of hip prostheses are currently available. Historically, 
hip prostheses are categorised according to their fixation: with or without bone 
cement. 
 
The development of the modern cemented hip prosthesis (Fig. 1) started in the 
1960s with the low friction arthroplasty designed by Sir John Charnley4. The design 
was eventually based on the use of a metal stem with a fixed 22 mm head, which 
articulates with a polyethylene cup. 
 This concept was a breakthrough in the development of the modern total hip 
prosthesis. Sir John Charnley introduced the use of polymethylmethacrylate bone 
cement to fill the gaps between the implant and bone, hence creating a stable situation 
for the metal stem and the polyethylene cup. He had such acceptable results that 
even today, the long-term data of the survival of the original Charnley prostheses 
with the polyethylene cup are part of the gold standard of THA. However, the 
Fig. 1A 
Example of a cemented 
total hip arthroplasty 
with polyethylene cup 
and polished stem.   
Fig. 1B
Radiographic  
appearance.
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long-term outcomes in younger patients were initially less favourable. Subsequently, 
technical improvements like a better cementing technique and improvements in 
implant materials were introduced to try to overcome loosening and improve long-
term survival. Unfortunately, implant loosening was still seen, especially in younger 
patients. Loss of implant fixation is mainly caused by aseptic loosening, a multi-
factorial process. During hip movement, friction of the metal head against the 
polyethylene cup results in small particles that accumulate in the joint cavity. These 
particles trigger the immune system by means of phagocytosis and activate cell 
types such as macrophages, fibroblasts, osteoblasts and osteoclasts5,6.  The inability 
to degrade these particles leads to a rise in the release of numerous cytokines and 
mediators that stimulate osteoclast formation and activity, leading to periprosthetic 
osteolysis7. 
This immune response that results in bone resorption around the components 
causes loosening, which has been described as “particle disease” and related osteolysis 
by Harris8.
Since initially these wear-related problems were considered to be related to 
the use of cement, the concept of uncemented total hip designs (Fig. 2) gained 
popularity. These designs were developed specially for younger patients suffering 
from hip osteoarthritis. Initial fixation is achieved by press-fit placement of 
components. 
Fig. 2A 
Cementless total hip arthro-
plasty with screw cup and 
titanium stem.   
Fig. 2B
Radiographic appearance.
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Depending on the design of the implant, additional screws, pegs or fins at the 
rim of the acetabular component can help to maintain implant position before bone 
ingrowth and long-term fixation are achieved. In contrast to cemented implants, 
many of these uncemented implants are made of titanium with a roughened surface 
or a coating of hydroxyapatite to enhance bony ingrowth and improve fixation. 
Unfortunately, osteolysis was also observed around these cementless components. It 
was then realized that this phenomenon was not related to the bone cement itself, 
but to the generation of wear particles, mainly made from polyethylene (PE). 
To decrease wear-related problems caused by these polyethylene particles, 
stronger types of polyethylene were developed. Highly cross-linked polyethylene 
and Vitamin E addition were introduced, but if these new materials will solve the 
problem remains uncertain, as a long follow-up is needed to determine survival. 
A different strategy for solving the wear problem was the development of new 
bearings, like ceramic on ceramic and metal on metal. In addition, surgeons and 
producers realized that these new hard bearings could be very attractive for young 
patients. Not only because of lower wear rates but also because they would enable 
the use of larger diameter articulations to decrease the rate of dislocation. Based on 
these technical innovations, the resurfacing hip (Fig. 3) was introduced in young 
patients, based on a large metal head and a cup with a large inner diameter. The 
resurfacing hip prosthesis was a concept that had previously been used but had 
been abandoned at the end of the 1970s due to high failure rates. However, with 
the growing demands of young patients and facilitated by the potential advantage 
of low wear and new materials, the resurfacing hip prosthesis was introduced again. 
Part of the new introduction strategy was that the new resurfacing hip designs 
Fig. 3A 
“Resurfacing” hip 
prosthesis with large 
diameter head.   
Fig. 3B
Radiographic  
appearance.
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were considered to better preserve bone on the femoral side than traditional hip 
designs and it was suggested that these implants are relatively easy to revise in case 
of loosening. The possibility of using large-diameter heads was expected to result in 
a better range of motion and a lower risk of dislocation. These potential advantages 
were used in the promotion of these implants in the orthopaedic practice and 
initially, younger patients were stimulated to take part in high level sports. This 
advice was adapted when it became known that survival of hip resurfacing had been 
compromised by high level of sports9. Further research showed that the range of 
motion of a resurfaced and a conventional total hip were not significantly different10, 
but larger-diameter heads were indeed associated with a lower risk of dislocation11,12. 
Recent literature shows high failure rates of resurfacing prostheses13 and 
national registries have confirmed these higher revision rates14. This led in 2010 
to withdrawal of one type of resurfacing hip prosthesis. However, the high mid-
term failure rates were not limited exclusively to this implant and a high number of 
serious side effects were seen in several designs. The local metal ion debris, which is 
generated by these implants can cause severe local problems with a high incidence 
of so-called pseudotumors15,16. In addition to local effects, these metal ions have 
shown to disseminate to other parts of the body by spreading to the lymph nodes, 
spleen, liver, and kidneys before being excreted in urine17. General side effects have 
been described in relation to high levels of chromium and/or cobalt; for example, 
cardiomyopathy18, risk of chromosomal aberrations19 and risk of carcinogenesis20 
as well as neurological  and endocrinological symptoms18,21. The Medicines and 
Healthcare Products Regulatory Agency (MHRA), responsible for regulating all 
medicines and medical devices in the United Kingdom, released a Medical Device 
Alert stating that patients with metal on metal hip implants should be reviewed and 
monitored on a regular base22. The Dutch Orthopaedic Association has endorsed this 
warning by the MHRA and has formulated a guideline on this subject23. The latest 
alert states that large diameter head (36 mm or more) metal on metal prostheses 
should not be implanted until further long-term results guarantee their safety.
Survival of THA in young patients has shown to be worse compared to 
survival in older patients24,25. An explanation might be that young patients put 
higher demands on their prosthesis25. Younger age by itself should be interpreted 
cautiously because activity levels may differ between patients26. Pre-existing bone 
loss may also affect the outcome, as many younger patients already had bone stock 
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problems at surgery. In normal hips, primary osteoarthritis is mostly seen in patients 
over 60 years. 
Both cemented and uncemented stems have performed well in young patients 
showing survival rates of more than 90% at 10 years27-29. A study on THA in 
patients younger than 55 years of age in Finland suggested that uncemented stems 
show a higher survival rate than cemented stems27 although this conclusion has been 
questioned30. In general, we can conclude that survival of the femoral component is 
acceptable and that failure of the stem is not the main reason for revision of THA 
in young patients.
Most problems with fixation are seen at the acetabular side and high failure 
rates have been reported in several series of young patients24,27,31. Clearly, the 
shift towards the use of uncemented cups in young patients has not solved the 
problem. Since cemented cups still show higher survival rates in younger patients 
compared to uncemented cups, there is limited evidence for the current trend 
of using uncemented cups in young patients32. Polyethylene wear and osteolysis 
compromise the success rate of uncemented cups27,33-36. Eskelinen et al. concluded 
from a nationwide study on THA in patients younger than 55 years that survival 
rates of uncemented cups are unsatisfactorily low when liner exchanges are taken 
into account27. Evaluating modern hip designs, only the Harris Galante II cup 
showed a 10-year survival rate of more than 80%, with revision of the cup for any 
reason as endpoint. A recent report from the Swedish Hip Register showed that 
after stratification into age groups, the long-term component survival with revision 
for any reason was lower after uncemented THA in all but the oldest age group37. A 
separate analysis of the cup revealed that uncemented cups had a significantly higher 
risk of cup revision due to aseptic loosening than cemented cups. This difference 
persisted even after exclusion of those revisions in which only liner exchange had 
been performed. Remarkably, the 2010 report of the Swedish Hip Registry stated 
that a reduced risk of cup revision was found for uncemented cups in patients up 
to 69 years38. This clearly demonstrates that the most durable option for acetabular 
fixation in young patients is still a topic of debate. 
The term “young patient” needs to be clarified as this term is used by numerous 
authors in different ways. The term “young patient” can mean active patients under 
65 years39 or it was used for patients with a mean age of 25 years40. In the first 
age group, most patients will suffer from primary osteoarthritis since in the latter, 
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practically all patients will suffer from an underlying disease. This also applies to the 
series of patients presented in this thesis and therefore, we would like to emphasize 
that these are different groups of patients and that results should be compared 
cautiously.    
Several other factors influence the outcome of THA in young patients. In 
addition to primary osteoarthritis, young patients often suffer from an underlying 
disease like rheumatoid arthritis, Perthes disease, osteonecrosis or developmental 
dysplasia of the hip (DDH) that cause degenerative hip disease or secondary 
osteoarthritis. Because of these underlying diseases, hip anatomy may be altered and 
the accompanying bone stock deficiencies could make it difficult to achieve stability 
with a standard implant. Patients with DDH often show a deficient acetabular 
superolateral rim, whereas protrusio acetabuli is more often seen in rheumatoid 
patients. These variations in anatomy require a patient-matched solution which 
might compromise the survival of the reconstruction. 
Depending on the type of acetabular defect, several techniques and implants 
can be used for reconstruction. A useful classification for acetabular defects has been 
made by the American Academy of Orthopaedic Surgeons (AAOS), committee on 
the hip41 (Table 2). 
Table 2: 
Classification of acetabular deficiencies (AAOS)
Type I Segmental deficiencies - Peripheral 
- Central (medial wall absent)
Type II Cavitary deficiencies - Peripheral
- Central (medial wall intact)
Type III Combined segmental/cavitary defects
Type IV Pelvic discontinuity
Type V Arthrodesis
A segmental defect (Type I) is a loss of cortical bone in the supporting 
hemisphere or a segmental defect of the medial wall. However, there should be no 
volumetric bone stock loss. In most cases with this type of defect, a superior rim 
defect is seen as in patients with DDH (Fig.4 A).
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1 Fig. 4A Radiograph of a 55-year old 
woman with DDH showing a 
high hip centre and a segmental 
defect, Type 1.   
Fig. 4B
Postoperative radiograph showing 
reconstruction of the acetabular 
defect using a solid graft with 
screws and a standard cemented 
cup in combination with a cemen-
ted stem after femoral shortening 
osteotomy. 
Several authors advocate the restoration of the centre of hip rotation42-45. If 
reconstruction with a standard cup is considered in a dysplastic hip, reconstruction 
of  the superolateral rim is mandatory. A frequently reported option is the use 
of solid grafts with a cemented cup as described by Wolfgang46 and modified by 
Lida et al47. Using this technique, the centre of rotation is restored and a standard 
acetabular implant can be used (Figure 4B). Comparison of grafting (32 cases) 
versus nongrafting (48 cases) of severe acetabular defects in a series of 64 patients 
showed higher survival rates for the grafted cases48. 
Impaction bone grafting with reconstruction of the rim using a mesh is a 
technique which was introduced and described by Slooff in 198449. Survival of 84% 
at 15 years was reported in a series of 28 acetabular reconstructions in patients with 
DDH50. Other surgeons prefer to use a reinforcement ring to achieve stability and 
good results have been reported51-54. Based on the reported radiographic signs of 
loosening, long-term survival might be a problem in the future53,54. 
Medial wall defects are rarely seen in isolation but protrusion acetabuli can 
result in this isolated defect. It can be dealt with in several ways and probably the 
easiest way is to use an uncemented cup, especially those designs that are based on 
the principle of side-ingrowth. A disadvantage is that the deficient bone stock is 
not restored, which can make future revisions complicated. Bone grafting is a more 
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biological approach; both structural grafting55 and impaction grafting techniques49 
have proven to be successful, including in patients with acetabular protrusion 
because of rheumatoid arthritis56. Restoration of the original hip centre of rotation 
is also advocated in patients with acetabular protrusion57,58.  
A cavitary defect (Type II) consists of a volumetric bone loss of the acetabular 
cavity while the rim and medial wall remain intact. This is a frequently encountered 
condition, both in primary and revision hip surgery. 
Filling the acetabular cavitary defect with bone cement should be reserved for 
elderly patients, as high failure rates have been reported for using only cement59,60 
and the use of additional bone grafts has been recommended.
Techniques using bone grafts to reinforce the medial wall have been 
described55,61,62 with good results after a mean follow-up of 4 (range 3-9) years63 for 
cemented as well as uncemented cups. Unfortunately, reports of this technique with 
longer follow-up are lacking. Impaction bone grafting as described above49 offers 
another durable solution.
Most acetabular defects are combined segmental/cavitary defects (type III). 
Treatment is based on one of the techniques described above or a combination of 
them.
In case of pelvic discontinuity (type IV), a rare condition, there is total 
separation of the superior and inferior part of the acetabulum. As described in 
a review on the treatment of pelvic discontinuity64, the main issues are healing 
the discontinuity and restoration of bone stock. Depending on the potential for 
healing, treatment should consist of plating the posterior column in combination 
with structural grafts or trabecular metal/cages. Custom-made implants can also 
be used, with or without additional allografts. Clear guidelines on the best type 
of implant or allograft are lacking because large series of patients treated for this 
condition are not available.
Treatment of patients with hip osteoarthritis and the related costs are a financial 
burden for society2,65 and if possible, length of hospital stay and costs should be 
minimised66. In addition to the fact that long-term survival is of great importance 
for the individual patient, the financial impact for society could be limited if only 
implants with a known long-term survival are used. A recent study on data of the 
National Joint Registry shows that a possible cost saving to the NHS of more than 
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£18 million per year can be made if cemented instead of uncemented hip designs 
were to be used in England and Wales67. As revision surgery of the hip is expensive 
compared to primary THA68, we should choose our primary implants based on the 
available evidence. Currently, choices of implants are mainly based on the preferences 
of the surgeon or the tradition of an institute. Better insight in associated costs of 
implants and revision surgery will result in better use of financial resources.
Questions addressed in this thesis are:
1. How many hip arthroplasties are performed in young patients in the 
 Netherlands and what types of hip prosthesis are most commonly used?
2. What is the outcome of cemented THA in very young patients under 30 years?
3. What are the radiographic and clinical results of acetabular impaction 
 bone grafting in patients younger than 50 years at long-term follow-up?
4. What is the outcome of acetabular solid grafting in DDH-patients?
5. What are the radiographic and clinical results of uncemented THA in 
 patients younger than 50 years? 
6. Are the hip implant-choices for young patients in The Netherlands 
 evidence-based?
7. What is the most long term cost-effective treatment of a young patient 
 in need for a THA? 
Outline of this thesis
This thesis focuses on the clinical outcome of THA in young patients and 
how to deal with acetabular defects. Question 1 is addressed in Chapter 2 which 
describes the distribution of hip implants in young patients in the Netherlands. 
Chapter 3 describes the clinical outcome of cemented THA in patients 
younger than 30 years at the time of surgery (question 2). Question 3 is addressed 
in Chapter 4, which discusses the results of a series of young patients with an 
acetabular defect reconstructed with impaction bone grafting. Chapter 5 shows the 
outcome of the same group of patients with a longer follow-up. 
Chapter 6 shows the outcome of solid grafting of the affected acetabulum in 
DDH-patients (question 4). The long-term outcome of the uncemented Zweymüller 
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hip prosthesis in patients younger than 50 years is discussed in Chapter 7 (question 
5). 
Whether current choices for hip implants for young patients in the Netherlands 
are evidence-based (question 6) is discussed in Chapter 8.
Finally, the most cost-effective solution for a young patient in need for a THA 
was determined using a Markov-model; the results are presented in Chapter 9 
(question 7).
Chapter 10 consists of the general discussion and summary of the studies 
presented in this thesis and the conclusion. Chapter 11 is the Dutch summary of 
this thesis.
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Hip implants in young patients in the Netherlands  
The Dutch Arthroplasty Register (in Dutch: Landelijke Registratie 
Orthopedische Implantaten, LROI) started in 2007 and contains the registration of 
all primary and revision hip and knee replacements performed in the Netherlands. 
The start of this national database was supported by Dutch healthcare insurance 
companies and gives transparency on the performance of implanted prostheses. 
All registered implants can be traced, which can be useful in case of any implant-
related problems or recalls. Furthermore, it enables nationwide population-based 
monitoring of Dutch patients and therefore examining the preferences of Dutch 
orthopaedic surgeons. 
The number of THAs performed in 1980 was 6,750. This number has risen 
to 16,000 in 1994 and to more than 23,000 in 2012. In the years 2009 - 2012, the 
number of THAs in the Netherlands has risen the past years as shown in Table 1. 
Data are presented starting in 2009, since in 2007 and 2008 not all THAs performed 
in the Netherlands were reported to the LROI.
Table 1:
Demographic characteristics of patients who underwent THA in 2009-2012. Source LROI: 
LROI-rapportage 2012; 2013. Nederlandse Orthopaedische Vereniging, ’s-Hertogenbosch.
2009 2010 2011 2012
Number of THA 21,001 22,893 23,441 23,815
Male (%) 33 33 33 33
Female 67 67 67 67
< 50 yrs (%) 5 5 5 5
 
At the moment, numerous hip designs are available, as described in the 
previous chapter. Historically, the main classification was based on type of fixation: 
with or without cement. The term ‘hybrid construction’ refers to the combination 
of cemented and uncemented components. The restrictive term ‘hybrid’ is reserved 
for an uncemented cup with a cemented stem while a cemented cup with an 
uncemented stem is called a ‘reversed hybrid’. As currently resurfacing hip designs 
are used only in a selected group of patients, data are not presented in this chapter. 
The distribution of the different types of hip designs for patients of all ages used 
in the Netherlands in 2012 is shown in Figure 1. Uncemented implants account 
for more than 62% of all registered primary THAs in patients of all ages. Type of 
fixation was not reported of 83 THAs.
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Figure 2 shows the method of fixation distributed per age group. In patients 
older than 85 at the time of their surgery, 38% were uncemented THAs. In patients 
younger than 50 years, uncemented implants were used in more than 78% of cases. 
 
A standard definition of a “young patient” is lacking in literature and the term 
has been used for different age groups of patients, as explained in Chapter 1. This is 
illustrated by observing the indications for THA in the different age groups. Figures 
3a-c show the primary diagnosis of patients receiving a THA in 2012. In patients of 
all ages (Fig. 3a), more than 87% received a THA because of primary osteoarthritis. 
A diagnosis as dysplasia for example counted only for 1.9%. 
In patients younger than 50 years at the time of surgery, primary osteoarthritis 
counted for 62.2% of cases (Fig. 3b). Dysplasia counted for 12.9% of cases.
In patients younger than 30 years at the time of their THA, only 26.9% had 
primary osteoarthritis as the diagnosis; almost 18% had dysplasia of the hip (Fig 3c). 
Secondary osteoarthritis accounted for 73.1% of 78 registered THAs.
Fig. 1 
Fixation method of total registered number 
of 24.595 primary THAs in patients of all 
ages in the Netherlands in 2012. Source 
data LROI - graphics LROI-Dashboard in 
ProMISe accessed December 2013. Note: 
The difference in the number of reported 
THAs between Table 1 and Figure 1 can be 
explained by the time of data collection. 
Fig. 2 
Method of fixation per age group in the 
Netherlands in 2012. Source data LROI 
- graphics LROI-Dashboard in ProMISe 
accessed December 2013
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Fig. 3A
Diagnosis of total registered 
number (n=24,595) of  
patients (all ages) 
for primary THA in the 
Netherlands in 2012. Source 
data LROI - graphics LROI-
Dashboard in ProMISe  
accessed December 2013
Fig. 3B 
Diagnosis of patients younger 
than 50 years at the time of 
their primary THA in 2012. 
Source data LROI - graphics 
LROI-Dashboard in ProMISe 
accessed December 2013
 
Fig. 3C 
Diagnosis of patients younger 
than 30 years at the time of 
their primary THA in 2012. 
Source data LROI; graphics 
LROI-Dashboard in ProMISe 
accessed December 2013 
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LROI data are registered in an internet-based datamanagement system 
called ProMISe (Project Manager Internet Server) from the section Advanced 
Datamanagement at the Leiden University Medical Centre (LUMC). ProMISe 
is an internet based application for the design, maintenance and use of clinical 
data management projects. Aggregated or anonymous data are available for study 
objectives according to the regulations of the LROI, after approval of the scientific 
committee of the LROI. Here, access to summary data on primary hip implants was 
obtained according to the above mentioned regulations. Several case mix variables of 
patients were available, such as gender, age, diagnosis and ASA score. BMI, smoking 
and Charnley Score were added to these variables in June 2013. The implant 
variables available are fixation method (uncemented, hybrid or cemented) and type 
of prosthesis (total, resurfacing or hemi-prosthesis). 
Countries like Sweden and Australia have registered implants for many years, 
which has shown to be of great benefit in tracking implant behaviour and detecting 
early failures. Since the start of the Dutch Arthroplasty Register in 2007, coverage of 
registration has improved to 94% of all hip and knee replacements in 2012. 
Besides the earlier mentioned case mix variables, Patient Reported Outcome 
Measures (PROM’s) were added to the registration in 2013. This will give us better 
insight into the performance of different types of prostheses and hospitals, as well as 
how patients experience their hip or knee replacement. Registration of other joint 
replacements of shoulder, elbow, wrist and ankle will start in 2014.

Chapter 3
Cemented total hip arthroplasty  
in very young patients 
Cemented hip designs are a reasonable 
option in young patients 
Busch VJ 
Klarenbeek R 
Slooff T 
Schreurs BW 
Gardeniers J 
Clinical Orthopedics and  Related Research.  2010 Dec; 468(12): 3214-20
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Abstract 
 
Background: Young patients with degenerative cartilage disease of the hip remain 
a challenge for the orthopaedic surgeon. Different treatment options are available 
of which uncemented hips are the most popular owing to long-term concerns 
about cemented implants. As an alternative, we have used a cemented hip design 
in combination with bone impaction grafting in patients with acetabular defects. 
Questions/purposes: We therefore determined the survival rates and radiological 
failures of cemented THA in patients younger than 30 years and reported clinical 
scores, complications and current state of the revised THAs. 
Methods: We retrospectively reviewed all 48 patients (69 hips) younger than 30 years 
at the time of surgery who had a primary cemented THA performed between 1988 
and 2004. Acetabular defects were reconstructed using bone impaction grafting in 
29 hips. Mean age at surgery was 24.6 years (range, 16–29 years). Revisions were 
documented, radiographs were analyzed, and the Kaplan-Meier method was used 
to determine survival for different end points. No patient was lost to followup, three 
patients (four hips) had died. Minimum followup was 2 years (mean, 8.4 years; 
range, 2–18 years). 
Results: Eight hips were revised (three for infection and five for aseptic loosening) 
and one hip dislocated for which open reduction was necessary. One additional 
cup was considered a radiographic failure. The 10-year survival was 83% (95% 
confidence interval, 69%–92%) with revision for any reason as the end point and 
90% (95% confidence interval, 77%–96%) with revision for aseptic loosening. 
Conclusions: We found a high survival rate of these cemented THAs in young patients. 
In young patients with acetabular bone defects we recommend reconstruction using 
cemented implants with bone impaction grafting.
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Introduction 
THA restores hip function, relieves pain, is cost-effective, and associated with 
high survival rates10, 24. Given this experience indications for THA have now been 
extended to younger ages including patients younger than 30 years 2– 4, 9, 12, 16, 17, 19, 20, 
23, 28–30, 32. However, most patients under the age of 30 years with osteoarthritis have 
some underlying disorder, such as developmental dysplasia of the hip, Legg-Calve´-
Perthes disease, or juvenile rheumatoid arthritis. Bone stock deficiencies and bone 
deformations often are present and can be an additional problem in achieving a 
stable and durable reconstruction. 
Several options are available to deal with acetabular defects in young 
patients. The most commonly used is likely an uncemented cup and if necessary 
a reinforcement ring, placed with or without bone grafts. Reported survival rates 
(with revision as an endpoint) on uncemented hips in patients younger than 30 
years with a minimal followup of 10 years vary from 49%31 to 90%23. We have 
preferred a cemented THA in our young patients and to reconstruct any acetabular 
defects with bone impaction grafting25 in combination with a cemented cup. 
The purpose of our study was to (1) determine survival of cemented prostheses in 
patients younger than 30 years and whether differences exist between hips placed 
with and without acetabular bone impaction grafting; (2) determine the clinical 
outcome of the surviving hips; (3) define radiographic failures; and (4) determine 
complications and current state of revisions. 
Patients and Methods 
We retrospectively reviewed all 48 patients (69 hips) younger than 30 years 
of age who had primary cemented THAs for primary or secondary osteoarthrosis 
between April 1988 and May 2004. Indications for THA were mainly osteonecrosis 
of the femoral head and juvenile rheumatoid arthritis (Table 1). Nineteen hips had 
previous surgeries at the hip. We excluded patients who had reconstruction for 
tumors. There were 32 female (46 hips) and 16 male patients (23 hips) with a mean 
age at operation of 24.6 years (range, 16.0–29.0 years). Twenty-one bilateral THAs 
were performed, and in two of these patients, the procedure was completed in a 
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single surgery. Three patients (four hips) died 1.4, 8.6 and 9.1 years after operation 
but they were evaluated at the outpatient clinic on a regular basis until their deaths 
and the data were included in the analyses. One patient with Crohn’s disease died of 
sepsis after colorectal surgery and another patient died because of aplastic anemia. 
The cause of death of a patient with juvenile rheumatoid arthritis was not known. 
The minimum followup was 2 years (mean, 8.4 years; range 2–18 years). No patient 
was lost to followup. 
Table 1:
Indications for THA
Indication Number of hips
Juvenile rheumatoid arthritis 18
Osteonecrosis of femoral head 21
Systemic lupus erythematosus 7
Acute lymphatic leukemia 3
Crohn’s disease 3
Nephropathy, kidney transplantation 2
Hypothalamic disorder 1
Aplastic anemia 1
Wegener’s disease 1
Unknown origin 3
Developmental dysplasia of the hip 7
Multiple epiphyseal dysplasia 2
Legg-Calve´-Perthes disease 6
Ankylosing spondylitis 5
Morquio’s disease 2
Ankylosis of unknown origin 2
Polycystic disease of the femoral head of unknown origin 2
Arthritis and osteomyelitis 2
Posttraumatic osteoarthritis 1
Psoriatic arthritis 1
A posterolateral approach was used in all hips without a trochanteric osteotomy. 
Acetabular defects were classified according to system of the American Academy of 
Orthopaedic Surgeons (AAOS) Committee on the Hip6. A Type I defect was seen 
in five hips, a Type II defect in 16 hips, and a Type III defect in eight hips. A metal 
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mesh was used in 14 hips to reconstruct a segmental defect. The remaining cavitary 
defect was reconstructed with bone impaction grafting. This technique has been 
reported in detail25. Twenty-nine of the 69 hips had acetabular impaction grafting 
using femoral head autografts in 23 hips. Fresh-frozen, nonirradiated femoral head 
allografts were used in three hips with a Type III defect, using one or two femoral 
heads. In three hips, both autografts and an allograft femoral head were used. 
Second-generation cementing technique was applied in all hips. All patients received 
systemic prophylactic antibiotics (2 g cefazolin) immediately before surgery. 
Several types of femoral and acetabular components were used (Table 2). Sizes 
of femoral heads used were 22 mm (9 hips), 28 mm (49 hips) and 32 mm (11 hips). 
Before 1989, Palacos®  bone cement (Merck, Darmstadt, Germany) was used and 
Surgical Simplex® (Stryker) from 1989 on. 
Table 2:
Types of implant
Type of acetabular implant No. of hips Type of femoral implant No. of hips
Stryker ExeterTM 29 Stryker ExeterTM 45
Depuy EliteTM Plus LPW 26 Depuy EliteTM 13
Zimmer Müller®/Allopro® 14 M.E. Müller® straight 11
Postoperatively all patients had prophylactic anticoagulation therapy for 
6 weeks or 3 months after surgery. Indomethacin was administered for 7 days to 
prevent heterotopic ossification. After 24 hours, passive movements were allowed, 
followed by ambulation with partial weightbearing with two crutches. After 6 
weeks, full weightbearing was allowed. Patients with an acetabular bone graft had a 
slightly altered protocol, allowing touch weightbearing during the first 6 weeks and 
from 6 to 12 weeks partial weightbearing allowing 50% of body weight. Patients 
with extensive acetabular reconstructions initially had a 6-week period of bed rest.
Patients were assessed clinically and radiographically at 6 and 12 weeks, at 6 months, 
at 1 year, and annually or biannually thereafter. The Harris hip score (HHS)13 and 
the Oxford Hip Questionnaire Score (OHQS)7 were used for clinical evaluation. 
Based on preoperative radiographs and the surgical reports, acetabular defects were 
classified according to the system of the AAOS Committee on the Hip6.
Three of us (VB, RK, BWS) independently reviewed serial radiographs to 
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determine the structural quality of the bone graft, radiolucencies and osteolysis, 
prosthesis migration, socket tilting, and heterotopic ossification. Graft incorporation 
was defined as the manifestation of a regular radiodensity and trabecular bone 
structure throughout the graft and host bone with a continuous trabecular pattern 
according to Conn et al.5. Radiolucent lines more than 2 mm wide were described 
and were defined as stable or as progressive in time. Acetabular zones were identified 
using the criteria of DeLee and Charnley8 and a radiographic failure was defined 
as radiolucent lines in all three zones and/or migration of 5 mm or more in any 
direction on the AP-pelvic view relative to the interteardrop line. Radiolucent zones 
on the femoral side were evaluated using the method of Gruen et al.11. Loosening 
of the femoral component was defined using the criteria of Harris et al.14. Definite 
loosening of the stem was defined as the appearance of a radiolucent line in all 
Gruen zones that did not exist on the immediate postoperative radiographs, a crack 
in the cement or fracture of the stem. Femoral prosthetic subsidence was considered 
abnormal if it was more than 2 mm18. Heterotopic ossification was classified 
according to Brooker et al.1. Followup radiographs were complete for 68 of the 69 
hips; for one patient (one hip), a recent radiograph was not available due to her 
pregnancy at the time of review. 
Kaplan-Meier survivorship analysis 15 was performed for the whole group, as 
well as for hips with and without acetabular bone impaction grafting. End points 
used were revision of one or both components for any reason and revision for aseptic 
loosening and radiographic loosening. The log-rank test was used to compare 
survival of the bone impaction group and the non-bone impaction group.
Results 
Survivorship of the total group was 90% (95% CI, 77%– 96%) at 10 years 
with revision for aseptic loosening as the end point (Fig. 1) (Table 3). With revision 
for aseptic loosening as the end point, the primary cemented cups had a survivorship 
of 87% (95% CI, 68%–95%) and the bone impaction group 95% (95% CI, 72%–
99%) at 10 years (Fig. 2). No differences in survival between the primary cemented 
and the bone impaction group were found. Eight hips had been revised. Three hips 
were revised because of septic loosening at 5.7, 7.3, and 7.8 years after the index 
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Fig. 1 
A Kaplan-Meier curve 
shows 
survivorship for the 
total group with 
revision for aseptic 
loosening as the 
end point. Dotted 
lines indicate 95% 
confidence 
intervals.
Fig. 2 
A Kaplan-Meier curve 
shows 
survivorship for the 
bone impaction 
group (solid line) and 
the primary 
cemented group 
(dotted line) with 
revision for aseptic 
loosening as the end 
point. 
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operation. In five hips, only a revision of the cup was performed because of aseptic 
loosening after 2.3, 3.1, 4.1, 5.0 and 8.6 years. Two revised cases had impaction 
grafting of which one patient had primary diagnosis juvenile rheumatoid arthritis. 
No additional stem revisions were performed. 
Table 3: 
Survivorship for different categories of patients
Category of patients 10-year survivorship 
in % (95% CI) 
End point revision for 
aseptic loosening
End point revision for 
any reason
End point 
radiographic failure
Primary cemented hips 87 (68–95)% 80 (59–90)%   87 (67–95)%
Acetabular bone impaction grafting 95 (72–99)% 89 (62–97)% 95 (72–99)%
All patients 90 (77–96)% 83 (69–92)%. 89 (77–95)%
The mean HHS of the 57 surviving hips in 37 living patients was 89 (range, 
55–100) and the mean OHQS was 19 (range, 12–42) after a minimum followup of 
2 years (mean, 8.4 years; range, 2–18 years). One patient with juvenile arthritis had 
a HHS of 55 and an OHQS of 42 and was limited in walking distance, unable to 
climb stairs, and experienced moderate pain.
Progressive acetabular radiolucent lines were seen in six of the 61 surviving 
hips: in one zone in four hips and in two zones in two hips. Osteolysis was evident 
in three hips and limited to one zone in two cases; the third case involved two zones. 
Socket migration of more than 10 mm had occurred in one hip. Tilting of the 
acetabular component was seen in two patients, of which one was progressive the 
latest years of followup. Heterotopic ossification was seen in 14 of the 61 surviving 
hips and was classified as Grade II (11 hips) and Grade III (three hips). In THAs 
with bone impaction grafting, incorporation of the graft was seen in all hips (Fig. 
3). None of the femoral components migrated more than 2 mm. A radiolucent 
line with an osteolytic lesion was seen in one hip in Gruen Zone 7; none of the 
surviving femoral components had evidence of radiographic loosening. One cup 
was considered loose, but revision has not been performed yet because of absence 
of complaints. 
One patient (one hip) underwent an early reoperation due to suspicion of 
infection but recovery was complete after débridement and antibiotics. Two patients 
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Fig. 3A–C 
(A) A preoperative radio-
graph shows the hips of a 
29-year-old woman with bila-
teral secondary osteoarthritis 
due to Bechterew’s disease 
who had the longest followup 
in our series. 
(B) A postoperative 
radiograph shows the hips 
after bilateral reconstruction 
of the acetabulum with bone 
impaction grafting for 
a cavitary defect and  
a cemented prosthesis.
 
(C) A radiograph at 17 and 
18 years after the  
reconstruction shows  
incorporation of the bone 
graft and no signs of  
loosening except for an  
acetabular radiolucent line  
at the right hip in zone III. 
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had a traumatic dislocation of the prosthesis, and closed reduction was successful in 
one, but for the other operative repositioning was needed. In one patient exploration 
of the femoral nerve was performed because of neurological deficit. The proximal 
part of the nerve could not be detected and recovery was incomplete. All eight 
revisions were performed in our own institute and all patients were followed after 
their revision. In seven hips, acetabular reconstruction with bone impaction grafting 
at revision surgery was performed and a cemented cup was placed. In two of the 
three revisions of the stem, reconstruction of a femoral defect was necessary using 
femoral bone impaction grafting and a cemented ExeterTM stem was inserted. For 
the eight revised hips the mean postoperative HHS was 88 (range, 41–100) and the 
mean postoperative OHQS of 20 (range, 12–54) at a minimum followup of 1 year 
(average, 4.5 years; range, 1–10 years). 
Discussion 
Degenerative cartilage disease of the hip in very young patients is often 
secondary to an underlying disease. Several options are available to deal with 
acetabular defects in young patients. The most used is an uncemented cup and if 
necessary a reinforcement ring, placed with or without bone grafts. Since 1979 we 
have preferred to reconstruct very young patients with a cemented THA, and in 
case of bone deficiencies, bone impaction grafting in combination with a cemented 
prosthesis. The purpose of our study was to (1) determine survival of the prosthesis 
in patients younger than 30 years and whether differences exist between hips placed 
with and without acetabular bone impaction grafting; (2) determine the clinical 
outcome of the surviving hips; (3) define radiological failures; and (4) determine 
complications and current state of revisions. 
We draw the reader’s attention to several limitations. First is the use of multiple 
implant designs; however, all types were cemented. As a referral center, we have not 
referred cases to other hospitals and therefore we have included all diagnoses and 
acetabular bone defects during the time of the study except those who had an implant 
placed for tumors. Apart from the different implants there was no selection bias 
since we used the same treatment protocol in all patients, and in case of bone stock 
deficiencies, we reconstructed the defect with bone impaction grafting. Further, no 
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patients lost to followup, and we therefore believe our data are reliable22. Second, 
our study had a relatively large group (26%) of patients with juvenile rheumatoid 
arthritis. These patients are probably less active compared to the other patients with 
a localized osteoarthritis of the hip in our series3, 28. In the literature, not all studies 
have the same conclusion relative to the outcome of THAs in rheumatoid arthritis, 
and in some studies, the outcome of this subgroup has reportedly worse outcomes 
relative to other plain osteoarthritic cases4, 27. Third, criteria for graft incorporation 
are difficult to define but Conn et al.5 stated that graft incorporation was defined as 
the manifestation of a regular radiodensity and trabecular bone structure throughout 
the graft and host bone with a continuous trabecular pattern. In the present series, 
acetabular bone grafting had been performed in 29 out of 69 cases and incorporation 
of the grafts was seen in all cases on a consensus base by three of the authors. The 
criteria used are still in debate in our department and future research has to bring 
more detailed criteria.
Our standardized treatment protocol was associated with a 10-year survival rate 
of 90% (95% CI, 77%–96%). Especially in young patients, we need techniques and 
implants with a proven long-term survival20, and apart from a series of patients with 
exclusively juvenile chronic arthritis4, 16, 17, 19, 23, there is limited literature regarding the 
survivorship and complications of THA surgery in patients younger than 30 years2, 
3, 9, 12, 20, 28–30 (Table 4). For the acetabular side, Torchia et al.30 reported a revision 
rate for the cemented acetabular component of 43% at an average followup of 12.6 
years. Sochart and Porter29 reported an acetabular rate of revision for cemented cups 
of 30% at a mean followup of 20 years. Maric and Haynes19 described a group of 
17 hips, including four uncemented hips, and reported that 6% of the acetabular 
components were revised after an average followup of 9.3 years. We found a rate of 
revision of 11.6% for the acetabular component at a mean followup of 8.4 years.
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Table 4. 
Literature# of THA in patients 30 years or younger at the time of operation
Study No. hips No. patients Mean age in 
years (range)
Mean followup 
in years 
(range)
Survivorship/
revised hips 
for all reasons 
(% of total) 
Cemented 
Cage et al. [2] 22 17* 18.4 (15–21) 10.6 (8–15) 1 (4.5%) 
Chandler et al. [3] 33 29 28 (19–35) 5.6 (4.8–7) 7 (21%) 
Chmell et al. [4] 66 39 19.9 (11–29) 15.1 (11–22) 70% at 15 yrs 
(acetabular 
revision)
Halley and Charnley [12] 68 39 25.9 3.3 (0.5–8) NR** 
Sochart and Porter [29] 83 55 24.9 (17–29) 20 (5–30) 89% at 10 yrs; 
65% at 25 yrs 
Torchia et al. [30] 63 50 17 (11–19) 12.6 (1.6–18.6) 73% at 10 yrs; 
55% at 15 yrs 
Witt et al. [32] 96 54 16.7 (11–27) 11.5 (5–18) 24 (25%) 
Busch et al. [current study] 69 48 24.6 (16–29) 8.4 (2–18) 83% at 10 yrs 
Uncemented 
Kumar and Swann [17] 25 16 24.9 (15–39) 4.5 (1–19) 3 (12%) 
Odent et al. [23] 62 34 18.3 (12–31) 6 (3–13) 90.1% at 13 yrs 
Wangen et al. [31] 49 44 25 (15–30) 13 (10–16) 24 (49.0%) 
McCullough et al. [21] 42 25 21 (11–35) 11.2 (8–13) 71% at 13 yrs 
Combined techniques 
Kitsoulis et al. [16] 20 10 15.8 (13–24) 9.2 (2–20) 2 (10%) 
Maric and Haynes [19] 17 17 18 (14–20) 9.3 (4.5–17) 2 (12%) 
Dudkiewicz et al. [9] 69 56 23.2 (14–29) 7.4 (2–23) 14 (20%) 
Abbreviations: # Literature reported until July 2009. 
  *  mixed group of patients with total hip and total knee prosthesis. 
  ** not reported.
We believe our protocol with bone impaction grafting is a biologically attractive 
approach, resulting in restoration of bone stock in these young patients. This can 
be a great advantage for future revisions, as can be expected in these young patients. 
We included in our data all patients who underwent revision and found reasonable 
functional scores except in one case. This study reflects our large experience with this 
technique26 over a period of 16 years. Of the 130 total hip arthroplasties we perform 
every year, we have annually treated fewer than five patients younger than 30 years 
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and only after intensive discussion and patient consent. Keeping in mind the high 
failure rates associated with increased demands within this cohort2–4, 9, 12, 19, 29, 30 we 
think a cautious approach of these young patients is important.
Our results of cemented THA in patients younger than 30 years show a 10-
year survival rate of 90% with end point revision for aseptic loosening. Loosening 
was mainly seen on the acetabular side and in case of an acetabular defect we 
recommend biological reconstruction using bone impaction grafting. 
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Abstract
Background: Acetabular bone deficiency can present a challenge during total hip 
arthroplasty, especially in young patients. 
Questions/purposes: The purpose of the present study was to evaluate the long-
term clinical and radiographic outcomes of primary and revision acetabular 
reconstruction with use of an impaction bone-grafting technique and a cemented 
polyethylene cup in young patients who had preexisting acetabular bone deficiency. 
Methods: Forty-two consecutive acetabular reconstructions were performed 
in thirty-seven patients who were younger than fifty years old (average, 37.2 
years old). The impaction bone-grafting technique was used for twenty-
three primary and nineteen revision acetabular reconstructions. Twenty-eight 
patients (thirty-one hips) were available for review after a minimum duration 
of follow-up of fifteen years. Clinical and radiographic results were assessed, 
and survivorship analysis was performed with the Kaplan-Meier method. 
 
Results: Eight hips were revised at a mean of twelve years (range, three to twenty-one 
years) after a primary recon-struction (four hips) or revision reconstruction (four 
hips). The revision was performed because of aseptic loosening of the acetabular 
component in four hips and because of culture-proven septic loosening in two. 
Two additional cups (both in hips that had had a revision reconstruction) were 
revised, during revision of the femoral stem, because of wear (one hip) or because 
of persistent intraoperative instability (one hip). Twenty-eight hips (in twenty-five 
patients) had retention of the acetabular component for a minimum of fifteen 
years. The mean Harris hip score for that group was 89 points. Twenty-six of these 
twenty-eight hips had no or slight pain. Kaplan-Meier analysis revealed a twenty-
year survival rate of 80% (95% confidence interval, 67% to 94%) with acetabular 
revision for any reason as the end point and of 91% (95% confidence interval, 80% 
to 100%) with acetabular revision because of aseptic loosening as the end point. 
Conclusions: Acetabular reconstruction with use of impaction bone-grafting and a 
cemented polyethylene cup is a reliable and durable technique that is associated 
with good long-term results in young patients with acetabular bone-stock defects. 
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Background
Despite improvements in cementing techniques, the reported rates of failure of 
cemented acetabular components in young patients are still high1-4. Since 1979, we 
have used impacted morselized cancellous bone graft and a cemented polyethylene 
cup to reconstruct the acetabulum during both primary and revision procedures 
in patients who have a loss of acetabular bone stock5. The goal of restoring lost 
bone is especially attractive when managing younger patients6. In 2001, we reported 
the results of forty-two acetabular reconstructions that had been performed with 
impaction bone-grafting in this same cohort of patients who, at that point, had 
been followed for ten to eighteen years7. The current study extends that follow-up 
to fifteen to twenty-three years after surgery. 
Materials and Methods 
Between July 1979 and December 1987, we performed an average of 220 
primary total hip arthroplasties per year. For all primary arthroplasties in patients 
without loss of acetabular bone stock, our practice is to use cemented components and 
not to use bone graft. During this time-period, we performed forty-two consecutive 
acetabular reconstructions with use of an impaction bone-grafting technique and a 
cemented polyethylene cup in thirty-seven patients with deficient acetabular bone 
stock who were younger than fifty years old. This was the only technique used in 
our department to treat acetabular bone stock loss. We reviewed all reconstructions 
(twenty-three of which had been performed during primary total hip arthroplasty 
and nineteen of which had been performed during revision total hip arthroplasty) 
after a minimum duration of follow-up of fifteen years after surgery. Six different 
surgeons, including two of the authors (T.J.J.H.S. and J.W.M.G.), performed the 
reconstructions. The study group included fifteen men and twenty-two women who 
had an average age of thirty-seven years and two months (range, twenty to forty-
nine years) at the time of the operation. One patient (one hip) was lost to follow-up, 
and four patients (five hips) died before the final review. 
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Indications 
Primary Acetabular Reconstructions 
Twenty-three primary acetabular reconstructions were performed in nineteen 
patients who had a loss of acetabular bone stock. The diagnosis was primary 
osteoarthritis in two hips, rheumatoid arthritis in eleven, and secondary osteoarthritis 
in ten. The causes of secondary osteoarthritis included congenital dislocation (three 
hips), avascular necrosis of the femoral head (two), tuberculous arthritis (two), 
posttraumatic arthritis (two), and ankylosing spondylitis (one). 
Revision Acetabular Reconstructions 
The indication for all nineteen acetabular revisions (in eighteen patients) was aseptic 
loosening. Thirteen revisions were performed at the site of a previous total hip 
arthroplasty, and six were performed at the site of a previous resurfacing arthroplasty. 
The diagnosis at the time of the primary procedure had been osteonecrosis of the 
femoral head (five hips), epiphysiolysis (four), congenital dislocation of the hip 
(two), rheumatoid arthritis (three), ankylosing spondylitis (two), protrusio acetabuli 
(one), tuberculous arthritis (one), and a bleeding disorder due to hemophilia (one). 
 
Classification of Acetabular Defects 
With use of the preoperative and immediate postoperative anteroposterior 
pelvic radiographs and the operative reports, the acetabular defects were classified 
on a consensus basis by three of the authors (B.W.S., T.J.J.H.S., and V.J.J.F.B.) 
according to the system of the American Academy of Orthopaedic Surgeons 
Committee on the Hip8. A segmental (type-I) defect was seen in one hip that was 
undergoing a primary procedure, a cavitary (type-II) defect was seen in twenty-seven 
hips (including sixteen that were undergoing a primary procedure and eleven that 
were undergoing a revision), and a combined (type-III) defect was seen in fourteen 
hips (including six that were undergoing a primary procedure and eight that were 
undergoing a revision). 
Surgical Technique 
The posterolateral approach without trochanteric osteotomy was used in all cases. 
For all reconstructions, the grafts were morselized with a rongeur and cancellous 
bone chips with a diameter of 0.7 to 1.0 cm were created. This technique has been 
described in detail7,9. 
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Primary Acetabular Reconstructions 
After resection of the femoral head, the acetabulum was reamed and all cartilage was 
removed. Our goal was to create a bleeding trabecular bone bed, and any segmental 
wall defects were closed. The femoral head was the source of the autograft for twenty 
of the twenty-three primary total hip arthroplasties, and an autogenous bone from 
the iliac crest was used for the other three. 
Revision Acetabular Reconstructions 
After removal of the failed components, interface tissue was sent for frozen-section 
analysis to rule out infection. On the basis of these results, a two-stage revision 
procedure was performed in two patients (Cases 30 and 35; see Appendix) for the 
treatment of suspected septic loosening. The acetabulum was reamed to create a 
bleeding trabecular bone bed. Segmental defects in the medial wall or peripheral 
defects of the acetabulum were closed with a slice of corticocancellous bone or 
with metal mesh. In four hips undergoing revision at the site of a failed resurfacing 
arthroplasty, we used the femoral head (two hips) or bone from the iliac crest (two 
hips). In two other such hips, autogeneous bone from the iliac crest was combined 
with a femoral head allograft. In the thirteen hips undergoing revision at the site of 
a failed total hip arthroplasty, we used fresh-frozen femoral head allograft, which has 
been our practice since 1984. 
Both Primary and Revision Reconstructions 
During both primary and revision arthroplasties, any remaining sclerotic areas were 
perforated with multiple 2-mm drill-holes, the bone bed was cleaned with use of 
lavage, and impaction bone-grafting was performed. A trial acetabular prosthesis 
and a mallet were used to distribute and impact the bone grafts. A goal of impaction 
grafting was to restore the original center of rotation of the hip, with the level of 
the transverse ligament used as a reference. The last trial prosthesis that was used 
for impaction was at least 2 mm larger than the proposed cup in order to allow for 
a cement mantle of sufficient thickness. In thirty-two hips, a thin Vitallium wire 
mesh (Mecron, Berlin, Germany) was used on top of the graft reconstruction. After 
pressurization of the bone cement, a 32-mm all-polyethylene cup was inserted. A 
Müller cup was used in twenty-five hips, and an Allopro cup was used in the remaining 
seventeen hips (Sulzer, Wintherthür, Switzerland). Regular bone cement was used for 
the primary arthroplasties, whereas gentamicin-impregnated cement (Palacos R or 
Palacos R with gentamicin; Merck, Darmstadt, Germany) was used for the revisions. 
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Postoperative Regimen 
Postoperative treatment for all patients included bed rest for six weeks, systemic 
administration of antibiotics for five days, administration of indomethacin as 
prophylaxis against heterotopic ossification for seven days, and oral anticoagulation 
therapy for three months. Passive exercises were allowed after twenty-four hours, 
followed by walking with partial weight-bearing after six weeks and full weight-
bearing after three months. 
 
Follow-up 
At the time of the final review, one patient (Case 4; see Appendix) had been 
lost to follow-up. Two patients who had been lost to follow-up at the time of the 
previous report7 were found and were included in this study. Four patients (five 
hips) (Cases 2, 14, 15, 22, and 33; see Appendix) died from causes that were 
unrelated to the operation at 4.3, 5.4, 9.0, and 15.4 years postoperatively. All of 
the patients who died had been followed on a regular basis until death and were 
included in the present study, but a Harris hip score from the time just prior to 
death was not available. None of them, however, had had a reoperation or a revision. 
All of the living patients with surviving hips returned for a clinical and radiographic 
examination, with the exception of two patients whose radiographs were sent from 
other clinics and whose hip scores were obtained by telephone. In the case of one 
patient, the hip score was incomplete at the time of the latest visit, so an update was 
performed by telephone. Preoperative Harris hip scores were not known. 
Radiographic Follow-up 
Serial anteroposterior and lateral radiographs were reviewed to determine the 
extent of incorporation of the graft, the presence of radiolucent lines, migration 
of the cup, and the formation of heterotopic ossification. Radiographic data were 
complete for thirty-eight hips, which were used for further analysis. The radiographic 
data were incomplete for two patients (three hips) and missing for one patient (Case 
4; see Appendix) who had been lost to follow-up. The graft was considered to be 
incorporated when the graft and the host bone were of equal radiodensity, with a 
continuous trabecular pattern throughout10. Zones of radiolucency were assessed 
on the anteroposterior radiographs with the method of DeLee and Charnley11, with 
a radiolucent line measuring 2 mm in width considered to be a positive finding. 
63
4
O
utcom
e of acetabular im
paction bone grafting in patients under 50 years
Radiolucent lines were defined as stable or as progressive over time. Heterotopic 
ossification was classified according to the system of Brooker et al.12.
Survivorship Analysis 
Kaplan-Meier survivorship analysis was performed for the entire group of hips 
treated with acetabular reconstruction as well as for the subgroups of hips treated 
with primary and revision acetabular reconstruction. The survivorship analysis was 
performed with three different end points: revision of the acetabular component 
for any reason, revision of the acetabular component for aseptic loosening, and 
radiographic signs of failure (defined as a radiolucent line in all three zones or 
migration of the acetabular component of ≥5 mm in any direction relative to the 
interteardrop line as seen on the anteroposterior pelvic radiograph). 
Results 
Clinical Results (see Appendix) 
Twenty-eight hips (in twenty-five living patients) that had retention of the 
index prosthesis were followed for a mean of 17.5 years (range, fifteen to twenty-
three years). The average Harris hip score in this group was 89 points (range, 60 to 
100 points). Twenty-six of these twenty-eight hips had no or slight pain. Two hips 
(Cases 17 and 34; see Appendix) with Harris hip scores of 64 and 60 points had 
moderate and mild pain, respectively. 
 
Primary Acetabular Reconstructions 
Twenty-three primary reconstructions were performed in nineteen patients for the 
treatment of a type-1 defect (one hip), a type-2 defect (sixteen hips), or a type-
3 defect (six hips). Four hips required acetabular revision. One hip with a type-
3 defect (Case 19; see Appendix) was revised because of culture-proven septic 
loosening 14.5 years after the index op-eration. Three hips (Cases 3, 21, and 23; 
see Appendix), including one with a type-2 defect and two with a type-3 defect, 
were revised because of aseptic loosening 6.4, 15.3, and 20.5 years after the index 
operation. 
64
C
ha
pt
er
 4
4
Revision Acetabular Reconstructions 
Nineteen revision reconstructions were performed in eighteen patients for the 
treatment of a type-2 defect (eleven hips) or a type-3 defect (eight hips). Four hips 
were rerevised. One hip with a type-2 defect (Case 28; see Appendix) was rerevised 
three years after the index operation because of culture-proven septic loosening. 
One hip with a type-3 defect (Case 41; see Appendix) was rerevised 11.7 years after 
the operation because of aseptic loosening. Another hip with a type-3 defect (Case 
37; see Appendix) was rerevised 12.3 years after surgery. In that case, a femoral 
revision had been planned for the treatment of osteolysis and pain. Intraoperatively, 
however, the hip was very unstable after isolated revision of the stem and therefore 
the original well-fixed cup was exchanged in order to correct the instability. Another 
hip with a type-2 defect (Case 30; see Appendix) was rerevised nine years after the 
operation because of recurrent dislocation and wear of the cup. 
Cavitary Defects Compared With Combined Defects 
Acetabular reconstruction was performed in twenty-seven hips with a cavitary (type-
2) defect and fourteen hips with a combined (type-3) defect. Of the eight hips in which 
the reconstruction failed, two (including one with a type-2 defect and one with a type-
3 defect) were revised because of septic loosening and two (including one with a type-
2 defect and one with a type-3 defect) were revised because of instability. Therefore, 
of the forty-one reconstructions, only four failed because of aseptic loosening, 
including one primary reconstruction in a hip with a cavitary (type-2) defect and one 
revision and two primary reconstructions in hips with a combined (type-3) defect. 
Radiographic Results 
Overall Results 
Of the twenty-eight hips in twenty-five patients with the implant still in situ that 
were available for radiographic review at the time of the final follow-up, sixteen 
appeared to have a well-fixed implant, with uniform radiodensity of the graft 
and the host bone and without progressive radiolucent lines (Figs. 1-A, 1-B, and 
1-C). None of the hips had pelvic osteolysis. Ten hips had periarticular heterotopic 
ossification: five hips had Brooker grade-I ossification, two hips had grade-II 
ossification, two hips had grade-III ossification, and one hip (Case 23; see Appendix) 
had grade-IV ossification. The hip with grade-IV ossification was asymptomatic. 
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Figs 1-A, 1-B, and 1-C  
Radiographs of the hip of a forty-seven-year-
old woman (Case 34; see Appendix) who 
underwent revision arthroplasty because of 
secondary osteoarthritis due to epiphysiolysis. 
Fig. 1-A 
Radiograph made before the index acetabular 
reconstruction, demonstrating loosening of 
the resurfacing prosthesis with creation of a 
cavitary acetabular defect.  
Fig. 1-B 
Radiograph made after reconstruction with 
impaction bone-grafting and a cemented cup, 
with use of Vitallium mesh to cover the graft. 
The use of metal mesh on top of the graft is 
not our current practice; for more than ten 
years, we have directly cemented the graft at 
the reconstruction site. The irregular structure 
of the graft can be seen.
Fig. 1-C 
Radiograph made sixteen years postoperati-
vely, showing no radiographic signs of loose-
ning and good incorporation of the graft. 
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Primary Acetabular Reconstructions 
Of the fifteen surviving hips that had undergone a primary reconstruction, three 
showed progressive radiolucent lines in one zone and two showed stable lines in one 
zone at the cement-bone interface. All four hips that were revised after a primary 
reconstruction (including one that was revised because of septic loosening and 
three that were revised because of aseptic loosening) showed complete loosening 
radiographically: three hips (Cases 3, 19, and 23; see Appendix) had progressive 
radiolucent lines in three zones, while the other hip (Case 21; see Appendix) had 6 
mm of migration of the cup. In the three hips with aseptic loosening the radiolucent 
lines were seen at the cement-bone interface, whereas in the one hip with septic 
loosening the radiolucent lines were seen at the graft-host interface. 
Revision Acetabular Reconstructions 
Of the thirteen surviving hips that had undergone a revision reconstruction, one 
hip (Case 26; see Appendix) showed progressive radiolucent lines in three zones 
as well as 10 mm of vertical migration of the cup 17.3 years after surgery. This 
hip was considered to have failed radiographically, but it was not revised because 
the patient had only mild symptoms. Six other surviving hips showed progressive 
radiolucent lines in one zone, and two hips had progressive lines in two zones. Two 
hips that were rerevised because of septic and aseptic loosening (Cases 28 and 41; see 
Appendix) showed progressive radiolucent lines in three zones and were considered 
to have failed radiographically. Of the other two revised hips, the one that was 
revised because of wear (Case 30; see Appendix) showed a progressive radiolucent 
line in one zone and the one that was revised because of intraoperative instability 
after a femoral revision (Case 37; see Appendix) was not loose at all. In the hips with 
aseptic loosening, the radiolucent lines were seen at the bone-cement interface. 
Additional Reoperations and Complications 
In addition to the two femoral stem revisions already mentioned (Cases 30 
and 37; see Appendix), two stems were revised because of aseptic loosening at six 
years (Case 26; see Appendix) and at twelve years (Case 27; see Appendix). During 
both reoperations, the acetabular cup was well fixed and was left in situ. In one 
patient (Case 17; see Appendix), periarticular ossifications were removed 1.2 
years postoperatively. One patient (Case 26; see Appendix) had development of a 
neuropraxia of the peroneal nerve, which resolved fully. 
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Survivorship Analysis 
Overall Results 
With revision of the cup for any reason as the end point, the survival rate was 92% 
(95% confidence interval, 83.5% to 100%) at ten years, 83% (95% confidence 
interval, 71.7% to 95.7%) at fifteen years, and 80% (95% confidence interval, 67.2% 
to 93.5%) at twenty years. With revision of the cup for aseptic loosening as the end 
point, the survival rate was 97% (95% confidence interval, 92.1% to 100%) at ten 
years, 94% (95% confidence interval, 86.9% to 100%) at fifteen years, and 91% 
(95% confidence interval, 80.4% to 100%) at twenty years. With radiographic signs 
of loosening as the end point, the survival rate was 92% (95% confidence interval, 84% 
to 100%) at ten years and 89% (95% confidence interval, 80% to 99%) at fifteen years. 
Primary Acetabular Reconstructions 
With revision of the cup for any reason as the end point, the survival rate after 
primary acetabular reconstruction was 95% (95% confidence interval, 85% to 
100%) at ten years, 88% (95% confidence interval, 73% to 100%) at fifteen years, 
and 82% (95% confidence interval, 63% to 100%) at twenty years (Fig. 2). With 
revision of the cup for aseptic loosening as the end point, the survival rate was 
95% (95% confidence interval, 85% to 100%) at ten years, 95% (95% confidence 
interval, 85% to 100%) at fifteen years, and 87% (95% confidence interval, 71% 
to 100%) at twenty years. With radiographic signs of loosening as the end point, 
the survival rate was 89% (95% confidence interval, 75% to 100%) at fifteen years. 
Revision Acetabular Reconstructions 
With revision of the cup for any reason as the end point, the survival rate after revision 
acetabular reconstruction was 89% (95% confidence interval, 75% to 100%) at ten 
years, 78% (95% confidence interval, 59% to 97%) at fifteen years, and 78% (95% 
confidence interval, 59% to 97%) at twenty years (Fig. 3). With revision of the cup 
for aseptic loosening as the end point, the rate of survival was 100% at ten years, 
93% (95% confidence interval, 82% to 100%) at fifteen years, and 93% (95% 
confidence interval, 82% to 100%) at twenty years. With radiographic signs of 
loosening as the end point, the rate of survival was 89% (95% confidence interval, 
76% to 100%) at fifteen years. 
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Fig. 2 
Kaplan-Meier curves 
(and 95% confidence 
intervals) showing 
the ten, fifteen, and 
twenty-year rates of 
survival following 
primary acetabular 
reconstruction with 
use of impaction 
bone-grafting, with 
revision for any 
reason and revision 
for aseptic loosening 
as the end points. 
Fig. 3 
Kaplan-Meier curves 
(and 95% confidence 
intervals) showing 
the ten, fifteen, and 
twenty-year rates of 
survival following 
revision acetabular 
reconstruction with 
use of impaction 
bone-grafting, with 
revision for any 
reason and revision 
for aseptic loosening 
as the end points. 
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Discussion 
Soon after the introduction of modern total hip arthroplasty with cement, it 
became clear that replacements in young patients were associated with high rates of 
failure due to loosening and wear13-23. Despite the introduction of second-generation 
cementing methods, which improved the rates of survival of the femoral component, 
the rate of failure of the acetabular component in young patients remained high. 
Ballard et al.1 reported that the rate of survival of cemented acetabular components 
in patients less than fifty years old was 76% at eleven years with revision because 
of aseptic loosening as the end point. Smith et al.2 reported that the cumulative 
rate of survival of cemented cups in young patients was 71% at eighteen years with 
revision because of aseptic loosening as the end point. With radiographic signs of 
loosening as the end point, the rate of survival of the cup in a mixed group of hips 
with metal-backed and all-polyethylene cups was 63% at eighteen years. Callaghan 
et al.3 reported that the rate of survival of cemented acetabular components in 
patients less than fifty years old was 76% at twenty-five years with revision because 
of aseptic loosening as the end point. However, the probability of survival of the 
acetabular component was only 54% (95% confidence interval, 41% to 67%) at 
twenty-five years when radiographic evidence of definite or probable loosening or 
revision for aseptic loosening was used as the end point. In the current study, the 
rate of survival of the cemented cup was 91% (95% confidence interval, 80.4% to 
100%) at twenty years with revision because of aseptic loosening as the end point. 
We believe that the long-term results in this mixed group of primary and revision 
acetabular reconstructions are very acceptable and are at least comparable with those 
of previous series of primary reconstructions with cement. 
Another option for acetabular revision is the use of a cementless acetabular 
component. Although such components are frequently used, long-term reports with 
a minimum of ten years of follow-up are scarce. Leopold et al.24 reported the results 
of 138 cementless acetabular revisions in 131 patients after an average duration of 
follow-up of 11.5 years. The rate of survival of the cup with re-revision for any reason 
as the end point was 89%, with fourteen of 130 hips having been rerevised; no cup 
was re-revised because of aseptic loosening. When all cups that had been lost to 
follow-up were considered as failures, as suggested by Murray et al.25, the worst-case 
scenario survival rate (including all acetabular re-revisions that had been performed 
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for any reason and all hips that had been lost to follow-up) was 84%. These data are 
comparable with the results for the revision group in the present study at the same 
follow-up interval. Templeton et al.26 reported on sixty-one consecutive revisions 
that were performed in fifty-five patients by one surgeon; all acetabular revisions 
were performed with a porous-coated Harris-Galante component. At the time of the 
review, none of the acetabular components had been re-revised because of aseptic 
loosening after a mean duration of follow-up of 12.9 years. However, eight (13%) 
of the sixty-one hips underwent additional procedures on the acetabulum during a 
reoperation and pelvic osteolysis was observed in 13% of the hips. Therefore, despite 
the very low rate of re-revision of the cementless metal shell for aseptic loosening, we 
believe that pelvic osteolysis will be the major problem as these uncemented cups are 
followed for longer periods. 
To our knowledge, although the number of patients in the present study is not 
large, the long-term results reported here are among the most favorable that have 
been published to date in patients younger than fifty years old2,3. The impaction 
bone-grafting technique is especially attractive for use in young patients with bone-
stock deficiencies (in whom future revisions can be expected) because bone stock is 
restored and relatively normal hip mechanics can be achieved. 
The strengths of the present study are that (1) we reviewed all consecutive 
reconstructions that had been performed before December 1987 with use of 
the impaction bone-grafting technique in young patients and (2) this was not a 
single-surgeon study. According to the criteria described by Murray et al.25, the 
reliability of our study is high. The loss-to-follow-up quotient was 0.125, and the 
worst-case scenario survival rate (which is based on the number of rerevisions that 
were performed for any reason, with all hips that had been lost to follow-up being 
considered as failures) was 79% at an average of 17.5 years. 
A possible limitation of our study is that fourteen of the reconstructions 
were performed in patients with rheumatoid arthritis, who theoretically are more 
sedentary than patients with osteoarthritis. While good results have been reported 
previously in association with the use of impacted morselized bone grafts in patients 
with protrusio acetabuli and rheumatoid arthritis27-29, the results of total hip 
arthroplasty in a nationwide study of young patients with rheumatoid arthritis who 
were less than fifty-five years old was disappointing at longer durations of follow-
up30. 
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Although Conn et al.10 suggested radiographic criteria for graft incorporation, 
it is difficult to determine whether there is incorporation of morselized bone grafts 
on radiographs. Only a biopsy can demonstrate the incorporation. Heekin et al.31, 
and recently van der Donk et al.6, demonstrated that impacted morselized bone graft 
showed overall good incorporation with cement. In contrast, other investigators have 
observed that the incorporation of structural bone grafts is often incomplete32,33 . In 
the group of four hips in the present study that failed after a primary reconstruction, 
the bone stock at the time of revision was found to be satisfactory, with only one 
hip demonstrating worsening of the defect (from a cavitary defect to a combined 
defect). In the group of four hips that failed after a revision, no hip had progressive 
bone stock deficiency (two hips had a cavitary defect both at the time of the index 
procedure and at the time of revision, and the other two hips had a combined defect 
at both time-points). In all cases, acetabular reconstruction with bone graft was 
possible in combination with a standard acetabular implant. 
The technique of performing acetabular impaction bone-grafting is demanding 
and has pitfalls. On the acetabular side, large trabecular bone chips with a diameter 
of between 0.7 and 1 cm should be used because smaller chips with a diameter of 0.2 
to 0.5 cm will produce inferior cup stability34. The chips that are produced by most 
commercial bone mills are too small for application in the acetabulum. Impaction 
of the bone grafts must be tight enough to create stability with use of a hammer 
and acetabular impactors. Compressing the grafts with an acetabular reamer in 
reverse also reduces initial cup stability34. An optimal cementation technique is also 
essential, including pressurization of the cement with a seal before introduction of 
the cup. 
According to our current postoperative protocol, these patients begin to walk 
on two crutches two days after surgery. For the first six weeks they are allowed toe-
touch weightbearing, and for the next six weeks they are permitted to place 50% 
body weight on the affected hip with use of two crutches. However, the period of 
immobilization or restricted weightbearing should be adjusted in relation to the 
complexity of the defects and their reconstruction.
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Abstract
Background: In a previous report we presented our results of forty-two acetabular 
reconstructions in thirty-seven patients under fifty years using impaction bone-
grafting and a cemented cup at a minimum of fifteen years of follow-up. 
Questions/purposes: What are the results of acetabular impaction bone-grafting and 
a cemented cup in young patients after twenty to twenty-eight years of follow-up? 
Methods: We evaluated clinical and radiographic results and we performed 
survivorship analysis using the Kaplan-Meier method. 
Results: Eight additional cups had to be revised, four because of aseptic loosening, 
three because of wear and one during a revision of the stem. Three additional cups 
were considered loose on radiographs. Survivorship of the acetabular reconstructions 
was 73% after twenty years and 52% after twenty-five years with revision for any 
reason as the end point. With revision for aseptic loosening as the end point, survival 
was 85% after twenty years and 77% after twenty-five years and for radiographic 
loosening, survival was 71% at twenty and 62% at twenty-five years. 
Conclusions: Our previous results have declined but the technique using impacted 
morselized bone graft and a cemented cup is a useful technique to restore bone 
stock in young patients with acetabular defects requiring primary or revision total 
hip arthroplasty.
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Background 
Previously, we reported the clinical and radiographic outcomes of forty-two 
consecutive acetabular reconstructions performed with use of an impaction bone-
grafting technique and a cemented cup in thirty-seven patients who were all younger 
than fifty years (average, thirty-seven years; range, twenty to forty-nine years) at 
the time of surgery1. We used impaction bone-grafting as a biological technique 
to reconstruct acetabular deficiencies in younger patients. This reconstructive 
technique was used in twenty-three primary and nineteen revision operations. The 
average follow-up in that study was seventeen years and six months (range, fifteen to 
twenty-three years). Kaplan-Meier analysis showed that the probability of survival 
of the acetabular component at fifteen years was 83% (95% confidence interval, 
72% to 96%) with the end point being revision of the cup for any reason and 94% 
(95% confidence interval, 87% to 100%) with the end point being revision of the 
cup for aseptic loosening1. The overall radiographic survival rate of the cup was 89% 
(95% confidence interval, 80% to 99%) at fifteen years. 
The purpose of the present study was to update the clinical and radiographic 
results of our previous report after a mean duration of follow-up of twenty-three 
years (range, twenty to twenty-eight years). 
Methods 
The study was approved by our institutional review board. Between July 1979 
and December 1987, we performed forty-two consecutive acetabular reconstructions, 
with use of an impaction bone-grafting technique and a cemented polyethylene 
cup, in thirty-seven patients who had deficient acetabular bone stock and who were 
younger than fifty years at the time of the operation. It was the only technique used 
in our department to treat acetabular bone stock loss. After a posterolateral approach 
and resection of the femoral head or removal of failed components, the acetabulum 
was reamed to create a bleeding bone bed. Segmental defects were reconstructed with 
use of a metal mesh or a solid graft. Before impaction, remaining sclerotic areas were 
perforated with multiple 2-mm drill-holes. In primary acetabular reconstructions, 
the femoral head was morselized with a rongeur to create cancellous bone chips with 
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a diameter of 0.7 to 1.0 cm. In hips with larger defects or when revision surgery 
was being performed, fresh-frozen nonirradiated femoral head allografts were used. 
In some early cases, bone grafts were taken from the iliac crest. After lavage of 
the acetabulum, the grafts were impacted with use of impactors and a mallet. The 
defect was reconstructed, layer by layer, until the defect was restored completely. 
Bone cement was pressurized into the impacted grafts with use of a seal. Before 
1989, we used Palacos bone cement (Merck, Darmstadt, Germany), and, from 
1989 on, we used Surgical Simplex bone cement (Stryker Howmedica, Newbury, 
United Kingdom). Regular bone cement was used for the primary arthroplasties, 
whereas gentamicin-impregnated cement was used for the revisions. To create a 
sufficient cement mantle, the last trial prosthesis that was used for impaction was at 
least 2 mm larger than the proposed cup. In the present series, twenty-five 32-mm 
Müller and seventeen 32-mm Allopro all-polyethylene cups (Sulzer, Winterthur, 
Switzerland) were used. Both components were manufactured from compression-
molded GUR 412 (RCH-1000; Ruhrchemie, Oberhausen, Germany) and sterilized 
by gamma radiation in air. Sixteen cemented Charnley-Müller curved stems (Protek 
AG, Bern, Switzerland), twenty-five cemented M.E. Müller straight stems (Protek 
AG), and one cemented Stanmore prosthesis (Biomet, Bridgend, United Kingdom) 
were used, all with a head size of 32 mm.
For this report, we reviewed all reconstructions (twenty-three [55%] primary 
and nineteen [45%] revision total hip reconstructions) at a minimum period of 
follow-up of twenty years. All patients were prospectively followed annually or 
biennially for at least twenty years, or until revision or death. 
Acetabular defects were classified according to the classification system of 
the American Academy of Orthopaedic Surgeons (AAOS) Committee on the 
Hip2 (Table I). Radiographic evidence of bone-graft incorporation was defined as 
equal radiodensity of graft and host bone, with a continuous trabecular pattern 
throughout, according to Conn et al.3. Radiolucent lines >2 mm wide were identified 
in the three zones of DeLee and Charnley4. Radiolucent lines were defined as stable 
or as progressive with time. As of the last review in 2008, all living patients with 
surviving hips were seen for clinical and radiographic examination and both a Harris 
hip score and an Oxford Hip Questionnaire Score5 were obtained. All patients who 
died during the period of follow-up were followed on a regular basis until their 
death, and their data were included in this report. Failure was defined clinically as 
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the need for revision of the acetabular component for any reason. A radiographic 
failure was defined as radiolucent lines in all three zones of DeLee and Charnley, 
or migration of 5 mm or more in any direction relative to the interteardrop line 
on the anteroposterior pelvic radiograph. Linear polyethylene wear was measured 
according to the method described by Livermore et al.6, and the measurements were 
corrected for magnification. 
The Kaplan-Meier analysis was performed with three different end points: 
revision of the acetabular component for any reason, revision of the acetabular 
component for aseptic loosening, and radiographic signs of failure. Kaplan-Meier 
survivorship analysis was performed for the whole group of hips treated with 
acetabular reconstruction and included 95% confidence intervals. A log-rank test 
was used to compare survival rates of subgroups. 
Table 1:
Patient demographics
Patients (no.) Hips (no.)
No. in series 37 42
Sex
     F 22 24
    M 15 18
Type of defects according 
to AAOS classification
   Segmental 1
Cavitary 27
   Combined 14
Deaths during follow-up period 8 10
Lost to follow-up 1 1
Revisions during follow-up 16
     Due to septic loosening 2
     Due to aseptic loosening 8
     Due to wear 4
     During stem revision 2
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Results 
Clinical Results 
Of the original group of thirty-seven patients (forty-two hips), one patient (one 
implant) was lost to follow-up and eight patients (ten implants) had died of causes 
unrelated to the surgery. At the time of the final review, nineteen surviving hips 
were in situ in seventeen patients and were clinically and radiographically evaluated 
after a mean follow-up period of twenty-three years (range, twenty to twenty-eight 
years). Unfortunately, one patient was unable to attend due to progressive dementia; 
however, her relatives reported no reoperation and no apparent clinical symptoms. 
For radiographic analyses for this patient, we used the last radiograph available, 
from 2005. The mean Harris hip score of the surviving hips was 88 (range, 44 to 
100), and the mean Oxford Hip Questionnaire Score was 20 (range, 12 to 41). 
Revisions 
Eight additional cups (19.5%) had to be revised after the previous report, which 
meant that sixteen acetabular revisions (39%) were performed overall. Two cups 
(4.9%) were revised because of culture-proven septic loosening after three and 14.5 
years. Eight reconstructions (19.5%) failed because of aseptic loosening and were 
revised after a mean of 17.3 years (range, 6.4 to 25.5 years), including four with a 
cavitary (type-2) defect and four with a combined (type-3) defect. Four reconstructions 
(9.8%) were revised because of wear and osteolysis after a mean of 18.8 years (range, 
8.9 to 25.4 years). Two cups (4.9%) were revised after 12.3 and 18.3 years during 
a revision of the stem because of persistent instability and matching problems. 
However, these six cups were both intraoperatively and radiographically well-fixed. 
Radiographic Results 
Follow-up radiographs were complete for thirty-seven hips (90.2%), which 
were used for further analysis. Data were incomplete for two deceased patients 
(three hips) and for the patient with dementia, for whom the latest radiograph was 
used. Of the nineteen hips in seventeen patients with the implant still in situ, twelve 
cups appeared to be well fixed with uniform radiodensity of the graft and the host 
bone and without progressive radiolucent lines. Three cups (7.3%) were considered 
loose radiographically. The radiographs of four additional hips showed progressive 
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radiolucent lines (in zone three in three hips, and in zones two and three in one hip). 
The radiograph of one hip showed a pelvic osteolytic area in zone one. Six hips had 
Brooker grade-I ossification, one hip had Brooker grade-II ossification, and three 
hips had Brooker grade-III ossification7. The mean polyethylene wear for the whole 
group of living patients with the implant still in situ was 2.0 mm (0.8 to 3.4 mm). 
Of the six surviving hips in five deceased patients, one cup showed a progressive 
radiolucent line in one zone8. Of the sixteen revised hips, ten showed definitive 
radiographic loosening of the cup. Four cups showed excessive polyethylene wear, 
and one of the four had associated pelvic osteolysis but migration or progressive 
lines in more than one zone were not seen. The remaining two cups were revised 
during revision of the stem and did not show progressive radiolucent lines. The 
mean wear of the revised cups measured 2.1 mm (range, 0 to 4.2 mm). 
Additional Reoperations and Complications 
As noted in our previous report, four revisions of the femoral component 
were done and, in one patient, periarticular ossifications were removed 
1.2 years postoperatively. Since the time of our previous report, there 
has been one additional femoral revision for aseptic loosening, and the 
cup was revised during the same operation. Neurapraxia of the peroneal 
nerve developed postoperatively in one patient but fully resolved. 
Survivorship Analysis 
Survivorship of the acetabular reconstructions according to the different end 
points is shown in Table II. With revision for any reason as the end point, survival 
of the acetabular component was 73% (95% confidence interval, 58% to 87%) 
at twenty years and 52% (95% confidence interval, 35% to 72%) at twenty-five 
years (Fig. 1). With revision for aseptic loosening of the cup as the end point, 
survivorship was 85% (95% confidence interval, 72% to 97%) at twenty years and 
77% (95% confidence interval, 62% to 92%) at twenty-five years of follow-up. 
With radiographic loosening of the cup as the end point, the survivorship was 71% 
(95% confidence interval, 55% to 86%) at twenty years and 62% (95% confidence 
interval, 44% to 80%) at twenty-five years. Comparison of survival rates of primary 
and revision reconstructions did not reveal any statistical differences. 
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Table 2:
Survival rates for the different periods of follow-up and end points
End point for 
survivorship of 
reconstructions
15-yearsurvival  
(95% Confidence 
Interval)
20-year survival  
(95% Confidence Interval)
25-yearsurvival 
(95% Confidence Interval)
Revision for any reason 0.84(0.72 to 0.96) 0.73 (0.58 to 0.87) 0.52 (0.35 to 0.72)
Aseptic loosening 0.94 (0.87 to 1.00) 0.85 (0.72 to 0.97) 0.77 (0.62 to 0.92)
Radiographic loosening 0.89 (0.80 to 0.99) 0.71 (0.55 to 0.86) 0.62 (0.44-0.80)
Fig. 1 
Kaplan-Meier survival curve for the entire group (black line) and the upper and lower 95% 
confidence intervals (gray lines), with revision of the acetabular component for any reason 
as the end point. 
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Conclusions
The technique of impaction bone-grafting is especially attractive for the 
purpose of obtaining a biological repair of the acetabular bone defect and facilitating 
future revisions in young patients. The follow-up was nearly complete in our study, 
and the fate of every reconstruction is known, except in one case. Probably due 
to the relatively small numbers, statistical differences could not be shown between 
survival of hips in the primary and revision subgroups and, therefore, the data are 
presented as overall results. 
In addition to the revised cups, three additional cups were seen to be 
radiographically loose and will probably need to be revised in the near future. 
Compared with the rates seen in our previous study, the survival rates have been 
deteriorating. Progressive wear and related osteolysis was seen in these younger and 
active patients, and this radiographic finding necessitated revision. Six of the sixteen 
revised acetabular components were both intraoperatively and radiographically 
well fixed, and this supports the hypothesis that it would not be the reconstruction 
itself but the secondary problems that would cause a decline in survival. The 
survival of 77% after twenty-five years, with an end point of revision of the cup 
for aseptic loosening, is comparable with long-term reports on cemented hips in 
young patients9,10,while we used this technique in demanding primary total hip 
arthroplasties and acetabular revisions. 
Uncemented hip designs are mostly used currently in young patients, but 
reports on uncemented cups with bone-grafting in patients younger than fifty years 
old with a minimum follow-up of fifteen years are lacking. However, good results 
with uncemented cups in combination with acetabular grafts in hip revisions are 
reported by several authors in older patients. In hips undergoing revision, Rudelli 
et al.11 showed a survival rate of 88.3% in uncemented cups, with an end point of 
revision for any reason, after a mean follow-up of 167 months in a group of forty-
two patients (forty-three hips) with a mean age at surgery of fifty-six years. Palm et 
al.12 reported a nine-year survival rate of the cup of 90.5% in a group of seventy-
nine patients in whom the median age was sixty-seven years. Lachiewicz and Poon13 
reported the results of thirty-four patients in whom morselized bone grafts were used 
in combination with a Harris-Galante porous-coated cup, and no revision because 
of loosening had taken place after a mean follow-up of seven years for the total 
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group of patients. Although these are good and promising mid-term results, longer 
follow-up is needed to prove the true clinical value of these cementless techniques 
in young patients. 
Pelvic osteolysis, which is seen at a higher frequency around uncemented 
components, is still an unsolved problem in young patients. In a series by Della Valle 
et al.14, very acceptable results were achieved with use of a porous-coated acetabular 
component, but osteolysis was observed in more than 30% of patients who were 
younger than fifty years. 
The technique of reconstruction, as reported in our study, has basically 
remained the same over the years, with only minor changes. In the first years, a 
metal mesh was placed on top of the impacted bone grafts just before cementation. 
After one decade, we realized that this mesh was not very functional, so metal mesh 
is now used only to reconstruct segmental defects. In addition, our rehabilitation 
program has been changed, with patients now mobilized earlier with earlier weight-
bearing, depending on the size of the reconstruction.
NOTE: The authors thank Jan Hendriks for his excellent statistical support. 
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Abstract
Background: Socket fixation in patients with acetabular dysplasia can be technically 
demanding but the use of structural grafts can help to reconstruct the original center 
of hip rotation. Because reported survival rates differ, construct survival seems to 
depend on the technique of graft preparation and fixation.
Questions/purposes: What is the survivorship of cemented sockets with acetabular 
roof graft in patients with severe acetabular dysplasia? Do clinical scores equal those 
of patients without acetabular grafting? 
Methods: We retrospectively reviewed 62 patients (74 hips) who had undergone 
cemented THA with acetabular roof graft. Mean age at surgery was 45 years (range, 
19–71 years). Revisions and radiographic failures were determined and clinical 
scores (Oxford, SF-12) were obtained and matched to a control group. Kaplan-
Meier analysis was used to determine survivorship at a minimum followup of 5 years 
(mean, 10.4 years; range, 5–16 years).
Results: Survivorship for all-cause revision was 98% (95% CI, 92.5%–100.0%) at 
10 years followup. Two hips were revised for aseptic acetabular loosening and one 
hip for polyethylene wear. All grafts incorporated and no additional radiographic 
loosenings were seen. Patients with grafting had higher Oxford scores compared 
with the control group but other scores were equal. 
Conclusions: In contrast to reported series and the common use of uncemented cups 
in patients with developmental dysplasia of the hip, we found high survivorship of 
cemented sockets with roof graft in severe acetabular dysplasia at a mean followup 
of more than 10 years. These patients showed higher Oxford scores than patients in 
a control group. This technique that restores bone stock is a reasonable solution for 
often young patients with dysplasia. 
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Introduction
Restoration of the center of hip rotation in patients with developmental 
dysplasia of the hip (DDH) is advocated by most authors35, 40, 50, 54 and this can 
be achieved in most patients using a standard hip implant without reconstruction 
of the deficient acetabulum. In more severe dysplastic cases, however, a deficient 
acetabulum may appear inadequate to support a standard implant. Several options 
are available to reconstruct the deficient acetabulum. The technique of impaction 
bone grafting was introduced by Slooff et al.47 and evaluation of this technique 
applied in young patients shows acceptable long-term survival rates of 77% at 
25 years with revision for aseptic loosening as the end point7. In a series of 84 
patients younger than 40 years at the time of surgery, 10-year survival of acetabular 
reconstruction using impaction bone grafting was 95% with revision for aseptic 
loosening13. In 28 acetabular reconstructions in 22 patients with primary diagnosis 
DDH 48, survivorship of 84% was reported at 15 years with revision for any reason 
as the end point. Impaction bone grafting of acetabular defects has developed as 
a proven technique with high long-term survival rates, but other options like the 
use of solid grafts are also available. Uncemented cups are the preferred technique 
today by most surgeons and several studies evaluated the survival of acetabular bulk 
grafting with uncemented THA2,14, 19, 22, 24, 31, 38, 43, 46, 49. However, few studies are 
available with a mean followup of 10 years or longer23, 31, 44. Hendrich and Mehling23 
presented a series of patients with DDH (56 hips) with a survival rate of 91.6% at 11 
years but substantial socket migration was observed in 19 hips. Kim and Kadowaki31 
showed 94% survival at 10 years in a series of 83 hips. Shetty et al.44 reported in 
a series of 15 cases that no revisions were necessary at 10 years of followup but 
observed resorption of the graft in five of 15 cases. Solid grafts with a cemented 
socket are less widely used and some early reports showed increase of failure rates 
at longer followup34, 39, 45. Mulroy and Harris39 reported a decline of survival in 
time with failure of 46% at 11.8 years. Shinar and Harris45 presented a total rate of 
loosened or revised cups of 60% after a followup of more than 16 years in a series 
of 81 cases of bulk grafts with cemented THA. Despite these discouraging results, 
long-term studies with a mean followup of 10 years or longer and high survival 
of bulk grafts and cemented THA have been reported1, 4, 12, 27, 28, 33, 50. Kobayashi et 
al.33 presented a series of 37 reconstructions using bulk grafts and cemented THA 
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without any reoperations at a mean followup of 19 years. Survival of acetabular bulk 
grafts seems to depend on the technique applied and younger age is related to lower 
survival of THA32, 42. 
To address the controversy in choice of treatment for patients with DDH, 
we therefore (1) determined the survival of roof grafts with a cemented THA; (2) 
evaluated survivorship of roof grafts in patients younger versus older than 50 years 
at the time of surgery; (3) determined radiographic failures and complications; 
and (4) compared the clinical scores of patients with roof grafting with those of a 
matched control group of patients with nondysplastic hips and, if possible, identify 
predictors of the scores. 
Patients and Methods 
We performed a retrospective, observational study by identifying all 62 patients 
(74 hips) with DDH from the prospective database at our institute who underwent a 
cemented THA in combination with an acetabular autogenous bulk roof graft from 
1995 to 2006. During that time we performed more than 900 primary THAs each 
year. The indication for THA with a roof graft was painful secondary osteoarthritis 
of the hip with a deficient acetabular roof of 20% or more. The contraindication 
was acetabular roof deficiencies of less than 20%. We excluded all patients who had 
no acetabular augmentation or required acetabular reconstruction using additional 
impaction bone grafting. Twenty-four hips had previous hip surgery. The study 
group consisted of 57 female patients (67 hips) and five male patients (seven hips) 
with a mean age at surgery of 45 years (range, 19–71 years). Three patients were lost 
to followup, leaving 59 patients for study. Three patients (three hips) died 1, 6, and 
12 years after surgery of causes unrelated to the surgery but their data were included 
in the survival analyses. The minimum followup was 5 years (mean, 10.4 years; 
range, 5–16 years). No patients were recalled specifically for this study; all data were 
obtained from medical records, radiographs, and questionnaires. 
The study cohort was younger with a predominance when compared with 
the control group (Table 1). The control group, however, had a greater level of 
comorbidity (Table 1). 
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Table 1: 
Details and clinical scores of study group and control group
Case-mix variables Study group (n = 30) Control group (n = 1312) p value 
Age (mean years, SD) 45.6 (10.9) 69.2 (9.7) < 0.0001* 
Sex (male/female) 1/29 553/759 <0.0001† 
Mean number comorbidities (SD) 0.8 (1.2) 1.9 (1.7) 0.002‡ 
Preoperative (SD) 
SF-12 PCS Not available 31.1 (13.6) 
SF-12 MCS Not available 50.8 (14.4) 
OHS Not available 41.9 (8.2) 
Outcome measures 
Postoperative (SD) 
SF-12 PCS 48.2 (10.5) 44.8 (15.9) 0.09* 
SF-12 MCS 52.5 (9.7) 54.0 (13.8) 0.39* 
OHS 16.9 (5.3) 21.3 (9.2) 0.009‡
Satisfied (number, %) 30 (100) 1198 (91.3) 0.10 
Abbrevations: *t-test; †chi square; ‡Mann Whitney U-test; PCS = physical component score; MCS = mental 
component score; OHS = Oxford hip score.
Preoperative radiographic documentation was complete for 50 hips and was 
reviewed by two of the authors separately (VB, SJB). DDH was graded in a blinded 
fashion according to the Crowe classification10, the system of Hartofilakidis et al.22, 
and the Edinburgh classification19 (Table 2), which additionally identifies problems 
the surgeon might encounter during reconstruction (eg, retained hardware) and 
distinguishes concerns on the acetabular and femoral sides. 
Table 2: 
Distribution of developmental dysplasia of the hip classifications according to Crowe, 
Hartofilakidis, and the Edinburgh classification systems 
Crowe Percent Hartofilakidis Percent Edinburgh system
A Percent F Percent
1 16 A 14 A1 14 F1 16
2 56 B 72 A2 70 F2 54
3 22 C 14 A3 16 F3 30
4 6
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A posterolateral approach without trochanteric osteotomy was used in all cases. 
If, based on preoperative radiographs, the original center of hip rotation needed to 
be restored or in case of a deficient roof of more than 20% during surgery, an 
anterosuperior solid graft was used for reconstruction. A wedge of the femoral head 
was taken and fixed with two cancellous screws with its sclerotic concave side toward 
the defect as an inlay graft (Fig. 1). Further reaming of the inferior part of the graft 
was performed to create the optimal space for insertion of a standard cemented 
Contemporary or Exeter low-profile, allpolyethylene cup (Stryker, Newbury, UK) 
(Fig. 2). This technique creates a relatively small acetabular bulk autograft, which is 
supported by host bone. A femoral shortening osteotomy was necessary in 14 cases 
(Crowe III and IV) to facilitate restoration of the original center of hip rotation. An 
Exeter stem (Stryker) was inserted using modern cementing techniques. All patients 
received systemic prophylactic antibiotics (1.5 g cefuroxime) before surgery. 
Fig. 1A–C  
Schematic overview 
of graft insertion and 
reaming.  
(A) Graft is fixated 
with two cancellous lag 
screws with its sclerotic 
concave side toward 
the defect as an inlay 
graft.  
(B) Reaming of the 
graft to prepare for a 
cemented socket.  
 
(C) Final situation 
before cementation and 
insertion of the  
acetabular component. 
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Postoperatively, all patients 
had chemical thromboembolism 
prophylaxis for 6 weeks or 3 
months after surgery. Patients 
were mobilized routinely and were 
allowed 50% weightbearing for 
6 weeks after surgery and then 
mobilized full weightbearing. Our 
standard postoperative protocol 
includes clinical and radiographic 
review at 6 weeks, 3 months, and 
1 year after surgery. After the first 
year, review took place on a regular 
base or on indication decided by 
the consultant. 
Postoperative radiographic 
documentation was complete of 
49 surviving hips in living patients 
at followup times ranging from 
2.5 to 15.3 years. One of us (VB) 
assessed structural quality and 
consolidation of the roof graft, interface radiolucencies and osteolysis, prosthesis 
migration, socket tilting, heterotopic ossification, and wear. Graft incorporation 
was defined as the manifestation of a regular radiodensity and trabecular bone 
structure throughout the graft and host bone with a continuous trabecular pattern 
according to Conn et al.9. Radiolucent lines more than 2 mm wide were described 
and were defined as stable or progressive in time. Acetabular zones were identified 
using the criteria of DeLee and Charnley14 and radiographic failure was defined 
as radiolucent lines in all three zones and/or migration of 5 mm or more in any 
direction on the AP pelvic view relative to the interteardrop line. Linear wear was 
measured as described by Livermore et al.36. Radiolucent zones on the femoral 
side were evaluated using the method of Gruen et al.20. Loosening of the femoral 
component was defined using the criteria of Harris et al.21. Definite loosening of 
the stem was defined as the appearance of a radiolucent line in all Gruen zones that 
Fig. 2  
Situation after cementation of the acetabular 
component with supporting graft and restoration 
of original center of hip rotation. 
100
C
ha
pt
er
 6
6
did not exist on the immediate postoperative radiographs, a crack in the cement, or 
fracture of the stem. Femoral prosthetic subsidence was considered abnormal if it 
was more than 2 mm37.
For the purpose of this study, patients were sent a questionnaire and were asked 
to complete the Oxford hip score11, the SF-1252, the EQ5-D5, and visual analog 
scale scores for pain26. The obtained information was combined with data available 
from the records. Complications were recorded according to the classification of 
Dindo et al.16.
Kaplan-Meier survivorship analysis30 was performed for the entire study 
cohort and additionally for patients who were 50 years or younger at the time of 
surgery versus patients who were older than 50 years. End points used were revision 
of one or both components for any reason and revision for aseptic loosening. A 
radiographic worst case scenario was included, in which the assumption was made 
that the patients without a recent radiograph (16 hips) and the three patients (three 
hips) lost to followup had failed at least radiographically (total of 26%). Conven-
tional worst case scenario survivorship was calculated comprising all known failures 
and those lost to clinical followup. Log-rank testing was used to compare survival 
rates of patients younger and older than 50 years.
The SF-12 and the Oxford hip scores for the study cohort were compared with 
a control group (Table 1). The control group consisted of patients undergoing a 
THA for primary osteoarthritis using conventional acetabular cementing techniques 
from a previously published study reporting the 1-year outcome according to the 
patient’s socioeconomic status8. The prior study also included bilateral THA; for the 
purposes of this study, only the first THA was included for comparative analysis. 
Parametric and nonparametric tests were used as appropriate to assess continuous 
variables for significant differences between groups. An unpaired Student’s t-test 
or a Mann-Whitney U-test was used to compare linear variables between groups. 
Dichotomous variables were assessed using a chi square test. All case-mix variables 
(age, sex, number of comorbidities, preoperative SF-12 mental component scores 
[MCS] and physical component scores [PCS], and the Oxford hip score) were 
entered into a multivariable linear regression model, using enter methodology, to 
assess the independent effect of the groups on outcome (SF-12 MCS and PCS and 
the Oxford hip score). All case-mix variables and postoperative SF-12 MCS and 
PCS and the Oxford hip score were entered into a multivariable binary logistic 
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regression model using enter methodology to assess the independent effect of the 
groups on satisfaction. We presumed an improvement greater than 3 points in the 
Oxford hip score would be clinically important. Statistical analysis was performed 
using Statistical Package for Social Sciences Version 17.0 (SPSS Inc, Chicago, IL, 
USA).
Results 
All-cause survivorship was 98% (95% CI, 93%–100%) at 10 years (Fig. 3). 
Thirty-seven hips were still at risk at 10 years of followup and all patients with a 
minimal followup of 5 years were included in the study. The conventional worst 
case scenario, assuming that all patients lost to followup were revised, showed a 10-
year survival rate of 93% (95% CI, 91%–96%). Radiographic worst case scenario 
analysis (assuming all patients with no radiographic followup as a radiographic 
failure) predicted a survivorship of 83% (95% CI, 69%–97%) at 10 years followup. 
Three hips had been revised, two hips for aseptic loosening of the cup at 7.9 and 
17.4 years after the index operation. One hip was revised after 12.4 years because of 
wear and instability. No stem revisions were performed. At the time of subsequent 
Fig. 3 
A Kaplan-Meier curve 
showing survivorship 
with revision for all 
reasons as the end 
point.
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revision, the grafts had integrated into the acetabular roof in all hips, as suggested 
by bleeding bone within the graft; the graft fixation screws were removed at the time 
of revision. 
Separate analysis of patients 50 years old or younger demonstrated a 
survivorship rate of 93% at 10 years (Fig. 4), which was similar to (p = 0.56) the 
survival of patients older than 50 years. 
Of the 47 surviving hips in living patients with complete radiographic followup, 
all grafts showed bony incorporation (Fig. 5A–C). Acetabular radiolucent lines were 
seen in 14 hips (30%), all in Zone 3. Osteoporosis was present in seven hips around 
the screws not adjacent to the acetabular component and was nonprogressive. Two 
hips showed osteolysis in Zone 1. None of the hips showed migration. The mean 
linear wear measured 0.07 mm per year (range, 0–0.27 mm). None of the femoral 
components migrated more than 2 mm. A progressive radiolucent line was seen 
in one hip in Gruen Zone 1; none of the femoral components had evidence of 
radiographic loosening. One femur had delayed union after shortening osteotomy 
but clinical symptoms were absent (Grade I according to Dindo et al). One patient 
sustained incomplete femoral nerve palsy but had a full recovery (Grade I). 
Fig. 4 
A Kaplan-Meier curve 
showing survivorship 
for patients 50 years 
or younger (blue) 
compared with those 
older than 50 years 
old (green) with 
revision for all 
reasons as the end 
point.
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Fig. 5A–C  
(A) Preoperative radiograph 
of a 55-year-old woman with 
bilateral DDH, classified as a 
Crowe III, Hartofilakidis C, and 
Edinburgh system A2 F3. 
(B) Postoperative radiograph 
showing bilateral reconstruction 
using roof grafts and a 
cemented Exeter THA after 
femoral shortening osteotomy.
 
(C) Radiograph 15 years after 
the reconstruction showing 
incorporation of the roof grafts 
without evidence of loosening 
or resorption of the graft but 
signs of wear.
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Two patients were diagnosed with a pulmonary embolism and one patient with 
postoperative deep vein thrombosis (Grade II). All were treated successfully with 
warfarin. One patient had three dislocations 2 years after surgery and closed 
reduction was successful without damage to the acetabular reconstruction (Grade 
IIIb). Revision was not necessary. 
Patients who had reconstruction using a roof graft had better (p = 0.009) 
Oxford hip scores. SF-12 PCS and SF-12 MCS were similar (p = 0.09 and p = 
0.39, respectively). Adjusting for confounding case-mix variables, roof grafting was 
not an independent predictor of outcome, although there was a trend toward a 
better outcome and greater satisfaction in the study cohort (Table 3). The median 
postoperative EQ-5D score was 89.5 for the study group. The EQ-5D score was not 
available for the control group.
Table 3: 
Results of multivariable binary logistic regression model
Outcome B 95% CI p value R2
SF-12 PCS -0.47 -4.2 to 3.3 0.81 0.15*
SF-12 MCS -2.30 -9.1 to 4.5 0.51 0.10*
OHS -1.3 -7.3 to 4.7 0.67 0.04*
Satisfaction 0.00005 - 0.99 0.38†
Abbreviations: * Linear regression analysis; †binary logistic regression analysis; PCS = physical component score; 
MCS = mental component score; OHS = Oxford hip score.
Discussion
 
Structural grafts have been used in patients with more severe dysplasia to 
reconstruct the original center of hip rotation. However, the reported survival 
rates differ considerably. We presume construct survival depends in part on the 
techniques used for graft preparation and fixation. To address the conflicting 
survival rates, we (1) determined the survival of roof grafts with a cemented THA; 
(2) evaluated survivorship of roof grafts in patients younger versus older than 50 
years at the time of surgery; (3) determined radiographic failures and complications; 
and (4) compared the clinical scores of patients with roof grafts with those of a 
matched control group of patients with nondysplastic hips and if possible identified 
predictors of the scores.
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Our study was associated with a number of limitations. First, 19 of the 74 hips 
did not have radiographs at final review. However, they were included in a worst case 
scenario analysis with a potential radiographic failure rate of 17% at a mean follow-
up of 10 years. Second, only one of us observed the postoperative radiographs at 
final review so we cannot provide any data on interobserver variability. Definite 
radiographic loosening however is expected to cause problems in young patients and 
the radiographic data do not jeopardize the presented data on revisions and survival 
rates. Third, we have not measured the level of activity of our patients, which 
might have influenced the survivorship and clinical scores. Because survivorship of 
THA seems to be related to activity of patients by means of accelerated wear and 
osteolysis42, it would be worthwhile including an activity score in our questionnaire 
in the future. Fourth, the present study has a retrospective design with a limited 
number of patients. However, this is the best evidence available at the moment and 
we have included all patients available with a minimal followup of 5 years or longer 
at our institute. 
All-cause survivorship was 98% at 10 years followup, which is comparable 
to other reported series on patients with DDH that show high survival of bulk 
acetabular grafts with a mean followup of 10 or more years (Table 4). Although 
high failure rates have been reported using bulk grafts with cemented THA34, 39, 45, 
we would like to confirm previous studies1, 4, 12, 18, 27, 28, 33, 50, 51 that high survival rates 
can be obtained using solid grafts with cemented THA. Comparison of grafting 
(32 cases) versus nongrafting (48 cases) of severe acetabular defects in a series of 64 
patients showed higher survival rates of grafted cases18. Solid grafts to reconstruct 
acetabular defects of more than 20% is the philosophy at our institute. Bulk grafts 
in combination with uncemented THA remain controversial. Several early reports 
2, 24, 29, 38, 43, 46, 49 show high survival rates but series with longer followup are scarce 23, 
31, 44. Shetty et al.44 reported in a series of 15 cases that no revisions were necessary at 
10 years of followup but observed resorption of the graft in five of 15 cases, a finding 
that was not present in our series. 
Survival of THA in young patients is lower than survival of THA in older 
patients, presumably because of their higher demands on their prosthesis32, 42, 
although we acknowledge the fact that age by itself should be interpreted cautiously 
in young patients because activity levels may differ between patients, also in time17. 
Unfortunately, we have not assessed activity in the present study so we made 
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subgroups of patients younger and older than 50 years old at the time of surgery. We 
could not detect a difference in survival between these two groups, possibly because 
of the small number of revisions in the present series. Longer followup is needed to 
confirm this hypothesis.
Table 4:
Overview of literature† of acetabular bulk grafts in patients with DDH 
with a mean follow-up of 10 years or longer
Author Number 
of hips
Number 
of 
patients
Mean age  
in years 
(range) 
Type of 
fixation
Mean 
followup 
in years 
(range) 
Survivorship 
revision for 
aseptic loosening/
radiographic
loosening
Akiyama et al. [1] 147 119 56 (38–76) Cemented 11.8 (6–15) 96%/91% at 15 years 
Bobak et al. [4] 45 41 46 (25–73) Cemented 11 (10–15) 100%/88% at 11 years 
Hendrich and 
Mehling [23] 
56 47 50.4 Uncemented 10.2 91.6%/88.9% at 11 
years 
Iida et al. [27] 133 112 53 (33–72) Cemented 12.3 (8–24) 96%/83% at 15 years 
Inao and Matsuno 
[28] 
20 18 48 (20–66) Cemented 12.9 
(10–18) 
100%/85% at 12.9 
years 
De Jong et al.[12] 116 102 64.4 (35–84) Cemented 17.6 
(11–26) 
85%/82% at 15 years* 
Lee et al. [34]‡ 102 95 51 (21–78) Cemented 10.2 (4–18) 65%/62% at 12 years 
Kim and 
Kadowaki [31] 
83 70 57 (33–72) Uncemented 11 (9–14) 94%/97% at 10 years* 
Kobayashi et 
al. [33] 
37 30 57 (48–73) Cemented 19 (10–26) 100%/100% at 19 
years 
Mulroy and Harris 
[39] 
46 37 46.5 (14–69) Cemented 11.8 
(10–16) 
80%/54% at 11.8 
years 
Rodriguez et 
al. [41] 
29 23 49 (20–78) Cemented 11 (7–17) 80% at 15 years/60% 
at 15 years
Shetty et al. [44] 15 15 59 (20–85) Uncemented 10 (8–11) 100%/100% at 10 
years 
Shinar and Harris 
[45] 
81 73 45.2 (16–69) Cemented 16.5 
(14–21) 
65%/40% at 16.5 
years* 
Stringa et al. [51] 21 19 51 (22–68) Cemented 10 (5–14) 100%/85% at 10 years
Current study 74 48 45 (19–71) Cemented 10.3 (5–16) 98%/98% at 10 years 
Abbrevations: *Survivorship with revision for any reason as the end point; ‡series of patients with different 
diagnosis; 57% had DDH; survival shown of primary THA in patients with DDH patients; †literature reported until 
September 2011; DDH = developmental dysplasia of the hip.
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Radiographic results of the present series compare favorably with reported 
series (Table 4) and we have included a worst case scenario showing 83% survival 
at 10 years assuming that all hips without a recent radiograph had failed. We did 
not observe extensive acetabular osteolysis with cemented socket fixation, which 
is a well-reported observation around uncemented cups6, 15. The use of an all-
polyethylene cup enables the use of thicker polyethylene in these patients who all 
have small acetabula; this may further reduce the incidence of polyethylene wear. 
Wear-induced osteolysis increases the risk of failure and compromises bone stock for 
future revision surgery. 
The improvement in patient-reported scores in the study group of patients 
with dysplastic hips and roof graft reconstruction compares favorably with our 
control group of patients with primary cemented THA with a difference in Oxford 
scores. An explanation might be that the amount of improvement is higher in 
reconstructed patients. Unfortunately, preoperative scores are not available because 
of the retrospective design of this study. 
The treatment protocol at the Royal Infirmary in Edinburgh for dysplastic hips 
consists of reconstruction of a deficient acetabular roof of more than 20% using a 
solid graft from the femoral head with a cemented THA. Our data suggest this is 
a biologically reasonable approach, resulting in restoration of bone stock in these 
relatively young patients. Although some authors recommend avoiding structural 
bone graft if possible29, bulk grafts for reconstruction of acetabular defects provide 
additional value for future revisions3. The technique was originally described by 
Wolfgang 53, has been further described by Iida et al.27, and has been performed 
in the same way throughout this study. In the early years, three cancellous screws 
were used for fixation but we believe two screws are sufficient. A femoral shortening 
osteotomy was necessary to restore the center of hip rotation in almost 20% of 
cases. Except for one delayed union of the femoral osteotomy in a patient without 
symptoms in the present series, the results of femoral osteotomy are good as reported 
previously25. We recommend the use of roof grafts with cemented THA in patients 
with DDH.
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Abstract
Background: Total hip arthroplasty in young patients is associated with high failure 
rates and the best option for this demanding group of patients remains controversial. 
 
Questions/purposes: What are the clinical and radiographic results of the uncemented 
Zweymüller total hip prosthesis in patients younger than 50 years?
 
Methods: We report the long-term results of 73 consecutive with a titanium threaded 
cup and a polyethylene insert in 67 patients younger than 50 years at the time 
of surgery (mean 43 years, range 23 - 49). Unbiased researchers followed patients 
clinically and radiographically and Kaplan-meier analysis was used to determine 
survival for different endpoints. 
 
Results: Three hips were revised for septic loosening, three cups for aseptic loosening 
and one hip because of a periprosthetic fracture. Three patients (3 hips) died and 
eight patients (9 hips) were lost to radiographic follow-up without any reoperation. 
The mean follow-up was 17.5 (15 - 21) years and the mean HHS was 90 (52 – 100). 
Survival with endpoint revision for any reason was 89% (95% C.I. 85 - 93) and 
with revision for aseptic loosening 94%  (C.I. 95 – 99) at 17 years, respectively. 
 
Conclusions: Zweymüller total hip arthroplasty with a titanium threaded cup and 
a polyethylene insert showed good long-term results, even in this group of young 
patients.
117
7
U
ncem
ented total hip arthroplasty in patients under 50 years
Introduction 
Total hip arthroplasty (THA) has become a successful procedure in 
orthopaedic surgery, especially in older patients. Treating end-stage osteoarthritis 
of the hip in young patients remains a challenge because a more active life-style 
and high demands on the prosthesis result in worse outcomes, particularly due to 
acetabular component failure1. The evidence for the use of uncemented implants in 
young patients remains a matter of debate2. Good midterm and long-term results 
using the Zweymüller Alloclassic total hip arthroplasty3-8 have been reported, but 
long-term outcomes in young patients are scarce9. The aim of our study was to 
evaluate the clinical and radiological results of the Alloclassic Zweymüller stem in 
combination with the conical self-tapping cement-free (CSF) titanium threaded 
cup and polyethylene insert and a ceramic head in patients younger than 50 years 
of age, with a follow-up of at least 15 years. Patients were reviewed in five hospitals 
in the Netherlands. 
Patients, implants and methods
 
IRB/Ethics committee decided approval was not required for this study. 
Between January 1987 and December 1994, 67 patients aged under 50 years at 
the time of operation received 73 Zweymüller stems in combination with the 
CSF cup and a polyethylene insert. The mean age of the patients was 43 (23 – 
49) years at surgery, and the group comprised 41 men and 26 women. Indications 
varied from primary osteoarthritis to osteonecrosis of the femoral head (Table 1). 
A posterolateral approach was used in all patients without a trochanteric osteotomy. 
Thirty-three Hochgezogen and 40 Stepless stems were inserted, all with the CSF 
cup with a polyethylene insert and a 32 mm ceramic head. Three patients (3 hips) 
died during follow-up. Seven patients (8 hips) refused to return to the hospital 
for clinical review, but their prosthesis was ‘in situ’ at the time of review so their 
data were used for survivorship analysis. Patients were clinically evaluated using 
the Harris Hip Score and a validated Dutch translation of the Oxford Hip Score10. 
Radiographs taken at the latest follow-up were analysed for signs of loosening, wear, 
osteolysis and heterotopic ossification. Loosening of the cup was defined as change 
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of cup angle of > 3 degrees, migration of > 5 mm11 or a complete radiolucent line in 
3 zones as defined by Delee and Charnley12. Femoral implant stability was classified 
as described by Engh et al13. Linear polyethylene wear was measured according to 
Livermore et al14 and osteolysis was defined as a lytic lesion of more than 5 mm 
that was not observed on the direct postoperative radiographs. Heterotopic bone 
formation was graded using the criteria of Brooker et al15. Survivorship analysis was 
calculated for different end-points using the Kaplan-Meier technique, including a 
worst-case scenario for survival of the cup. 
Table 1: 
Preoperative diagnosis
Diagnosis Number of hips (percentage) 
Idiopathic osteoarthritis 45 (62%) 
Rheumatoid arthritis 11 (15%) 
Ankylosing spondylitis 2 (3%) 
Avascular femoral head necrosis 9 (12%) 
Posttraumatic osteoarthritis 6 (8%) 
Results 
Revisions and clinical results 
Seven hips were revised after a mean of 7.1 (2-17) years. Three hips were revised 
(at 2.0, 2.3 and 5.5 years) because of septic loosening, all by two-stage procedures. 
Three hips were revised (at 6.8, 7.0 and 17.1 years) because of aseptic loosening of 
the cup and one stem revision was performed because of a traumatic periprosthetic 
femoral fracture at 9 years. Of the 55 unrevised hips in living patients available for 
clinical review, the mean Harris Hip Score was 91 (52 – 100) at a mean follow-up 
of 17.5 years. The mean Oxford Score was 22 (14 – 43). One patient had a HHS of 
52 and an Oxford Score of 43, mainly because of pain but an obvious cause could 
not be identified. 
Complications 
Besides the revised hips, three hips required re-intervention. Excessive 
heterotopic bone formation (Brooker grade IV) was removed in one hip. One 
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femoral component was revised three days after the index operation because of 
leg length discrepancy and one patient fractured the acetabulum 14 days after the 
operation for which revision of the cup was necessary. In view of the short period 
after the index-operation and unrelated causes to the prosthesis, these events were 
classified as re-interventions and not as failures of the prosthesis. Five hips (6.8%) 
dislocated within 10 weeks of operation and all underwent closed reduction without 
any symptoms in the long term. 
Radiographic analysis 
Of the 66 unrevised hips, follow-up radiographs were complete for 55 hips at 
final review (Fig. 1). Three cups of the unrevised hips were considered loose but no 
additional radiographic failures of the stem were seen. The mean linear wear of the 
unrevised hips in living patients measured 1,2 (SD 0,9) mm after an average follow-
up of 17,5 (SD 5,9) years. Osteolysis was seen at acetabular zone 2 and 3 in three 
cases. Of the hips without any re-operation, heterotopic ossification was seen in 31 
cases, grade 1 in 14 hips, grade II in 7 hips, and grade III in 10 hips. In 24 hips no 
heterotopic ossification occurred. 
Fig.1  
Radiograph of a 
Zweymüller stem (type 
Hochgezogen) with the 
CSF cup in a  
69-year old male more 
than 21 years after the 
index operation with  
no evidence of  
loosening but  
showing polyethylene 
wear. 
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Survivorship analysis 
Cumulative survival with endpoint revision of any of the components for any 
reason was 89% (C.I. 85-93%) (Fig. 2) and for aseptic loosening survival was 94% 
(C.I. 95-99%) at 17 years. With revision of the stem for any reason as the endpoint, 
survival was 94% (CI 92-96%) and for the cup survival was 90% (CI 92-98%) at 17 
years. In a worst-case scenario for the cup where radiological failures were included 
and patients without a recent radiograph were considered failures, survival was 84% 
(CI 81-87%) at 17 years.
Discussion
 
Total hip arthroplasty in young patients remains a challenge, and the preferred 
implant in these active patients is a source of debate2. Meta-analysis of cemented 
and uncemented implants in this context is inconclusive16. Both cemented and 
uncemented stems perform well in young patients with survival rates of more 
than 90% at 10 years17 but higher failures rates are seen on the acetabular side. 
Eskelinen et al.17 found that in patients younger than 55 years of age survival rates 
of uncemented cups were unsatisfactory when liner exchanges were taken into 
account. Modern hip designs were evaluated and only the Harris Galante II cup 
Fig. 2 
Kaplan-Meier survival  
curve with endpoint  
revision of any of the 
components for any 
reason.
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showed a 10-year survival rate of more than 80% at 10 years with revision of the 
cup for any reason as an end-point. A recent report by the Swedish Hip Registry 
demonstrated that after stratification into age groups, the long-term component 
survival with revision for any reason was lower after uncemented THA in all but 
the oldest age group18. A separate analysis of the cup revealed that uncemented 
cups had a significantly higher risk of cup revision due to aseptic loosening than 
cemented cups. This difference even persisted after exclusion of revisions where only 
liner exchange had been performed. In conclusion, a durable fixation of the cup 
and wear-related problems are the primarily issues to be improved in uncemented 
total hip arthroplasty, especially in young patients. In our study, the CSF cup also 
performed worse compared to the stem but survival of the cup with endpoint 
revision for any reason was still 90% at 17 years. This compares favourably to other 
reported survival rates of uncemented cups in young patients. Reigstad et al.9 showed 
a survival rate of 89% of the Endler titanium-backed screw cup (all revisions) at 18 
years but a drawback could be that the liner in this cup is not exchangeable in case 
of polyethylene wear. Aldinger et al.19 showed high survival rates of a gritblasted 
femoral component but low survival rates (38% and 68% at 17 years) of two types 
of smooth-surface threaded cups which they now no longer use. Therefore, porous-
coating of a threaded cup and bony in-growth are essential to achieve stability and 
higher survival rates at longer follow-up. The design of the Zweymüller rectangular 
stem and the conical threaded cup fulfil these criteria and provide primary stability 
to facilitate bony in-growth20. The main limitation of our study is its retrospective, 
unblinded design and the number of patients who could not return for follow-
up. However, we have included a worst-case scenario. The Zweymüller total hip 
arthroplasty with the CSF cup showed good clinical and radiological results with 
high survival rates compared to other reported series, even in this group of patients 
younger than 50 years of age.
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Abstract
Background: Many types of THAs exist to treat young patients with degenerative 
hip disease. Currently, uncemented hip designs are mostly used in young patients 
in the Netherlands.  
Questions/purposes: Are the hip implant-choices for young patients in The Netherlands 
evidence-based?
 
Methods: We examined all reported outcomes of uncemented and cemented total 
hip arthroplasties in patients younger than 50 years of age listed in Medline (1966- 
1 January 2009) and PubMed, and scrutinised reference lists of relevant papers. In 
addition, we evaluated relevant data in the Swedish Hip Arthroplasty register.
 
Results: 109 relevant articles were identified, 37 of which had a mean follow-up 
longer than 10 years. Although uncemented hip implants are widely used in patients 
under 50 years of age, there are only 2 reports that fulfil the criteria published by the 
National Institute for Clinical Excellence (NICE) in the United Kingdom (follow-
up of >10yrs and survival of ≥90%). 
 
Conclusions: Current trends relating to implant selection remain unsupported by 
survival data, and additional information about the long-term results of newer 
implants is essential. As matters stands, the most reliable results relate to cemented 
implants.
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Introduction 
Total hip arthroplasty (THA) is one of the most successful and cost effective 
interventions of modern medicine1, 2. The era of cemented total hip arthroplasty 
was initiated by Sir John Charnley (1961), but it soon became apparent that the 
outcome of the procedure in younger patients was less favorable3-5. As a result, 
uncemented hip implants were developed for these patients, based on anticipated 
osseointegration of bone into a rough or coated outer surface (sometimes covered 
with hydroxyapatite). Such implants have been available for more than 25 years. 
In many countries uncemented total hip implants dominate the market and are 
frequently used in younger patients. In some countries, cemented implants are 
hardly ever used in patients under 50 years of age. Over 90% of all THAs inserted in 
North America are uncemented, while >90% of all THAs implanted in Scandinavia 
and some countries in Europe are cemented, creating the so-called ‘north Atlantic 
divide’. The objective of THA in young patients is long-term implant survivorship6. 
Most short-term and intermediate-term studies are not helpful in differentiating 
failing components from successful ones6. The discussion relating to uncemented 
and cemented total hip arthroplasties in young patients has continued7, 8, prompting 
us to perform a literature review of all available studies about THA in patients under 
the age of 50. Long-term outcome of THA is generally defined as the outcome 10 
years or more after surgery. For this review we adopted the recommendations of the 
NICE 2003 report of a survival rate of 90 percent or more of the whole implant 
at 10 years9. We studied the literature relating to THA in patients under the age of 
50 which allowed examination using these criteria. We also performed a statistical 
analysis of the results of uncemented and cemented outcomes in studies with a 
mean follow-up longer than 10 years on average. 
Methods 
A systemic literature review was performed searching Medline and PubMed 
(1966 - 1 January 2009) for articles related THA in patients less than 50 years. Two 
groups of key words were used in combination with each other (group 1: less, 50, 
fifty, 45, 40, forty, 35, 30, thirty, 25, 20, twenty, or young* and group 2: arthroplast*, 
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hip, acetabul*, femor*, component*, cement*, uncement*, or noncement*). 
Asterisks were used to expand the search field of a key word. We also searched the 
reference list of selected papers for relevant additional studies. Inclusion criteria were 
as follows: primary total hip arthroplasty, age at index surgery <50, and minimum 
mean follow-up of 10 years. An additional inclusion criterion was used incorporating 
the NICE criteria of survival of ≥90% with an endpoint of revision for any reason 
of either component for the descriptive review. We also included combinations of 
fixation techniques (multiple techniques). In ‘hybrid’ THA uncemented cups are 
combined with cemented stems, and in ‘reverse hybrid’ THA cemented cups are 
combined with uncemented stems. Exclusion criteria were studies with only bipolar 
or resurfacing arthroplasty, THA for tumours, reports of only one component, and 
studies with incomplete data (for example studies only reporting aseptic survival). 
Revision was defined as the removal or replacement of one or more components of 
the arthroplasty. Liner exchanges in uncemented implants were also considered as 
a revision. The retrieved articles were first scanned for relevance and subject. The 
resulting articles were evaluated in relation to the number of patients and THAs, age 
of the population (mean and range), duration of follow-up, type of implant(s) used, 
surgical techniques used (cemented, uncemented, hybrid or multiple techniques) 
and survival outcome. When survival was only depicted graphically, the 10 year 
survival was estimated from the graph. Authors of articles with acceptable long-
term results (>10 yrs) were contacted if the results at 10 years were not reported 
or no survival graph was present, to obtain the 10 years results of these studies. 
The articles were reviewed by two independent reviewers and both extracted data 
from the articles. For statistical analysis, update studies of previous reports were 
excluded from the statistical analysis in order to prevent inclusion of the same results 
more than once, and only studies with an endpoint of revision for any reason were 
included. A scatter plot was used to outline any publication bias and we used a 
weighted regression analysis for testing significant differences in survival between the 
different fixation types, correcting for (if reported) population size, 95% confidence 
intervals, and number of patients remaining after 10 years. 
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Results 
Papers 
The search query resulted in 2999 ‘hits’ and after evaluation and selection 
109 studies reported THA survival in patients under the age of 50. Of these 109 
studies, 37 studies had a mean survival of >10 years, and 15 articles complied 
with the criteria of a reported survival of ≥90% after a mean follow-up of >10 
years. Figure 1 summarises the articles included in the search. Table 1 summarises 
details of articles on THA in patients under the age of 50, with a minimum 
average follow-up of 10 years, and with a survival of ≥90% with endpoint 
revision for any reason of either component. Of the 15 remaining studies, 1 
was about uncemented implants, 13 were about cemented THA and 1 reported 
the use of multiple techniques (uncemented and hybrid implant fixation). No 
prospective comparable studies were available which fulfilled the search criteria. 
 
Fig. 1:
Results of the search query and selection after the use of the search criteria.
Search query:
2999 hits
Cemented Uncemented Hybrid
Multiple
TechniquesSearch Criteria
Age <50 years:
N=109
Follow-up <10 years:
N=37
Survival >90%:
N=15
53
26
13
36
6
1
3
1
0
17
4
1
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Table 1:
Overview of the studies that fulfill the adapted NICE criteria after a mean follow-up  
of 10 years
Study Ref. No. 
Hips
No. 
Patients
Mean age
(range)
Follow-up
(range)
Type of 
Implant
Survival THP endpoint 
any reason (95% C.I.)
Uncemented
McCullough 
et al (2006) 
10 42 25 21 (11-35) 11.2 (8-13) HA CAD-
CAM 
90% (78-97%) 
Cemented 
Boeree et al. 
(1993) 
11 46 34 38 (24-49) 12 (10-18) Charnley & 
Howse 
90% (n/a) 
Callaghan et 
al. (1998)* 
15 93 69 42 (18-49) 20 (5-25) Charnley 90% (84-96%) 
Emery et al. 
(1997) 
12 57 46 41 (17-49) 13 (0.3-21) Stanmore 90.8% (n/a) 
Joshi et al. 
(1993) 
13 218 141 32 (16-40) 16 (10-24) Charnley 93% (SE 1.8) 
Keener et al. 
(2003)* 
14 93 69 42 (18-49) 25.8 (25-
n/a)† 
Charnley 90% (84-96%) 
Kerboull et 
al. (2004) 
17 287 222 40.1 (15-
50) 
14.5 (0.5-25) Charnley-
Kerboull 
95.9% (92.8-98.4%) 
Kobayashi et 
al. (1997) 
18 66 n/a 37 (18-50) 14 (10-20)† Charnley 98.2% (n/a) 
Lewthwaite 
et al. (2008) 
19 123 101 42 (n/a-50) 12.5 (10-17) Exeter 94.4% (89-98%) 
Sochart et al. 
(1997) 
21 226 161 31.7 (17-
39) 
19.7 (2-30) Charnley 93% (90-96%) 
Sochart et al. 
(1997) 
20 43 24 28 (19-39) 22.7 (0.1-
30.3) 
Charnley 91% (82-100%) 
Sullivan et al. 
(1994)* 
16 89 67 42 (18-49) 18 (16-22) Charnley 90% (84-96%) 
Wroblewski 
et al. (2004) 
22 190 173 41 (18-50) 15.6 (1-31) Charnley 94.9% (89.7-100%) 
Wroblweski 
et al. (2007) 
23 292 195 38 (12-50) 15 (1-36) Charnley 93% (90-96%) 
Hybrid 
None 
Multiple 
techniques 
Singh et al 
(2004) 
24 38 33 42 (22-49) 10 (5.3-14.2) HA JRI 
Furlong 
Hybrid: 100% (78-100%) 
Uncemented: 96%  
(75-100%)
Abbreviations: *: Updates of same cohort; †: deceased excluded. HA: Hydroxyapatite-coated. 
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Uncemented total hip implants 
Only one study about uncemented implants fulfilled the NICE criteria, the 
study by McCullough et al.10, in which a survival of 90% at 10 years was reported, 
following the use of a custom-made hydroxyapatite-coated femoral implant. They 
studied 42 hips in 25 patients with inflammatory polyarthropathy. The mean age 
in this study was 21 (11-35) years. Patients aged less than 16 years had the highest 
risk of failure of the femoral component (28.5% at 10 years). However, in normal 
standard orthopaedic practise it is very unusual to implant custom made prostheses. 
Cemented total hip implants 
Boeree and Bannister11 reported the outcome of 46 cemented THAs in 34 
patients under 50 years. The average age was 38 (24-49) years. Most had rheumatoid 
arthritis (12 hips) or congenital hip dysplasia (11 hips). The survival rate was 90% 
at 10 years, marginally meeting the NICE criterion. Emery et al.12 reported on 57 
THAs in 46 patients under the age of 50 years. The average age was 41 (17 to 49) 
years and the average follow-up was 13 years. Most frequent diagnoses were primary 
osteoarthritis (23 hips), rheumatoid arthritis (12 hips) and congenital hip dysplasia 
(10 hips). The survival of the implant was 90% at 10 years. After 10 years there was 
a large decline in survival with a survival of 68% at 15 years. Joshi et al.13 reported 
on the long-term outcome of 218 cemented THAs in 141 patients under 40 years 
(mean 32, range 16-40 years). Indications were rheumatoid arthritis (74 hips), 
congenital hip dysplasia (47 hips), ankylosing spondylitis (41 hips) and osteoarthritis 
(56 hips). The survival of the implant with an endpoint being revision of any part 
of the prostheses was 93% at 10 years and 75% at 20 years. Keener et al.14 reported 
the 25 years results after 93 cemented THAs in 69 patients under 50. The average 
age was 42 (18-49) years. Diagnoses varied, but most had congenital hip dysplasia 
(28 hips), primary osteoarthritis (11 hips) and posttraumatic arthropathy (11 hips). 
However, the survival rate at 10 years was not reported, but the reported survival 
curves indicate that the 10 year survival fulfils the 90% criterion. The survival rate 
with an endpoint of revision for any reason was reported as 69% at 25 years and 
60% at 30 years. The evaluated cohort in the study of Keener et al was an update of 
the same cohort first reported by Callaghan et al .15 and Sullivan et al.16, all showing 
the same results after 10 years. Kerboull et al. reported the results of 287 Charnley-
Kerboull implants17. The 222 patients had a mean age of 40 (15-50) years and were 
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followed up for up to 25 years. There was no significant differences in implant 
survival in patients under and above the age of 40. The only predictive factor for 
loosening was a wear rate higher than 0.1 mm per year. Kobayashi et al.18 reported 
the outcome of 66 cemented THAs in patients under 50 years. The average age was 
37 (18-50) years. Most frequent diagnoses were rheumatoid arthritis (18 hips) and 
osteoarthritis. At 10 years cup survival was 98%. Stem survival was not reported at 
10 years but at 16 years was 96%. Even if cup and stems revisions were performed 
separately, (and including one revision for septic loosening excluded by the authors), 
the 90% survival at 10 years criterion was fulfilled. Revisions rates were highest in 
the patients with rheumatoid arthritis. Lewthwaite et al.19 reported the results of 
the cemented Exeter THA in patients under the age of 50. They observed implant 
survival of 94.4% after 10 years, after evaluation of 123 hips in 101 patients. A 
significant proportion (44 patients) of their original population was excluded from 
analysis. By 10 years, 6 hips had been revised and 1 periprosthetic fracture occurred 
but the original components retained. Sochart and Porter20 reported the long-term 
results of 43 THAs in 24 young patients (mean age 28 years) who had ankylosing 
spondylitis, 18 to 30 years after surgery. Implant survivorship was 91% at 10 years, 
73% at 20 years and 70% at 30 years. A further report by Sochart and Porter observed 
the long-term results of 226 cemented THAs in 161 patients in patients under 4021. 
The average age was 32 (17-39) years. Indications were congenital dislocation of 
the hip (60 hips), primary osteoarthritis (66 hips) and rheumatoid arthritis (100 
hips). Implant survivorship was 91% at 10 years, 67% at 20 years and 65% at 25 
years. Primary osteoarthritis was associated with the worst results (86% survival at 
10 years). Wroblewski, Siney and Fleming provided two reports, probably based on 
one population under 50, with survivorship fulfilling the NICE criteria. A subgroup 
of 190 hips in 173 patients with low-wear rates achieved implant survival of 95% at 
10 years22. The second paper reported 292 hips in 195 patients with inflammatory 
arthritis and survival of 93% after 10 years23. They concluded that wear and aseptic 
cup loosening were the main long-term problems. 
Hybrid total hip implants 
There were no studies available of ‘hybrid’ implanting techniques which 
fulfilled our study criteria. 
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Multiple implantation techniques 
Singh et al.24 reported excellent implant survival in 38 hips in 33 patients. 
All patients had an uncemented JRI Furlong hydroxyapatite coated stem, the first 
14 hips received a cemented cup and the remaining 24 a screw-fit hydroxyapatite 
coated cup. The mean age was 42 (22-49) years with an average follow-up of 10 
(5.3-14.2) years. The reversed hybrid arthroplasties showed implant survival of 
100% at 10 years and uncemented arthroplasties 96% at 10 years. 
Scandinavian Hip Registers 
The last available annual report of the Swedish National Hip Arthroplasty 
Register is from 200725, including survival of the cohorts of all cemented and 
uncemented THAs inserted in patients younger than 50 years in Sweden in 
the period 1992-2007. At 10 years, both cemented and uncemented implants 
demonstrated survivorship under 90%. At 16 years implant survival of cemented 
THAs in males was 74.7% (95%C.I. 67.4-82.1) and 72.5% (95%C.I. 66.4-78.7) 
in females. At the same time point (16 years) implant survival of uncemented THAs 
was 57.4% (95%C.I. 47.5-67.4) in males and 54.3% (95%C.I. 46.8-61.7) in 
females. Unfortunately, no detailed reports on individual implants were available to 
allow assessment of newer uncemented implants.
 
Statistical analysis 
For statistical analysis, a scatter plot of all studies with a follow-up longer than 
10 years with any survival rate was created (n=37) (Fig. 2). The log of the number of 
patients included in the studies was related to the overall outcome (survival) of the 
THA with an endpoint of revision for any reason of either component. 37 studies 
were included and the different fixation types were noted separately. No specific 
outliers were observed and therefore no publication bias was observed. Articles 
which were updates of previous work were not included in this statistical analysis (2 
studies of cemented implants), and 1 study about cemented implants did not report 
survival with the endpoint of revision for any reason and was excluded. Singh et 
al.24 reported in their study covering multiple techniques the results of uncemented 
implants separately and therefore these results could be included. Ultimately, 23 
studies covering 3759 patients with cemented THA (26 studies minus 2 updates and 
1 incomplete report), and 7 studies of uncemented implants covering 372 patients 
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were included (6 studies plus the results of the uncemented implants of Singh et 
al.). A weighted regression analysis showed significantly better survival of cemented 
THA compared to uncemented THA: 87.7% (95%CI: 83.2-92.2%) versus 75.2% 
(95%CI: 66.3-84.1%) (difference: 13.7% (95%CI:9.7-17.7%); p< 0.001).
Discussion
 
Although uncemented implants are frequently selected for patients under 50 
years of age (in some countries are exclusively used in these patients), there is limited 
clinical evidence that these implants really have improved the outcome for these 
patients at 10 years or more after surgery, based on the results reported. A confusing 
factor in assessing studies of uncemented hips is the fact that revision of a failed insert 
of an uncemented acetabular metal shell is not always reported as a revision. Not all 
studies report this exchange as a revision, which can make a dramatic difference in 
the reported outcome. Cup survival with an endpoint of revision of the metal shell at 
14 years is 70%, but including liner exchange it is 54% (Capello et al.26). We believe 
that liner exchanges should be considered revisions. Further confusion is created 
Fig. 2 
Scatter plot of the studies with a follow-up of more than 10 
years. 
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by the fact that many studies report only cup or only stem survival. In practice, 
patients will benefit only if both components survive. A confounding factor in our 
conclusions and statistical analysis could be that the underlying diagnoses of the 
hip disease and the activity levels of patients are not comparable between cemented 
and uncemented series. There was considerable heterogeneity, and patients with 
primary osteoarthritis appeared to have poorer outcomes than those with rheumatic 
diseases or other underlying hip diseases. However, it should be remembered that in 
some countries uncemented implants are used for all young patients, and therefore 
it seems unlikely that this factor biased our conclusion. Unfortunately, long-term 
results of the newer generation uncemented implants are not yet published. We 
identified 9 studies of uncemented THA that had a minimum mean follow-up of 
10 years10, 26-33. Only one met the NICE criteria, but this related to custom made 
prosthesis in low demand patients. Two important studies that did not fulfill the 
inclusion criteria deserve discussion. Kim et al. reported a series of 118 hips in 80 
patients with a mean follow-up of 9.8 years34. This study demonstrated survival 
of an uncemented hip of 99%. These results are likely to fulfill the NICE criteria 
in the future. However, there was a very high rate of polyethylene wear. The other 
study which merits attention is that of McAuley et al.6. The average follow-up was 
only 6.9 years. In the study they report a calculated survival rate of 89% at 10 years, 
approaching the NICE criteria. This study reported 561 uncemented THAs in 488 
young patients. The mean age of was 40 years (16-50 years). The main indications 
were osteoarthritis (249 hips) and osteonecrosis (111 hips). The survival rate at 15 
years in their cohort was 60% with the endpoint being revision for any reason. A 
survival rate of >90% after a mean of 10 years is not a guarantee of good very long-
term survival. For example, Emery et al.12 demonstrated implant survivorship of 
90% at 10 years, just fulfilling the criteria. After 15 years survivorship was 68%, a 
decrease of 22% in 5 years. Survival data for cemented THAs naturally has a greater 
retrospective reach, and has been reported as 60% after 30 years (Keener et al.14), 
75% after 20 years (Joshi et al.13), again 75% after 20 years (Devitt et al (35)) and 
73% at 20 years (Sochart and Porter20, 21). The longest duration for uncemented 
reported survivorship (endpoint revision for any reason) at 15 years is 60% (McAuley 
et al.6). Although uncemented implants have been used for over 25 years, most first 
generation implants were abandoned. Modern uncemented implants incorporate 
improvements in design, but they have yet to confirm their efficacy by long-term 
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follow-up. Some 2nd and 3rd generation uncemented implants have demonstrated 
good short-term results, such as the series reported by Delaunay et al.36. After a 
mean follow-up of 7.3 years they reported implant survival of 100%. Kennedy et 
al.37, observed implant survival of 94% after 5 years, with a mean follow-up of 7.5 
years. The Swedish hip register confirms the poorer outcome of all arthroplasties in 
patients under 50 years of age. The survivorship of uncemented implants is inferior 
to cemented implants, but these observations of large cohorts of patients may be 
biased because older implants with inferior outcomes may overshadow better results 
of some newer prostheses. Unfortunately, no detailed information about individual 
implants used in young patients is available in the Swedish register. In recent years, 
a variety of alternative bearing surfaces have become available. Highly cross-linked 
polyethylene, ceramic and metal bearings may influence implant survivorship in 
future. Nevertheless, the outcome of both cemented and uncemented THA in 
young patients continues to be disappointing. Most literature which fulfils the 
criteria of survivorship of ≥90% after 10 years is based on cemented implants. The 
long-term results of newer uncemented implants are necessary to support their use 
in young patients.
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Chapter 9
Cost-effectiveness of cemented 
versus uncemented total hip 
arthroplasty  
A cemented cup with acetabular impaction 
bone grafting is a very cost-effective treatment 
option in young patients 
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Abstract
Background: Acetabular deficiencies in young patients in need for THA can be 
restored in several ways during total hip arthroplasty. 
 
Questions/purposes: Impaction bone grafting of acetabular defects is a biological 
approach, but is it cost-effective on the long term? 
 
Methods: We designed a decision model for a cost-utility analysis of a cemented 
cup with acetabular impaction bone grafting versus an uncemented cup, in terms 
of cost per quality-adjusted life year (QALY) for the young adult with acetabular 
bone deficiency, in need for a total hip arthroplasty. Outcome probabilities and 
effectiveness were derived from the Radboud University Nijmegen Medical Centre 
and the Norwegian Hip Register. Multiple sensitivity analyses were used to assess 
the contribution of the included variables in the model’s outcome. 
 
Results: Cemented cups with impaction bone grafting were more cost-effective 
compared to the uncemented option in terms of costs per QALY. A scenario 
suggesting equal primary survival rates of both cemented and uncemented cups still 
showed an effect gain of the cemented cup, but at higher costs. 
Conclusions: Based on this model, the first choice of treatment of the acetabular 
bone deficient osteoarthritic hip in a young patient is reconstruction with impaction 
bone grafting and a cemented cup.
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Background and purpose
Cost-effectiveness of orthopaedic procedures is of growing importance. Total 
hip arthroplasty (THA) has proven to be a very cost-effective procedure 1,2. However, 
young patients often outlive their implant. Particularly in these young patients, we 
need techniques and hip prostheses with a favourable long-term outcome3,4 as they 
are at great risk for revision. The outcome of both primary and revision surgery plays 
an important role in the cost-effectiveness of treatment of these patients. Clearly, the 
cup is the weakest link of THA5,6. Young patients with hip osteoarthritis often have 
acetabular bone stock defects at their primary surgery due to underlying diseases, 
which may hamper the longevity of the cup even more. Uncemented hip designs 
have gained worldwide popularity and are the first choice of treatment in young 
patients at the moment, also in case of acetabular defects. IBG in combination with 
a cemented cup is another treatment option for these young patients7 in which the 
deficient acetabular bone stock is restored. Excellent long-term survival data of this 
technique are reported8-13 including long-term data of revision cases14-16. However, 
this biological approach of reconstructing the osteoarthritic hip is time-consuming 
in theatre and is technically more demanding. 
We hypothesize that for young patients, the efforts of acetabular impaction 
bone grafting and a cemented cup are beneficial and justified on the longer term 
compared to the use of uncemented cup designs without grafting. 
Patients and methods
Economic modelling 
We have designed a decision model (Figure 1) to determine the cost-effectiveness 
of acetabular impaction bone grafting. The model has two modalities for the young 
patient with an acetabular defect and hip osteoarthritis: a cemented cup with 
acetabular impaction bone grafting versus an uncemented cup. We have expressed 
our findings in terms of costs, quality-adjusted life years (QALYs) and incremental 
costs per QALY gained. In the Netherlands, an incremental cost-effectiveness ratio 
(ICER) of less than 80.000 Euros is generally thought to be cost effective by policy 
makers, depending on the burden of the underlying illness17. 
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Fig. 1: Markov Model
Markov model with cycles of one year to estimate QALYs and costs accumulating over a 
time period of fifteen years. 
Successful THA
Postrevision THA
Dead
Postrevision THA
Postrevision THA II
Dead
Postrevision THA II
Postrevision THA III
Dead
Postrevision THA III
Dead
Successful THA
Postrevision THA
Postrevision THA II
Postrevision THA III
Cemented THA + IBG
Dead
Successful THA
Postrevision THA
Dead
Postrevision THA
Postrevision THA II
Dead
Postrevision THA II
Postrevision THA III
Dead
Postrevision THA III
Dead
Successful THA
Postrevision THA
Postrevision THA II
Postrevision THA III
Uncemented THA
Dead
Young patient in need 
for THA
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We have constructed a discrete-state Markov model similar to Spiegelhalter18 
and modified the model to approach the actual situation of a young adult in need 
for a hip replacement. The model has cycles of one year to estimate QALYs and 
costs accumulating over a time period of fifteen years from a hospital perspective, 
discounted at a standard annual rate of three percent for both QALYs and costs. The 
first two treatment branches consist of a cemented cup with impaction bone grafting 
and an uncemented cup. The branching points thereafter represent transition to a 
different health state. Table 1 illustrates a transition matrix underlying the Markov 
model with the key health states (survival, post revision THA, post revision THA 
II, post revision THA III and death) and possible transitions between them during 
each cycle. 
Table 1:  
Markov transition matrix
Markov States Successful THA Post revision 
THA
Post revision 
THA II
Post revision 
THA III
Dead
Successful THA P1 P2 0 0 P3
Post revision THA 0 P4 P5 0 P6
Post revision THA II 0 0 P7 P8 P9
Post revision THA III 0 0 0 P10 P11
Dead 0 0 0 0 P12
P1 to P12 are the transition probabilities calculated based on the model
Overall, through our model we considered a hypothetical population aged 
thirty-seven years or older in need for a hip replacement. We have constructed our 
model in TreeAge pro Suite 2009 (Williamstown, USA) and assessed it by two-
dimensional Monte Carlo simulation. We ran our model for sixteen cycles. We 
calculated the time spent in each health state and by attributing costs and quality of 
life weights to each health state. Total costs and QALYs were established for each of 
the treatment options.
As we were interested in long-term results of both techniques, we have 
incorporated survival of revision surgeries with accompanying costs.
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Uncertainty
Our model took into account the uncertainty around several input parameter 
point estimates, which are listed in Table 2a. We defined a probability distribution 
of such a model input parameter on the basis of its point estimate and standard 
deviation (Gamma distribution) or range (Triangular distribution). We ran our 
model a thousand times, established through estimation of two-dimensional 
Monte Carlo simulation, running random trials and each time randomly selecting 
simultaneously a value for all the stochastic parameters from their respective 
distributions. We calculated mean costs and mean QALYs by averaging across all 
1000 simulations. Furthermore, we did a sensitivity analysis to test the impact of 
the discount rate on the ICER. We also explored a scenario where primary survival 
of uncemented cups is made equal to cemented cups with impaction bone grafting. 
We have made several clinical assumptions and we discuss their possible impact on 
the model or their appropriateness (Table 2b).
Table 2a:  
Input parameters
Input parameter value source
Survival 
Survival rates primary cemented cups with 
impaction bone grafting
See table 3 Busch et al, 2011
Survival first cemented cup revision with 
impaction bone grafting
See table 4 Schreurs et al, 2009
Survival primary uncemented cups See table 3 Norwegian Arthroplasty Register
Survival first uncemented cup revision See table 4 Norwegian Arthroplasty Register
Survival 2th revision/year  
(cemented and uncemented THA)
0.035 Lie et al, 2004 
Costs (in Euro’s)
Material costs cemented treatment See table 5 Cost prices at our hospital
Material costs uncemented treatment See table 5 Obtained from manufacturers of  
3 common uncemented THA’s 
Hospital admission costs/day 575 Dutch Guidelines to Costs in Medical Care
Miscellaneous
Probability of peri-operative death  
(primary operation);
0.0034 Chang et al, 1996
Probability of peri-operative death 
(revision operation)
0.012 Chang et al, 1996
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Table 2b:  
Clinical assumptions and their appropriateness
Assumption Appropriateness 
Survival rates Derived from clinical data; high impact on final outcome, 
as shown in second scenario with equal survival rates.
Costs We have calculated the costs as accurate as possible; 
high impact on final outcome. 
Equal probabilities of infection, death and functional 
class after THA 
We think this is an appropriate assumption with minor 
impact on the outcome.
Survival data
Survival data were gathered of acetabular components in patients younger than 
50 years at the time of primary surgery (Table 3). For the cemented option with 
impaction bone grafting we used data of a previously reported series of 42 acetabular 
reconstructions with a mean age of 37 years at the time of operation9. Survival at 15 
years was 84 % (95 % CI: 72-96 %) with failure for all reasons as the endpoint. For 
the first revision in our model, we have used survival data of 62 acetabular revisions 
in 58 patients with a mean age of 59 years16. Survival at 15 years was 84 % (95 % 
CI: 70-92%) (revision for any reason).
For the uncemented option in the model, data were obtained from the 
Norwegian Arthroplasty Register. Unpublished data of 1289 patients younger than 
50 years with primary hip osteoarthritis, who had received an uncemented cup, 
were analyzed and survival rates were determined (Table 3). The most commonly 
used cups were Trilogy (Zimmer), Tropic (Landos), Duraloc (DePuy) and Reflection 
uncemented (Smith&Nephew). The probability of survival of primary uncemented 
cups was 61% (95% CI: 57-65 %) at 15 years. Survival of the first uncemented cup 
revision was based on 76 patients and was 52% (95 % CI: 35-67 %) at 15 years. As 
survival rates of the cup solely were not available for the second revision, we used the 
same data for both cemented and uncemented revisions as presented by Lie et al19, 
with a survival rate of 59,5 % (95 % CI: 54-65 %) at 10 years. Using power root 
transformation the yearly survival was calculated at 0,035. This was extrapolated to 
obtain a 15-year survival rate for the second revision. We made the assumption that 
after failure of the second revision a third revision was done.
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Table 3:  
Transition rates primary cups 
Cemented cup with acetabular impaction bone 
grafting9
Uncemented cup*
Follow up (years) Probability of survival Follow  up (years) Probability of survival
1 0,999250562 1 0,992262513
2 0,973678425 2 0,992670263
3 0,999150722 3 0,984153261
4 0,998951101 4 0,984019486
5 0,999000999 5 0,977123523
6 0,971897783 6 0,965153817
7 0,998552099 7 0,972251185
8 0,969980231 8 0,948415917
9 0,998452399 9 0,967455365
10 0,998153416 10 0,946107059
11 0,96874379 11 0,957199658
12 0,967623698 12 0,944124718
13 0,997406742 13 0,936720462
14 0,96499208 14 0,943993804
15 0,963727695 15 0,932704963
Abbreviations: * data from Norwegian Arthroplasty Register
Table 4:  
Transition rates revision cups
Cemented cup with acetabular  
impaction bone grafting16
Uncemented cup*
Follow up (years) Probability of survival Follow  up (years) Probability of survival
1 0,993739442 1 0,949016676
2 0,99290076 2 0,942351298
3 0,992161921 3 0,932667282
4 0,991620804 4 0,966830284
5 0,97311066 5 0,866132348
6 0,99000099 6 0,951919181
7 0,989707047 7 0,907243594
8 0,968902401 8 0,939232149
9 0,987703096 9 0,929612731
10 0,963835319 10 0,920987316
11 0,936607051 11 0,985901607
12 0,956665824 12 0,98400984
13 0,954551432 13 0,983477577
14 0,980969198 14 0,980969198
15 0,979527868 15 0,979527868
Abbreviations: * data from Norwegian Arthroplasty Register
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Costs
The costs of an intervention consisted of material costs, costs of operation 
theatre and costs of hospital admission. The material costs are based on a total 
cemented or total uncemented hip arthroplasty. For calculation of the costs of the 
cemented option with acetabular impaction bone grafting, we used data of 79 most 
recently operated patients younger than fifty years in the period 2007 - 2010 at the 
Radboud University Medical Centre Nijmegen (Table 5). 
Table 5:  
Costs (in Euros)
Cemented Uncemented
Material costs primary THA (range) 2086 (1633-2784) 2675 (2112-3355)
Material costs revision THA (range) 3086 4382 (3816-4703)
Theatre costs primary THA 1623 1096
Theatre costs revision THA 1980 1452
Costs of the uncemented option were calculated as if they were performed at 
the Radboud University Medical Centre Nijmegen. To minimize the possibility of 
selection bias regarding costs of uncemented hip arthroplasty, we have averaged the 
registered prices of three very commonly used uncemented total hip designs in the 
Netherlands (Table 5). The mean operation time of cemented hip arthroplasty using 
impaction bone grafting was 123 minutes and we assumed that an uncemented 
hip arthroplasty at our hospital would take 40 minutes less (20 minutes for the 
impaction bone grafting procedure, two times 10 minutes for cementation). This 
assumption was made for both primary and revision operations. The costs of all 
revisions were assumed to be equal.
Mean duration of hospital admission for a cemented hip arthroplasty using 
impaction bone grafting at our institute was 7.2 days. We assumed that the length of 
stay in hospital of patients with an uncemented hip arthroplasty was 5 days, which 
is in concordance with previous data20. Hospital admission time was set at ten days 
for all revision cases. Hospital costs were adapted from the Dutch Guidelines to 
Costs in Medical Care21. We assumed that other costs (indirect costs) like visits to 
outpatients’ clinic, radiological review, laboratory testing and physiotherapy were 
equal for both cemented and uncemented treatments and we have decided not to 
include these in our model. 
150
C
ha
pt
er
 9
9
Utilities
Effectiveness is expressed in QALYs gained. Health-related quality of life 
was determined by a functional class as being used by the American College of 
Rheumatology22. Harris Hip Scores were converted to the functional classes (Table 
6) by the system described by23. No difference between cemented and uncemented 
hip arthroplasty was made for the division of functional classes. The following 
assumptions were made: patients with successful cemented or uncemented implants 
have the same utility or QALY value after the initial postoperative period. The 
mortality rates of patients who survived their hip surgery do not differ from the 
age-adjusted mortality rates of patients without a hip prosthesis implanted, as 
calculated by Statistics Netherlands (CBS) life-tables24. Mortality rates of the life-
tables were used starting at the age of 37,5 and 59,5 for the primary surgery and 
the first revision, respectively. These numbers are based on mean ages at surgery of 
the patients in our cemented series as described above. For the second revision, data 
starting at the age of 74,5 was used. Probability of death was assumed equal for both 
the cemented and the uncemented branch. Regarding determining infection rate25 
after primary and revision arthroplasty, we assumed there was no difference between 
older and younger patients and no difference between cemented and uncemented 
prostheses. 
Table 6:  
Conversion of Harris Hip Scores to Quality of Life (HRQOL)
Outcome Harris Hip Score HRQOL
Excellent 90-100 1
Good 70-89 0.8
Fair 40-69 0.5
Poor <40 0.3
Table 7: 
Incremental cost-effectiveness ratio
Scenario Strategy Costs 
(Euro)
Incremental 
cost (Euro)
Effectiveness
(QALYs)
Incremental 
effectiveness
(QALYs)
ICER
(euro/QALY)
Basecase Cemented 
cup
9500 11.491 0.451 dominates
Uncemented 
cup
10900 1400 11.040 dominated
Equal survival Cemented 
cup
9526 986 11.4906 0.0236 41765
Uncemented 
cup
8540 11.4670
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Results
The point estimate of the incremental cost-effectiveness ratio (ICER) in the 
baseline scenario shows that a cemented cup with impaction bone grafting is more 
cost-effective compared to the uncemented option, in terms of costs per QALY. 
When exploring the scenario in which survival rates of primary uncemented cups 
are made equal to primary cemented cups with IBG, the point estimate of the ICER 
Fig. 2: Incremental cost-effectiveness plane 
Incremental cost-effectiveness plane showing 2 scenario’s. In the baseline scenario (black 
dots), almost 90% of the simulated ICERs lay in the southeast quadrant meaning that 
cemented plus IBG is more cost-effective than the uncemented option. The second scena-
rio with equal survival rates for both options (red dots) still shows an effect gain (higher 
QALY) for cemented plus IBG but at higher costs. 
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becomes €43.500 per QALY gained (Table 7). Through incorporating uncertainty 
in the analyses, the results of both scenarios are presented as an incremental cost-
effectiveness plane (Figure 2) and as a cost-effectiveness acceptability curve (CEAC) 
(Figure 3). In these figures, the uncemented option is always the baseline comparator. 
In the baseline scenario almost 90% of the simulated ICERs lay in the southeast 
quadrant meaning that a cemented cup plus IBG is the most cost-effective option 
(Figure 2). About 10% of the simulations fall in the northeast quadrant, implying a 
trade-off between extra costs and extra effects. So, in 10% of the simulations, a gain 
in QALY’s is still seen using cemented cups with IBG but at higher costs. 
The second scenario suggesting an equal survival of cemented and uncemented 
Fig. 3: Cost-effectiveness acceptability curves 
Cost-effectiveness acceptability curve showing that in the baseline scenario, if ‘policyma-
kers’ are willing to pay a small amount of money for a QALY gained (> €0) they can be 
90% confident that cemented plus IBG is the most cost-effective option. The second scena-
rio shows that the willingness to pay has to be in excess of €80.000 for policymakers to be 
about 80% confident that cemented plus BIG THA is the most cost-effective option.
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cups still shows an effect gain for cemented cups plus IBG, however at an extra cost 
(on average the more expensive solution). So, patients still have a rise in QALY’s on 
the longer term but at higher costs compared to an uncemented cup.
Figure 3 shows in the baseline scenario that if ‘policymakers’ are willing to 
pay a small amount of money for a QALY gained (more than 0 Euro) policymakers 
can be 90% confident that a cemented cup plus IBG is the most cost-effective 
option. The other scenario shows that the willingness to pay has to be more than 
€80.000 for policymakers to be about 80% confident that a cemented cup plus IBG 
is the most cost-effective option. Varying the discount rate in the baseline scenario 
over the range [0,5%] showed that cemented plus IBG option kept dominating the 
uncemented option and was still the most cost-effective option. In the alternative 
scenario, the ICER was sensitive to alterations in the discount rate. A higher discount 
rate resulted in a worse outcome (higher ICER). 
 
 
Discussion
As we were interested in the cost-effectiveness of acetabular impaction grafting 
to treat the bone deficient osteoarthritic hip in a young patient, we have designed 
a model comparing two modalities: a cemented cup with grafting versus an 
uncemented cup. It shows that on the longer term, impaction bone grafting with a 
cemented cup is more cost-effective than the use of an uncemented cup. 
The current trend to use uncemented cups in young patients seems not to be 
supported in literature5. Regarding costs, a recent study on data of the National 
Joint Registry shows that a possible cost saving to the NHS of more than 18 million 
pounds per year can be made if cemented instead of uncemented hip designs were 
used in England and Wales26. Another recent study on cost-effectiveness of different 
types of total hip replacements in older patients concludes that uncemented 
prostheses do not improve health outcomes sufficiently to justify their higher costs27. 
These studies confirm our findings in the way that uncemented hip designs are less 
cost-effective compared to cemented total hip prostheses. 
A strength of our study is that in our model we acknowledge the fact that 
the technique of impaction bone grafting takes additional time and materials and 
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we have included these costs in our model. Other strengths are the fact that we 
have incorporated three revisions with accompanying costs in our model and we 
have used advanced statistical software (TreeAge pro Suite 2009) to construct 
our model. A point of criticism on our study could be that the survival rates of 
primary uncemented cups are worse than the rates of cemented cups. However, 
these numbers were derived from the reliable Norwegian Arthroplasty Register and 
constitute a consecutive series of young patients treated with uncemented cups.
We are aware of the fact that our study is based on hip designs used several 
years ago and that nowadays articulations with highly cross-linked polyethylene are 
more commonly used than conventional polyethylene. However, long term results 
of uncemented cups with highly cross-linked polyethylene are not available. To 
overcome criticism on these limitations in our model, we have explored a scenario 
in which the survival rates of primary uncemented cups are made equal to primary 
cemented cups with impaction bone grafting. In this scenario, an effect gain for 
a cemented cup with impaction bone grafting was still seen, but at higher costs. 
So, even with equal survival rates for both acetabular options, reconstruction of an 
acetabular defect with impaction bone grafting and a cemented cup seems to be 
beneficial on the long term. Another limitation of our study might be that costs of 
treatments and materials may differ between hospitals and that some hospitals may 
have arranged lower prices. We realise this could be a limitation in applying the 
conclusions of this study to other hospitals. Nevertheless, costs were calculated as if 
all prostheses were placed in our hospital without any discounts, to have a baseline 
comparator of the 2 techniques. The advantage of this model is that the input can 
be updated with new information in the future.  
We have optimized the parameters of the uncemented option by not taking into 
account any additional material costs for dealing with bone defects or periprosthetic 
fractures, which are more common using uncemented designs or at uncemented 
revision operations. Also the estimation of length of stay is in favour of uncemented 
hip arthroplasty. Besides this, we have compared survival data of cemented cups in 
difficult cases with acetabular defects to data of uncemented cups without the need 
for acetabular reconstruction, which might be of positive influence on the outcome 
of the uncemented treatment. Even using these data, cemented hip arthroplasty with 
impaction bone grafting is still more cost-effective than the uncemented option in 
young patients. 
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Patients with acetabular defects however could have been less active because 
of an underlying disease, which might have contributed to high survival rates of the 
cemented cases. As we know that higher levels of activity are of negative influence 
on survivorship of THA28, we have measured the polyethylene wear of cemented 
sockets with impaction bone grafting and an average wear rate of 0.08 mm/year 
was seen. These wear rates are in concordance with rates of cemented sockets with 
impaction bone grafting of larger patient populations previously reported11. This 
suggests the study group was equally active and representative for young patients 
in need for a THA. However, higher wear rates using conventional polyethylene 
liners are reported in young patients29 so adding an activity score to clinical scores in 
future will be a more accurate way to measure activity levels.
We realize that the first step in our model is based on a small group of forty-two 
cemented cases with acetabular impaction bone grafting. Recently however, we have 
analysed all patients younger than fifty years (177 hips) that underwent acetabular 
impaction bone grafting in our department and survivorship of the cup at 15 years 
was 80.7 % with revision for any reason as the end point. This strengthens the data 
used in the present model.  In addition, the survival of the cups reconstructed with 
bone impaction grafting in patients under forty years11 also supports the survival 
data used in the present study and these are two independent data sets. We are aware 
of studies that show less favourable results of acetabular impaction bone grafting, 
especially those evaluating reconstruction of larger acetabular defects30. This means 
that the outcome of this model might not be translated to other institutions where 
the technique and circumstances are different. On the other hand, other reports 
show high success of the same technique14,15. Reported survival rates vary, as survival 
rates of other techniques like uncemented series do.  
Especially in young patients, treatments with higher initial costs can be more 
cost-effective when survival rates turn out to be high. We have modelled three 
revisions and recognized the functional outcomes of patients after revision surgery 
are inferior to those of patients after primary hip replacement, as a major concern 
for young patients is the need for revision.  
Cost effectiveness analysis of orthopaedic treatments may be a helpful tool in 
clinical decision-making for hospitals and health policy makers. In the present study, 
cemented cups with acetabular impaction bone grafting were more cost-effective 
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than uncemented cups in terms of costs per QALY for the young patient in need for a 
hip replacement with an acetabular defect. We recommend impaction bone grafting 
with a cemented cup for reconstruction of the bone deficient osteoarthritic hip in a 
young patient, as this seems to be a reliable alternative to the more commonly used 
uncemented cups.
157
9
C
ost-eff
ectiveness of cem
ented versus uncem
ented TH
A
References
1. Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of 
life in total hip and total knee arthroplasty. A qualitative and systematic review of the 
literature. J Bone Joint Surg [Am] 2004;86:963-74.
2. Räsänen P, Paavolainen P, Sintonen H, Koivisto AM, Blom M, Ryynänen OP, Roine RP. 
Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years 
and costs. Acta Orthop 2007;78:108-15.
3. Howard JL, Kremers HM, Loechler YA, Schleck CD, Harmsen WS, Berry DJ, 
Cabanela ME, Hanssen AD, Pagnano MW, Trousdale RT, Lewallen DG. Comparative 
survival of uncemented acetabular components following primary total hip arthroplasty. 
J Bone Joint Surg (Am) 2011;93(17):1597-604.
4. McAuley JP, Szuszczewicz ES, Young A, Engh CA, Sr. Total hip arthroplasty in patients 
50 years and younger. Clin Orthop Relat Res 2004;418:119-25.
5. de Kam DC, Busch VJ, Veth RP, Schreurs BW. Total hip arthroplasties in young patients 
under 50 years: limited evidence for current trends. A descriptive literature review. 
Hip Int. 2011 Sep-Oct;21(5):518-25.
6. Norwegian Arthroplasty Register. Report 2010. Available from http://www.haukeland.
no/nrl/.
7. Slooff TJ, Huiskes R, van Horn J, Lemmens AJ. Bone grafting in total hip replacement 
for acetabular protrusion. Acta Orthop 1984;55:593-96.
8. Busch V, Klarenbeek R, Slooff T, Schreurs BW, Gardeniers J. Cemented hip designs are 
a reasonable option in young patients. Clin Orthop Relat Res 2010;468(12):3214-20.
9. Busch VJ, Gardeniers JW, Verdonschot N, Slooff TJ, Schreurs BW. Acetabular 
reconstruction with impaction bone-grafting and a cemented cup in patients younger 
than fifty years old: a concise follow-up, at twenty to twenty-eight years, of a previous 
report. J Bone Joint Surg (Am) 2011; 93:367-371.
10. Garcia-Cimbrelo E, Cruz-Pardos A, Garcia-Rey E, Ortega-Chamarro J. The survival 
and fate of acetabular reconstruction with impaction grafting for large defects. Clin 
Orthop Relat Res 2010 Dec;468(12):3304-13.
11. de Kam DC, Gardeniers JW, Hendriks JC, Veth RP, Schreurs BW. Cemented polyethylene 
cups in patients younger than 40 years. Clin Orthop Relat Res. 2009;467(7):1753-64.
158
C
ha
pt
er
 9
9
12. Schreurs BW, Slooff TJ, Gardeniers JW, Buma P. Acetabular reconstruction with bone 
impaction grafting and a cemented cup: 20 years’ experience. Clin Orthop Relat Res 
2001 Dec(393):202-15. 
13. Somford MP, Bolder SB, Gardeniers JW, Slooff TJ, Schreurs BW. Favorable survival 
of acetabular reconstruction with bone impaction grafting in dysplastic hips. 
Clin Orthop Relat Res 2008;466(2):359-65. Epub 2008 Jan 10.
14. Comba F, Buttaro M, Pusso R, Piccaluga F. Acetabular revision surgery with impacted 
bone allografts and cemented cups in patients younger than 55 years. Int Orthop 
2009;33(3):611-6. Epub 2008 Feb 9.
15. van Egmond N, De Kam DC, Gardeniers JW, Schreurs BW. Revisions of extensive 
acetabular defects with impaction grafting and a cement cup. Clin Orthop Relat Res 
2011;469(2):562-73. Epub 2010 Oct 8.
16. Schreurs BW, Keurentjes JC, Gardeniers JW, Verdonschot N, Slooff TJ, Veth RP. 
Acetabular revision with impacted morsellised cancellous bone grafting and a cemented 
acetabular component: a 20- to 25-year follow-up. J Bone Joint Surg (Br) 2009; 91:1148-
1153. 
17. Raad voor de Volksgezondheid. Rapport 2006. Available at www.rvz.net. Accessed April 
2012.
18. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Bayesian methods in health 
technology assessment: a review. Health Technol Assess. 2000;4(38):1-130.
19. Lie SA, Havelin LI, Furnes ON, Engesaeter LB, Vollset SE. Failure rates for 
4762 revision total hip arthroplasties in the Norwegian Arthroplasty Register. 
J Bone Joint Surg (Br) 2004; 86:504-509.
20. Husted H, Jensen CM, Solgaard S, Kehlet H. Reduced length of stay following hip 
and knee arthroplasty in Denmark 2000-2009: from research to implementation. 
Arch Orthop Trauma Surg 2012;132(1):101-4.
21. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardization of costs: the Dutch 
manual for costing in economic evaluations. Pharmacoeconomics 2002; 20:443-454 
22. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid 
arthritis. JAMA. 1949;140:659-662.
23. Chang RW, Pellisier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty 
for osteoarthritis of the hip. JAMA. 1996; 275(11):858-65.
159
9
C
ost-eff
ectiveness of cem
ented versus uncem
ented TH
A
24. CBS. Life tables The Netherlands. Available at www.statline.nl, http://statline.cbs.nl/
StatWeb/publication/?DM=SLNL&PA=80386NED&D1=a&D2=0&D3=0&D4=a&
D5=l&HDR=T&STB=G4,G1,G2,G3&VW=T. Accessed April 2012.
25. Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip 
or knee arthroplasty. Instr Course Lect. 1999;48:111-22. 
26. Griffiths EJ, Stevenson D, Porteous MJ. Cost savings of using a cemented total hip 
replacement: an analysis of the National Joint Registry data. J Bone Joint Surg (Br). 
2012;94(8):1032-5.
27. Pennington M, Grieve R, Sekhon JS, Gregg P, Black N, van der Meulen JH. Cemented, 
cementless, and hybrid prostheses for total hip replacement: cost effectiveness analysis. 
BMJ. 2013; 27;346:f1026. 
28. Sochart DH. Relationship of acetabular wear to osteolysis and loosening in total hip 
arthroplasty. Clin Orthop 1999;363:135-150.
29. Nikolaou VS, Edwards MR, Bogoch E, Schemitsch EH, Waddell JP. A prospective 
randomised controlled trial comparing three alternative bearing surfaces in primary 
total hip replacement. J Bone Joint Surg (Br) 2012;94(4):459-65.
30. van Haaren EH, Heyligers IC, Alexander FG, Wuisman PI. High rate of failure of 
impaction grafting in large acetabular defects. J Bone Joint Surg (Br). 2007; 89(3): 296-
300.
160
161
Chapter 10
General discussion, summary  
and conclusion
162
C
ha
pt
er
 1
0
10
General discussion, summary and conclusion
The aim of this thesis is to determine the clinical outcome of THA in young 
patients and how to deal with acetabular defects. In this view, seven questions were 
formulated and these questions will be discussed in the current chapter.
1. How many hip arthroplasties are performed in young patients in the 
Netherlands and what types of hip prosthesis are most commonly used? 
 Chapter 2 presents the distribution of different types of hip designs currently 
used in the Netherlands as reported in the Dutch Arthroplasty register1. In 2012, 
the number of yearly implanted total hip arthroplasties had risen to almost 25,000; 
the distribution of the different types is shown in Table 1 of Chapter 2. Around 5% 
of these patients were younger than 50 years at the time of operation and more than 
75% of all hip replacements in these young patients were uncemented designs (Fig. 
2 in Chapter 2). The use of uncemented hip implants has increased over the years. 
The National Joint Registry of England and Wales reported that of all procedures 
in 2005, 22% were uncemented designs whereas in 2011 this figure had grown 
to 41% in patients of all ages2. In patients younger than 50 years, uncemented 
hip replacements accounted for approximately 64% of females and 60% of males. 
These rates were approximately 16% in females and 12% in males for cemented hip 
designs. The remaining 20% of females and 28% of males in this age group received 
a hybrid construction of resurfacing hip prosthesis. 
The Swedish Hip Arthroplasty Register has also shown a slight increase in 
the use of uncemented implants, but cemented implants are still used for more 
than 80% of cases, regardless of the patient’s age3. Between 1992 and 2011, a shift 
towards the use of uncemented implants and hybrid constructions can be seen in 
the younger age group. 
In Norway, reversed hybrid constructions with a cemented acetabulum and 
an uncemented stem have been performed more frequently in the age group under 
60 years4.
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In general, we conclude that it is an international trend to use uncemented hip 
designs and components in young patients. In Chapter 8 we will discuss whether 
this trend is in agreement with the clinical evidence.
2. What is the outcome of cemented THA in very young patients under 
30 years?
Chapter 3 shows the outcome of 48 patients (69 THAs) younger than 30 
years who had a primary cemented THA performed between 1988 and 2004. 
Acetabular defects have been reconstructed using bone impaction grafting in 29 
hips. Mean age at surgery was 24.6 (16-29) years. No patient was lost to follow-up 
but three patients with four THAs had died. The mean Harris Hip Score (HHS) of 
the 57 surviving THAs in 37 living patients was 89 (55–100) and the mean Oxford 
Hip Questionnaire Score (OHQS) was 19 (12–42) after a minimum follow-up of 
2 years (mean 8.4 years; range 2–18 years). Eight hips were revised after a mean 
follow-up of 8.4 (2-18) years, three for infection and five for aseptic loosening. One 
additional cup was considered a radiographic failure. Survival was 83% with revision 
for any reason and 90% with revision for aseptic loosening as the end point after 10 
years of follow-up. Especially in these very young patients, we need techniques and 
implants with demonstrated long-term success. Reviewing the available literature on 
the outcome of THA in these young patients under 30 years (Table 4 in Chapter 3) 
we have presented an acceptable survival for cemented THA, keeping in mind that 
most failures are seen of the acetabular component. In case of an acetabular defect 
at primary surgery, we recommend acetabular impaction bone grafting to restore 
bone stock.
3. What are the radiographic and clinical results of acetabular 
impaction bone grafting in patients younger than 50 years at long-
term follow-up?
Acetabular defects are often seen in young patients with secondary 
osteoarthritis of the hip and several treatment options exist. In Chapter 4 and 5, we 
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have investigated whether impaction bone grafting in combination with a cemented 
cup to reconstruct acetabular defects is a durable long-term solution. We studied 
42 consecutive acetabular reconstructions in 37 patients younger than 50 years old 
(average 37.2 years) at the time of operation. Twenty-three primary and 19 revision 
operations had been performed. The mean follow-up was 23 (20-28) years and at 
final review one patient was lost to follow-up and 8 patients (10 hips) had died. 
Sixteen cups had been revised, 2 because of septic loosening and 8 because of aseptic 
loosening. Another 4 cups had been revised because of wear and osteolysis and 2 
cups during a stem revision but these were found to be well-fixed. Survival of the 
acetabular reconstructions, with end point revision for any reason, was 73% after 
20 years and 52% after 25 years. With revision for aseptic loosening as the end 
point, survival was 85% after 20 years and 77% after 25; for signs of loosening on 
radiographs, survival was 71% at 20 years and 62% at 25 years. 
At present, uncemented cups are most frequently used in young patients, 
but long-term reports on uncemented cups with bone grafting in young patients 
are lacking in the literature. Good mid-term results have been presented in older 
patients however, Rudelli et al.5 showed a survival rate of 88% of uncemented cups, 
with an end point revision for any reason, after a mean follow-up of 14 years in a 
group of 42 patients (43 THAs) with a mean age at surgery of 56 years. Palm et al. 
6 reported a 9-year survival rate of the cup of 90.5% in a group of 79 patients in 
whom the median age was 67 years. Lachiewicz and Poon7 have reported the results 
of 34 patients in whom morselized bone grafts had been used in combination with 
a Harris-Galante porous-coated cup, and no revision because of loosening had taken 
place after a mean follow-up of 7 years. Although these are good and promising 
mid-term results, longer follow-up is needed to demonstrate the true clinical value 
of these uncemented techniques in young patients. 
Over time, the results of cemented cups with acetabular impaction bone 
grafting have deteriorated. However, this study is one of the few worldwide available 
describing results of THA in young patients with a mean follow-up of 23 years. The 
technique of using impacted morselized bone graft in combination with a cemented 
cup is useful to restore bone stock in young patients whose acetabular defects require 
primary or revision total hip arthroplasty.
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4. What is the outcome of acetabular solid grafting in DDH-patients?
Socket fixation in patients with acetabular dysplasia can be technically 
demanding. Most surgeons try to restore the centre of hip rotation and in most 
cases this is possible with a standard cup. In the more severe cases however, bone 
stock may not be sufficient to support a standard cup, which makes reconstruction 
of the acetabulum necessary. Several options are available, including impaction bone 
grafting which has been discussed in previous chapters. In patients with DDH, 
this technique has been shown to be effective with high long-term survival rates8. 
However, structural or solid grafts can also help to reconstruct the original centre of 
hip rotation and restore normal hip biomechanics. In Chapter 6 we have described 
the results of 62 patients with DDH who had 74 cemented THAs with solid 
acetabular roof grafts. Mean age at surgery was 45 years (range 19-71 years) and the 
mean follow-up was 10.4 years (range 5-16 years). Patients with grafting had higher 
Oxford scores compared with the control group (p=0.04) but other scores were 
equal. A scientific explanation for this difference could not be found. It might be 
that the improvement of the score was higher in grafted patients but unfortunately, 
pre-operative scores were not available. Two hips were revised for aseptic acetabular 
loosening and one hip for polyethylene wear. All grafts were incorporated and no 
additional radiographic loose cups were seen. The survival rate at 10 years of follow-
up for revision for any reason was 98% (95% CI, 92.5%-100.0%). Although high 
failure rates have been presented in literature, these survival rates are comparable to 
other series of patients with DDH receiving acetabular structural grafting that show 
high survival rates (Table 4 in Chapter 6).
The treatment protocol followed in Edinburgh for dysplastic hips is a 
biologically attractive approach, resulting in restoration of bone stock in these 
relatively young patients. Although some authors recommend avoiding structural 
bone grafts if possible9, bulk grafts for reconstruction of acetabular defects have 
shown to provide additional value for future revisions10. We assume that survival 
of the reconstruction is mainly determined by the preparation and fixation of the 
graft. The technique was originally described by Wolfgang11 and further described 
by Iida et al.12 and has been performed the same way throughout this study. A wedge 
of the femoral head is taken and fixed with two cancellous screws with its sclerotic 
convex side towards the defect as an inlay graft (Figure 1 in Chapter 6). In the early 
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years, three cancellous screws were used for fixation of the graft. Later it has been 
shown that two screws are sufficient. In contrast to the reported series we found high 
survivorship of cemented sockets with roof graft in severe acetabular dysplasia with a 
mean follow-up of more than 10 years. Solid grafting in case of an acetabular defect 
can offer a durable solution for patients with DDH. 
 
5. What are the radiographic and clinical results of uncemented THA 
in patients younger than 50 years? 
 
Currently, uncemented THA seems to be the most popular solution for young 
patients with degenerative hip disease. Chapter 7 describes the long-term results 
of 73 consecutive Zweymüller total hip arthroplasties with a titanium threaded 
cup and a polyethylene insert in 67 patients aged under 50 years (mean 43 years, 
range 23-49). Three patients (3 hips) had died and an additional 7 patients (8 hips) 
without any reoperation had no radiographic follow-up. After a mean follow-up 
of 17.5 (range, 15-21) years, 3 hips had been revised for septic loosening, one for 
a periprosthetic fracture and 3 cups for aseptic loosening. The mean HHS was 90 
(52-100) and the mean Oxford Score was 22 (14-43). Survival with an end-point 
of revision for any reason was 89% (95% C.I. 85-93) and of revision for aseptic 
loosening was 94% (C.I. 95-99) at 17 years. In a worst-case scenario for the cup 
where radiological failures were included and patients without a recent radiograph 
were considered failures, the survival rate was 84% (CI 81-87%) at 17 years. 
This compares favourably to other reported survival rates of uncemented cups in 
young patients. Aldinger et al13 showed high survival rates of a grit blasted femoral 
component, but low survival rates (38% and 68% at 17 years) of two types of 
smooth-surface threaded cups which are now no longer in use. It seems that porous-
coating of a threaded cup to promote bony in-growth is essential to achieve stability 
and higher survival rates at longer follow-up. A study of 83 cementless Zweymüller 
Alloclassic stems with a 28 mm metal-on-metal bearing in 73 young, active patients 
showed excellent results14. Only patients with high activity levels were selected for 
review; patients with severe dysplasia and rheumatoid arthritis were excluded. Three 
different acetabular components had been used of which 24 were titanium threaded. 
This series of patients showed a 10-year survival rate of 100% (CI 89.6-100%).
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Eskelinen et al.15 concluded in a nationwide study on THA in patients younger 
than 55 years that survival rates of uncemented cups are unsatisfactorily low when 
liner exchanges are taken into account. We acknowledge the fact that many types 
of uncemented hip designs are available which makes comparison between groups 
of implants difficult. In chapter 7 we describe the results of the Zweymüller total 
hip prosthesis with a titanium threaded cup. In this series of young patients, high 
survival rates were achieved at 17 years of follow-up.
  
6. Are the hip implant-choices for young patients in The Netherlands 
evidence-based?
As many types of THAs exist to treat young patients with degenerative hip 
disease, we have reviewed the available literature on this topic to determine the 
optimal treatment. Results of this review are given in Chapter 8. We examined all 
reported outcomes of uncemented and cemented total hip arthroplasty in patients 
younger than 50 years of age listed in Medline between 1966 - 2009 as well as those 
mentioned in PubMed. In addition we scrutinised the reference lists of relevant 
papers. Data provided by the Swedish Hip Arthroplasty Register3 were evaluated: 
109 relevant articles were identified, 37 of which had a mean follow-up longer than 
10 years. Although uncemented implants are widely used in patients under 50 years 
of age, at the time of this study only 2 reports fulfilled the criteria of survival by 90% 
at the 10-year follow-up, as recommended by the National Institute for Clinical 
Excellence (NICE)16. Cemented implants have been in use for a longer period with 
many studies meeting the survival criteria (Table 1 in Chapter 8). A confusing 
factor in assessing studies of uncemented hips is that revision of a failed insert of an 
uncemented acetabular metal shell has not always been reported as a revision. Thus, 
discrepancies in the reported outcome may exist. A critical note concerning the 
survival rates as reported by National Registries could be that many different types 
of uncemented hip designs have been gathered and the poorer outcome of those 
implants with an inferior survival may obscure the outcome of those designs with a 
better performance. This study concluded that the highest survival rates were related 
to cemented implants; thus the current trend to use uncemented implants has not 
yet been supported by the available literature.
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7. What is the most long-term cost-effective treatment of a young patient 
in need for a THA?
Total hip arthroplasty has proven to be a cost-effective procedure in older 
patients17. In young patients however, clinical outcome is less favourable and costs 
for future revisions should be included when calculating long-term costs. We did 
a cost-effectiveness analysis based on a health care perspective to compare two 
modalities for the young patient with symptomatic osteoarthritis. We have designed 
a decision model for a cost-utility analysis for a cemented cup with acetabular 
impaction bone grafting versus a cementless cup, in terms of cost per quality-
adjusted life year (QALY). The model and its outcomes are presented in Chapter 9. 
Outcome probabilities and effectiveness were derived from the Radboud University 
Medical Centre and the Norwegian Hip Register. Cost data were gathered at the 
Radboud University Medical Centre. Multiple sensitivity analysis was used to assess 
the contribution of the variables included in the model’s outcome. Cemented cups 
with impaction bone grafting dominate the cementless cup option in terms of costs 
per QALY. A scenario suggesting equal primary survival rates of both cemented 
and cementless cups continues to show an effect gain for the cemented cup but at 
a higher cost. 
Remarkably, choices of hip implant differ greatly among hospitals and the 
criteria for these choices are not transparent. Costs of implants determine the cost-
effectiveness to a large degree. A recent study on data from the British National 
Joint Registry shows that a possible cost saving to the NHS of more than 18 million 
pounds per year could be made if cemented instead of cementless hip designs 
were to be used in England and Wales18. Criteria for choices of implants should 
become more transparent as costs play an important role in cost-effectiveness of 
THA. Obviously, initial costs are not the only factor because treatments with higher 
initial costs may be more cost-effective if the survival rates turn out to be higher. 
We have modelled three subsequent revisions and recognized that the functional 
outcomes of patients after revision surgery are inferior to those of patients after 
primary hip replacement. Because the possibility of a revision is a major concern for 
young patients, such costs should be included in the analysis. With this model we 
have provided a helpful tool for clinical decision-making for hospitals and health 
policy makers. In the present study, cemented cups with acetabular impaction bone 
grafting were more cost-effective than cementless cups in terms of costs per QALY 
for the young patient in need for a hip replacement.
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Conclusion
Several options are available for treatment of the young patient with 
degenerative hip disease, but what the most durable solution is remains controversial. 
This thesis shows that good long-term results can be reached with both cemented 
and uncemented hip designs. However, to date the majority of papers with high 
survival rates are based on cemented hip designs. Although the initial outcome of 
our uncemented study is impressive, there is no information about the outcome of 
revisions. The debate whether cemented or uncemented THA would be the most 
durable solution for young patients is also blurred by the fact that results for many 
different hip designs have been gathered and evaluated as a group. Because we had to 
base our conclusion on the available literature we had to conclude that, in general, 
the cemented THA in young patients seems to be the most durable solution for 
young patients. Perhaps time is the only factor to show us otherwise.
Many different types of hip prostheses are currently used for young patients in 
the Netherlands. Recently, the Dutch Orthopaedic Association (NOV) published 
a list of approved hip designs*, classified according to their survival rates known 
from international registries (e.g. the Swedish Hip Arthroplasty Register) and 
available literature. We would like to plea for further standardization in the use 
of only well-performing hip designs in Dutch hospitals, especially in younger 
patients. In addition, concentration of  treatment of “complex hips” by specialised 
surgeons enables them to build expertise in this field and this might optimize Dutch 
orthopaedic care for young patients with degenerative hip disease. 
With regard to acetabular defects in young patients, we can conclude that it 
appears that a biological reconstruction is the most durable option as these patients 
probably face a second or third operation. Reconstruction using grafts, whether 
solid or morselized, is the preferred method, in combination with a cemented cup. 
From an economical point of view, reconstruction using impaction bone grafting 
and a cemented cup is more cost-effective compared to a primary uncemented cup 
as shown in Chapter 9. We hope that the outcome of this thesis will play a role in 
decision making by hospitals and orthopaedic surgeons when choosing the most 
preferable prosthesis in young patients. 
*available online at http://www.orthopeden.org/uploads/ZA/rV/ZArVe9kSozX79e0P8yJW4w/Advies-NOV-bestuur-over-het-
gebruik-van-primaire-heupprothesen-10-feb-2013.pdf
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Summary in Dutch/Nederlandse samenvatting
Het doel van dit proefschrift is om de klinische resultaten van een totale 
heupprothese bij jonge patiënten te beschrijven en om aan te geven hoe men het 
beste om kan gaan met botverlies van de heupkom (acetabulaire defecten). In 
dit kader werden zeven vragen geformuleerd die in dit hoofdstuk zullen worden 
besproken.
1. Hoeveel heupprothesen worden in Nederland geplaatst bij jonge 
patiënten en welke typen worden het meest gebruikt?  
In 2007 is het Landelijk Register Orthopedische Implantaten (LROI) begonnen met 
de registratie van alle heup- en knieprothesen geplaatst in Nederland. Met behulp 
van deze data wordt in hoofdstuk 2 de verdeling beschreven van verschillende 
soorten heupprothesen die momenteel gebruikt worden in Nederland. 
Het aantal primair geplaatste totale heupprothesen is gestegen tot bijna 25.000 in 
2012, waarvan ongeveer 5% werd geplaatst bij patiënten jonger dan 50 jaar. Grofweg 
bestaan er twee verschillende typen heupprothese op basis van fixatie aan het bot: met 
en zonder gebruik van botcement. Meer dan 75% van alle heupprothesen bij deze 
jonge patiënten waren van het ongecementeerde type (afbeelding 2 in hoofdstuk 
2). Het gebruik van ongecementeerde heupimplantaten is toegenomen door de 
jaren heen. Het Nationale implantatenregister van Engeland en Wales meldde 
dat 22% van alle heupimplantaten geplaatst in 2005 van het ongecementeerde 
type waren. In 2011 is dit percentage gegroeid tot 41% bij patiënten van alle 
leeftijden. Bij patiënten jonger dan 50 jaar werd in meer dan 60% van de gevallen 
een ongecementeerde heupprothese geplaatst. In een veel kleiner percentage werd 
gekozen voor een gecementeerde heupprothese, namelijk 16% bij vrouwen en 12% 
bij mannen. In de overige gevallen werd gekozen voor een hybride constructie of een 
resurfacing heupprothese. 
Het Zweedse heupregister toont ook een lichte stijging in het gebruik van 
ongecementeerde implantaten, maar gecementeerde implantaten worden nog 
steeds gebruikt in meer dan 80% van de gevallen (alle leeftijden). In de jongere 
leeftijdsgroep in de periode van 1992 tot 2011 is een verschuiving te zien naar het 
gebruik van ongecementeerde implantaten en hybride constructies.
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In het algemeen kunnen we concluderen dat er een internationale trend 
bestaat om te kiezen voor ongecementeerde heupimplantaten voor jonge patiënten. 
In hoofdstuk 8 bespreken we of deze trend wordt ondersteund door bewijs in de 
beschikbare literatuur.
2. Wat zijn de resultaten van gecementeerde heupprothesen bij 
patiënten onder 30 jaar?
In hoofdstuk 3 worden de resultaten beschreven van 48 patiënten (met 69 heupen) 
jonger dan 30 jaar, bij wie een primaire gecementeerde heupprothese geplaatst werd 
tussen 1988 en 2004. In geval van een acetabulair defect vond opbouw plaats met 
botsnippers volgens de zogenaamde botimpactie techniek. De gemiddelde leeftijd 
bij operatie was 24.6 jaar (16-29 jaar). Alle patiënten werden gevolgd echter 3 
patiënten (met 4 heupprothesen) zijn overleden. Na een gemiddelde follow-up van 
8.4 (2-18) jaar waren 8 heupprothesen gereviseerd; 3 in verband met een infectie 
en 5 in verband met aseptische loslating. Bij 1 patiënt werd radiologisch loslating 
geconstateerd van de cup. De overleving van de heupprothese werd berekend volgens 
de Kaplan-Meier methode en was 83% met revisie voor alle redenen en 90% met 
revisie voor aseptische loslating als eindpunt na 10 jaar. 
Met name zeer jonge patiënten die in aanmerking komen voor een 
heupprothese zijn gebaat bij een nieuwe heupconstructie met bewezen succes op 
lange termijn. In vergelijking met de beschikbare literatuur over heupprothesen bij 
patiënten onder 30 jaar (tabel 4 in hoofdstuk 3) worden goede resultaten gezien van 
de botimpactie techniek in combinatie met een gecementeerde heupprothese. In 
geval van een acetabulair defect raden wij herstel van botverlies aan met gebruik van 
de acetabulaire botimpactie techniek.
 
3. Wat zijn de resultaten op lange termijn van herstel van acetabulaire 
defecten door middel van de botimpactie techniek bij patiënten jonger 
dan 50 jaar?
Bij jonge patiënten met secundaire artrose van de heup worden regelmatig 
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acetabulum defecten gezien waarvoor verschillende behandelingsmogelijkheden 
bestaan. In hoofdstuk 4 en 5 hebben we onderzocht of reconstructie van deze 
defecten met behulp van geïmpacteerde botsnippers in combinatie met een 
gecementeerde cup een duurzame oplossing biedt voor de lange termijn. We hebben 
42 opeenvolgende acetabulum reconstructies onderzocht in 37 patiënten die jonger 
waren dan 50 jaar ten tijde van operatie. Er werden 23 primaire en 19 revisie 
operaties uitgevoerd en de gemiddelde follow-up was 23 (range 20-28) jaar. Bij de 
laatste evaluatie bleek dat 8 patiënten (met 10 heupprothesen) waren overleden en 
dat één patiënt niet meer te traceren was. Er werden 16 acetabulum componenten 
gereviseerd: 2 vanwege septische loslating en 8 vanwege aseptische loslating. In 4 
gevallen werd slijtage van de cup en osteolyse gezien en 2 cups werden gereviseerd 
tijdens een steelrevisie; tijdens de operatie bleek dat de laatstgenoemde cups goed 
gefixeerd waren. De overleving van deze acetabulaire reconstructie was 73% na 20 
jaar en 52% na 25 jaar, met als eindpunt revisie voor alle redenen. Met revisie voor 
aseptische loslating als eindpunt was de overleving 85% na 20 jaar en 77% na 25 
jaar. Met radiologisch falen van de reconstructie als eindpunt bleek de overleving 
71% na 20 jaar en 62% na 25 jaar.
Bij jonge patiënten worden tegenwoordig vaak ongecementeerde cups gebruikt, 
soms in combinatie met botgrafts. Hiervan zijn goede resultaten beschreven op korte 
termijn maar langere follow-up is nodig om te zien of botgrafts met ongecementeerde 
cups een duurzame oplossing zijn voor de jonge patiënt.
Na verloop van tijd is de overleving van gecementeerde cups met acetabulaire 
opbouw met geïmpacteerde botsnippers duidelijk afgenomen. Dit is echter een 
van de weinige, wereldwijd beschikbare studies die resultaten van heupprothesen 
beschrijven bij jonge patiënten op deze lange termijn. Het gebruik van geïmpacteerde 
botsnippers is een nuttige techniek om acetabulaire botdefecten te herstellen bij 
jonge patiënten.
4. Wat zijn de resultaten van solide botgrafts om acetabulaire defecten 
te herstellen bij patiënten met congenitale heupdysplasie?
Fixatie van het acetabulaire component bij patiënten met heupdysplasie kan 
technisch een uitdaging zijn. Door de meeste chirurgen wordt gestreefd naar herstel 
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van het oorspronkelijke centrum van heuprotatie en vaak lukt dat met gebruik 
van een standaard cup. In ernstige gevallen kan het acetabulumdefect te groot zijn 
voor een standaard component en dan is een aanvullende techniek noodzakelijk. 
Er bestaan verschillende opties om deze defecten te herstellen en de techniek met 
geïmpacteerde botsnippers werd reeds in eerdere hoofdstukken besproken. Ook 
bij patiënten met heupdysplasie blijkt deze techniek effectief te zijn op de lange 
termijn. Een andere mogelijkheid om het oorspronkelijke centrum van heuprotatie 
te herstellen is het gebruik van een structurele of solide botgraft. In dat geval 
wordt een botblok gebruikt om het defect op te vullen waarna de cup geplaatst 
kan worden. In hoofdstuk 6 worden de resultaten beschreven van 62 patiënten 
met heupdysplasie bij wie 74 gecementeerde heupprothesen met solide acetabulaire 
grafts werden geplaatst. De gemiddelde leeftijd bij operatie was 45 (19-71) jaar en 
de gemiddelde follow-up was 10,4 (5-16) jaar. De studie vond plaats in Edinburgh 
in Schotland.
Twee heupprothesen werden gereviseerd vanwege aseptische loslating van 
de cup en 1 heupprothese voor slijtage van de cup. Alle botgrafts toonden goede 
ingroei en naast de gereviseerde cups werden geen radiologische loslatingen gezien. 
Uit analyse bleek dat patiënten met acetabulaire botgrafts hogere Oxford scores 
hadden vergeleken met de controlegroep (p = 0.04); andere scores waren gelijk. De 
overlevingskans van de constructie met solide grafts was na 10 jaar 98% met revisie 
voor alle redenen als eindpunt. 
Hoewel eerder beschreven resultaten sterk wisselen zijn de door ons aangetoonde 
overlevingskansen vergelijkbaar met andere studies die goede resultaten beschrijven 
van solide botgrafts bij patiënten met heupdysplasie (tabel 4 in hoofdstuk 6).
Het behandelprotocol voor patiënten met heupdysplasie zoals dat gevolgd wordt 
in Edinburgh betreft, evenals de botimpactie techniek, een biologisch aantrekkelijke 
benadering aangezien botdefecten hersteld worden met lichaamseigen materiaal. 
Hoewel sommige auteurs het gebruik van solide botgrafts bij heupdysplasie afraden 
is wel degelijk aangetoond dat herstel met deze botgrafts van nut is voor toekomstige 
ingrepen. De overleving van de reconstructie wordt mede bepaald door de wijze 
van prepareren en aanbrengen van de botgraft. De wijze waarop de techniek in 
Edinburgh wordt toegepast is in grote lijnen hetzelfde gebleven. Er wordt een wig 
uit de heupkop genomen welke ter hoogte van het acetabulaire superolaterale defect 
wordt gefixeerd  met twee schroeven (figuur 1 in hoofdstuk 6). Hierbij sluit de 
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bolle kant van de graft goed aan op het holle defect van het acetabulum. Na goede 
compressie van de graft op het bekken kan na voorbereiding van het acetabulum op 
standaard wijze een gecementeerde cup geplaatst worden.
In tegenstelling tot eerdere studies hebben wij goede resultaten gevonden van 
deze lichaamseigen solide botgrafts in combinatie met gecementeerde heupprothesen. 
Ook na een gemiddelde follow-up van meer dan 10 jaar blijkt deze techniek een 
duurzame oplossing voor patiënten met ernstige heupdysplasie.
5. Wat zijn de radiologische en klinische resultaten van ongecementeerde 
heupprothesen bij patiënten jonger dan 50 jaar? 
 
Tegenwoordig is het gebruik van een ongecementeerde heupprothese de 
meest gebruikte oplossing voor een jonge patiënt met artrose van de heup. 
In hoofdstuk 7 worden de klinische en radiologische resultaten van een 
ongecementeerde heupprothese beschreven. Wij evalueerden 73  Zweymüller 
totale heupprothesen met een titanium schroefcup en een polyethyleen insert in 
67 patiënten. De gemiddelde leeftijd ten tijde van operatie was 43 (23 - 49) jaar. 
Na een follow-up van gemiddeld 17,5 (15 – 21) jaar bleek dat 3 patiënten (met 3 
heupprothesen) waren overleden en dat 7 patiënten (met 8 heupprothesen) niet 
meer te traceren waren. Drie heupprothesen werden gereviseerd ten gevolge van 
septische loslating, 3 cups vanwege aseptische loslating en 1 prothese vanwege 
een periprosthetische fractuur. Van de patiënten beschikbaar voor evaluatie was 
de gemiddelde Harris Hip Score 90 (52-100) en de gemiddelde Oxford score 
22 (14 - 43). De overlevingskans met als eindpunt revisie voor alle redenen was 
89% en met als eindpunt revisie voor aseptische loslating 94% na 17 jaar. Er werd 
een worstcase scenario voor de cup geanalyseerd waarin radiologische loslatingen 
werden opgenomen en waarin patiënten zonder een recente röntgenfoto werden 
beschouwd als gefaalde constructie. In dat scenario was de overleving 84% na 
17 jaar. Voor zover er resultaten gerapporteerd zijn over andere ongecementeerde 
heupprothesen bij jonge patiënten zijn de door ons gevonden overlevingskansen 
gunstig. Een landelijk onderzoek in Finland naar totale heupprothese bij patiënten 
jonger dan 55 jaar laat namelijk zien dat de overlevingskans van ongecementeerde 
cups onbevredigend laag is als revisie vanwege een versleten insert wordt 
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meegenomen. Er zijn veel verschillende typen ongecementeerde cups beschikbaar 
met uiteenlopende resultaten en overlevingskansen en in hoofdstuk 7 hebben we de 
resultaten beschreven van slechts één type. In deze reeks van jonge patiënten werden 
echter hoge overlevingskansen gevonden van de Zweymüller totale heupprothese 
met een titanium schroefcup na 17 jaar. Het blijkt dat een poreus oppervlak van de 
prothese en benige ingroei essentieel zijn voor goede stabiliteit en langdurige fixatie 
van dit model heupprothese. 
6. Zijn de keuzes voor heupimplantaten voor jonge patiënten in 
Nederland gebaseerd op bewijs in de huidige literatuur?
De beschikbare literatuur werd beoordeeld op dit onderwerp om de optimale 
behandeling te bepalen en de resultaten van dit onderzoek zijn weergegeven 
in hoofdstuk 8. Medline en Pubmed werden gebruikt om alle beschikbare 
studies te vinden die resultaten van gecementeerde en ongecementeerde totale 
heupprothesen bij patiënten jonger dan 50 jaar meldden in de periode van 1966 
tot 2009. Referentielijsten van de gevonden artikelen werden bekeken om overige 
relevante  literatuur te vinden. Daarnaast werden gegevens uit het  Zweedse 
heupregister geanalyseerd. Er werden 109 relevante artikelen gevonden waarvan 37 
een gemiddelde follow-up van langer dan 10 jaar meldden. Slechts twee studies 
over ongecementeerde heupprothesen voldoen aan de criteria van overleving van 
minimaal 90% na 10 jaar follow-up, zoals gepubliceerd door het National Institute 
for Clinical Excellence (NICE). Daarentegen voldoen meerdere studies over 
gecementeerde heupimplantaten aan dit criterium (tabel 1 in hoofdstuk 8). 
Vervanging van een versleten insert bij een ongecementeerde heupprothese 
wordt niet altijd gerapporteerd als een revisie en dit kan vergelijking van 
overlevingscijfers tussen studies moeilijk maken. Ook dient men bij interpretatie 
van overlevingscijfers van Nationale registers voorzichtig te zijn aangezien data van 
verschillende typen heupprothesen worden verzameld. Een slechter presterende 
ongecementeerde prothese kan de uitkomst van goed presterende prothesen 
overschaduwen. De conclusie van dit hoofdstuk is dat op dit moment de hoogste 
overlevingskansen worden gezien bij gecementeerde heupimplantaten en dat de 
huidige trend om ongecementeerde implantaten te gebruiken bij jonge patiënten 
niet wordt ondersteund door beschikbare literatuur.
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7. Wat is op lange termijn de meest kosteneffectieve behandeling van 
een jonge patiënt met artrose van de heup?  
Inmiddels is het bewezen dat het plaatsen van een totale heupprothese een 
zeer kosteneffectieve procedure is bij oudere patiënten en dat de kwaliteit van leven 
sterk verbeterd. Bij jonge patiënten zijn de resultaten echter minder gunstig. Juist 
bij deze groep is het raadzaam om kosten van revisieoperaties mee te nemen in 
de berekening van de kosten op de langere termijn. In dit kader hebben wij  een 
kosteneffectiviteitstudie verricht waarbij twee behandelingsstrategieën worden 
vergeleken voor de jonge patiënt met artrose van de heup en een acetabulair defect. 
We hebben een beslissingsmodel ontworpen om de kosteneffectiviteit te bepalen 
van een gecementeerde cup met acetabulaire opbouw versus een ongecementeerde 
cup, in termen van kosten per quality-adjusted life year (QALY). Het model en de 
resultaten hiervan worden gepresenteerd in hoofdstuk 9. Gegevens over kosten en 
overlevingscijfers werden verzameld in het Radboud University Medical Centre en 
het Noorse Heup Register. Meervoudige gevoeligheidsanalyse werd gebruikt om 
de bijdrage van de diverse variabelen op de uitkomst van het model te beoordelen. 
Uit deze analyse blijkt dat het plaatsen van een gecementeerde cup met 
acetabulaire opbouw kosteneffectiever is dan het plaatsen van een ongecementeerde 
cup, in termen van kosten per QALY. Ook in een scenario met gelijke 
overlevingskansen van gecementeerde en ongecementeerde cups wordt nog steeds 
een effect winst van de gecementeerde cup gezien maar tegen hogere kosten. 
Analyse toont dat een groot deel van de uitkomst van het model wordt bepaald 
door kosten van de prothese. Een recente studie in Groot-Brittannië laat zien dat 
een mogelijke kostenbesparing voor de National Health Service (NHS) van meer 
dan £18 miljoen per jaar zou kunnen worden gerealiseerd wanneer gecementeerde 
in plaats van ongecementeerde heupprothesen zouden worden gebruikt in Engeland 
en Wales. 
Opmerkelijk genoeg verschillen de gebruikte heupimplantaten sterk tussen 
de diverse ziekenhuizen in Nederland. Criteria voor de keuze van implantaten 
zouden transparanter moeten worden aangezien de kosten van deze implantaten 
een belangrijke rol spelen in de kosteneffectiviteit. Naast de kosten is uiteraard de 
effectiviteit of overleving van een heupprothese van belang. Bij jonge patiënten is 
vaak een revisieoperatie noodzakelijk op termijn en dit brengt hogere kosten met zich 
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mee. Om hier rekening mee te houden zijn drie revisies met bijbehorende kosten 
opgenomen in het model. Daarnaast is in het model verwerkt dat de tevredenheid 
en functionaliteit van patiënten na een revisieoperatie vaak minder is. In deze studie 
is een gecementeerde cup met acetabulaire opbouw een kosteneffectievere methode 
dan een ongecementeerde cup voor de jonge patiënt met artrose van de heup. Dit 
model zou een nuttig instrument kunnen zijn voor ziekenhuizen, beleidsmakers 
en orthopedisch chirurgen om meer inzicht te krijgen in kosteneffectiviteit van 
implantaten en daarmee hun keuze voor een heupimplantaat te onderbouwen.
Conclusie
Er zijn verschillende opties voor de behandeling van de jonge patiënt met artrose 
van de heup, echter welke de meest duurzame oplossing is blijft controversieel. Dit 
proefschrift toont aan dat goede lange termijn resultaten kunnen worden bereikt 
met zowel gecementeerde als ongecementeerde heupimplantaten. Op basis van 
de huidige literatuur dient men echter te concluderen dat het merendeel van de 
beschikbare studies die een hoge overleving van heupprothesen laten zien zijn 
gebaseerd op gecementeerde heupimplantaten. Hoewel de resultaten van onze studie 
betreffende een type ongecementeerde heupprothese goed zijn hebben we nog geen 
informatie over de resultaten van revisieoperaties van deze prothesen. De discussie of 
gecementeerde of ongecementeerde heupimplantaten de meest duurzame oplossing 
voor jonge patiënten zijn wordt ook vertroebeld doordat resultaten van verschillende 
modellen heupprothesen  worden verzameld en als groep worden geëvalueerd. Als 
we onze keuze baseren op de beschikbare literatuur dan moeten we concluderen dat 
in het algemeen deze in het voordeel is van gecementeerde implantaten bij jonge 
patiënten. Wellicht dat dit beeld na verloop van tijd gaat veranderen.
In Nederland worden momenteel veel verschillende soorten heupprothesen 
gebruikt bij jonge patiënten. Recentelijk heeft de Nederlandse Orthopaedische 
Vereniging een lijst van goedgekeurde ontwerpen gepubliceerd*, gerangschikt 
volgens de overlevingskansen bekend uit de internationale registers en beschikbare 
literatuur. Wij willen pleiten voor een verdere standaardisatie van goed presterende 
heupimplantaten voor Nederlandse ziekenhuizen, in het bijzonder voor jonge 
*beschikbaar online op http://www.orthopeden.org/uploads/ZA/rV/ZArVe9kSozX79e0P8yJW4w/Advies-NOV-bestuur-over-het-
gebruik-van-primaire-heupprothesen-10-feb-2013.pdf
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patiënten. Daarnaast zou concentratie van de behandeling van “complexe 
heupaandoeningen” door gespecialiseerde chirurgen bevorderlijk kunnen zijn om 
meer expertise op dit gebied op te kunnen bouwen. Dit zou de orthopedische zorg 
voor jonge patiënten met artrose van de heup ten goede kunnen komen.
Met betrekking tot acetabulaire defecten bij jonge patiënten gaat de voorkeur 
uit naar biologische reconstructie. Dit lijkt de meest duurzame optie aangezien 
deze patiënten waarschijnlijk geconfronteerd gaan worden met een of meerdere 
revisieoperaties. Reconstructie kan gebeuren met behulp van solide botgrafts en/of 
geïmpacteerde botsnippers, in combinatie met een gecementeerde cup. Op basis van 
kosteneffectiviteit gaat de voorkeur uit naar reconstructie van een acetabulair defect 
door middel van geïmpacteerde botsnippers en een gecementeerde cup. 
We hopen dat de uitkomst van dit proefschrift een rol gaat spelen in de 
besluitvorming van ziekenhuizen, beleidsmakers en orthopedisch chirurgen in het 
kiezen van de meest duurzame behandeling van de jonge patiënt met artrose van de 
heup.
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Vincent Busch werd op 28 november 1976 geboren in Nijmegen. Na het 
behalen van zijn artsexamen in 2002 startte hij met zijn eerste onderzoek 
op de afdeling orthopedie in het Radboud UMC. Dit onderzoek op 
het gebied van heupartrose bij jonge patiënten werd de basis voor zijn 
promotieonderzoek. Sinds 2011 werkt hij als orthopedisch chirurg in de 
Sint Maartenskliniek met als aandachtsgebieden behandeling van heup- en 
knieproblematiek.
The young osteoarthritic hip:  
Clinical outcome of total hip arthroplasty and a cost - effectiveness analysis
Artrose van de heup is een veelvoorkomend probleem en kan mensen behoorlijk beperken in 
hun dagelijkse activiteiten. Ook bij jonge mensen komt heupartrose voor, maar dan is er vaak 
een onderliggende oorzaak zoals reuma of heupdysplasie. Als pijnstilling niet meer helpt kan een 
heupprothese uitkomst bieden. Er zijn echter veel verschillende soorten prothesen en technieken 
beschikbaar. Maar wat is de beste methode op lange termijn? En wat te doen als er sprake is van 
botverlies van de heupkom? Wat is de meest kosteneffectieve methode op lange termijn? 
Dit proefschrift beschrijft de klinische resultaten van diverse technieken om jonge patiënten met 
heupartrose te behandelen en hoe om te gaan met botverlies van de heupkom.  
